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“It is not the strongest of the species that survives, nor the 
most intelligent that survives. It is the one that is the most 
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N. gonorrhoeae is the aetiological agent of the sexually transmitted disease gonorrhoea. 
The bacteria has adapted to be an obligate human pathogen and it possesses the ability to 
survive intracellularly by the expression of virulence factors. Post-translational 
modifications are found in all organisms, and are involved in the regulation of the 
metabolism and gene transcription. In this study we investigated the acetylation by acetyl-
phosphate in N. gonorrhoeae by deleting genes from the phosphotransacetylase-acetate 
kinase pathway to control acetyl-phosphate production. We found that the metabolism 
and virulence was altered by the change of acetyl-phosphate concentration, molecule 
responsible for the acetylation of proteins. Furthermore, we proposed a regulatory 
pathway for the PTA-AK pathway which involved the histone-like family deacetylase 
(HDAC). Finally, the data obtained suggests that the enzyme Pta is essential for the 
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Bacteria have existed on Earth for billions of years leading them to evolve and adapt to 
their environment for the inheritance of their genome. It is considered that approximately 
one billion bacterial species exist worldwide and that the environment is a crucial factor 
for the bacterial diversity (Dykhuizen, 2005). Microorganisms have been able to adapt 
and survive in different niches depending on the nutrients available, however, only a small 
number of bacteria are able to survive within the human body. Due to the existence of 
different microenvironments across the body, bacteria colonise specific niches that 
provide for their metabolic requirements. More than a hundred molecules are accessible 
as carbon sources for commensals and symbiotic bacteria for the generation of energy 
and growth (Brown, Palmer and Whiteley, 2008; Eisenreich et al., 2010). 
Around 1,000 species of bacteria are living in our body contributing to the appropriate 
functioning of our metabolism (Munoz-Elias and McKinney, 2006). However, evolution 
determined that some species of bacteria possess genes that encode factors that can harm 
human cells. Moreover, only a select group of prokaryotes have adapted to survive 
intracellularly (de Barsy and Greub, 2013). These bacteria have developed different 
virulence factors to invade and colonise different cells (i.e. epithelial cells, macrophages) 
but specifically, they have adapted to exploit the metabolites found in these niches. It has 
been shown that intracellular bacteria only metabolise a few carbon sources, found within 
host cells, necessary for the biosynthesis of different metabolites required for replication 





























































1 Ray et al., 2009; 2 Waligora et al., 2014; 3 Brown, Palmer and Whiteley, 2008; 4 Parsons 
et al., 1996; 5 Château and Seifert, 2016; 6 Harvey et al., 2001.  
One of the facultative intracellular bacteria able to survive and reproduce within 
phagosomes is Neisseria gonorrhoeae (gonococcus), a Gram-negative gonococcus and 
the etiological agent of the sexually transmitted infection gonorrhoea. It was first thought 
that N. gonorrhoeae solely grew in glucose, pyruvate, and lactate (Stephen A Morse, Stein 
and Hines, 1974). However, genomic sequencing and enzymatic assays revealed that 
gonococcus possesses enzymes capable to utilise amino acids as carbon source (Baart et 




the human body at high concentrations, especially in the niches where Neisseria 
gonorrhoeae colonises (i.e. human serum, leukocytes, female genital tract, ejaculate) 
(Gao et al., 1998; Atack et al., 2014). This three-carbon molecule has been shown to be 
relevant for the pathogenesis of the gonococcus; it contributes to molecular mimicry; 
decreases reactive oxygen intermediates; enhances general metabolism; and it appears to 
be metabolised by the phosphotransacetylase-acetate kinase (PTA-AK) pathway 
(Britigan et al., 1988; Mcgee and Rest, 1996; Parsons et al., 1996; Gao et al., 1998).  
However, in recent years, a process thought to be only present in eukaryotic cells, has 
been found in several microorganisms, possessing a role in the post-translational 
modification of proteins involved in the pathogenesis of bacterial infections (Wagner and 
Payne, 2013; Kuhn et al., 2014). Acetyl-phosphate (AcP) is a high energy molecule found 
as an intermediate metabolite in different pathways, being produced by gonococcus in the 
PTA-AK pathway. The main role of this molecules is to acetylate enzymatically or 
nonenzymatically the ε-amino group of lysine residues (Nε-lysine), this post-translational 
modification has shown to be relevant for the activation of some virulence genes in 
bacteria (Barak and Eisenbach, 2001; Starai and Escalante-Semerena, 2004; Verdin and 
Ott, 2013). Moreover, a recent study demonstrated the presence of Nε-lysine acetylation 
in Neisseria gonorrhoeae and the relation it has with virulent factors (Post et al., 2017). 
The study of the role of intracellular metabolites in gonococci, specifically AcP, is an 
attractive field of research for the better understanding of its pathogenesis. 
1.1 Acetate metabolism 
The central metabolic pathway (CMP) includes the pathways, glycolysis, pentose 
phosphate, pyruvate metabolism, and tricarboxylic acid cycle (TCA). Glucose is the 




encoded enzymes in the bacteria. N. gonorrhoeae metabolises glucose through the ED 
pathway since it does not encode the gene phosphofructokinase, key enzyme for 
glycolysis that phosphorylates fructose-6-phosphate to fructose-1, 6-bisphosphate. The 
final product of both glycolysis and ED is pyruvate (Wolfe, 2005; Baart et al., 2007, 
2010).  
Pyruvate is metabolised by the pyruvate dehydrogenase complex (PDC). This complex is 
formed by pyruvate dehydrogenase E1, dihydrolipoamide acetyltransferase E2, and 
dihydrolipoamide dehydrogenase. A series of reactions catalyses the conversion of 
pyruvate to acetyl-coenzyme A (acetyl-CoA). The latter molecule is the final product of 
different metabolic pathways including, amino acids and fatty acids metabolism (Sauer 
and Eikmanns, 2005; Patel et al., 2014).  
Acetyl-CoA has two paths two follow, enter either the TCA or the phosphotransacetylase-
acetate kinase pathway (PTA-AK). When acetyl-CoA is metabolised through TCA 
energy is synthesised for the growth of the bacteria. In the PTA-AK pathway the acetyl-
CoA is transformed first to acetyl-phosphate (AcP) by the enzyme phosphotransacetylase 
(Pta) and then AcP is converted to acetate.  
During bacterial growth in medium where glucose is the sole carbon source acetate is 
excreted extracellularly at high concentrations due to saturation of the CMP. This 
phenomenon is known as carbon overflow. The saturation of the TCA promotes the path 
of acetyl-CoA to the PTA-AK pathway which it is used as an escape valve of carbon 
overflow. An interesting effect was described in E. coli as acetate switch where acetate is 
now used as carbon source (Schilling et al., 2015; Bernal, Castaño-Cerezo and Cánovas, 
2016). As consequence of this switch, the biomass production is decreased and the 




Acetate is metabolised by two enzymes to convert is to acetyl-CoA, acetate kinase 
(AckA) and acetyl-coenzyme A synthetase (Acs). At low and high concentration, acetate 
is mainly metabolised by Acs and AckA, respectively (Brinsmade and Escalante-
Semerena, 2007; Campos-Bermudez et al., 2010). However, a recent study in E. coli 
demonstrated that acetate metabolism was significantly reduced in a ΔackA than in a Δacs 
isogenic strain. Proving that ackA is the responsible enzyme to metabolise acetate during 
acetate overflow (Enjalbert et al., 2017). This study provided evidence of the importance 
of the PTA-AK pathway for the acetate metabolism. Moreover, the intermediate acetyl-
phosphate produced in this pathway has given attention to researchers due to the role it 
possesses in post-translational modifications of proteins. 
1.2 Phosphotransacetylase-acetate kinase pathway 
Acetyl-coenzyme A (acetyl-CoA) is final product of several pathways and this molecule 
is then metabolised via TCA. However, when the cycle is limited due to carbon overflow, 
acetyl-CoA is metabolised through the PTA-AK pathway, releasing acetate as a final 
product and obtaining a molecule of ATP. This pathway is composed by the two enzymes 
named after this metabolic route (fig. 1.1) (Wolfe, 2005; Sadykov et al., 2013). 
 
Figure 1.1. PTA-AK pathway. Acetyl-CoA is converted to acetyl-phosphate by the enzyme 




reactions are reversible. AcP is the responsible molecule for the non-enzymatically acetylation 
and it is also a substrate for the phosphorylation of proteins. Pi, orthophosphate; CoA-SH, 
coenzyme A; ADP, adenosine diphosphate; ATP, adenosine triphosphate (Verdin and Ott, 2013). 
Several studies have highlighted the importance of PTA-AK in bacterial metabolism 
during carbon overflow. The depletion of this pathway has shown decrease in biomass 
yield, reduce in bacterial fitness to survive, and lack to growth in medium with acetate. 
Moreover, the deletion of this pathway in bacteria such as Staphylococcus aureus has 
caused cell death (Chang et al., 1999; Somerville et al., 2003; Ramos-Montañez et al., 
2010; Sadykov et al., 2013; Won et al., 2021).  
Moreover the intermediate acetyl-phosphate has gained recent interest in bacteria due to 
its dual role to donate acetyl and phosphoryl groups to enzymes, causing enzymatic 
regulation and altering the metabolism of organism. 
 Phosphotransacetylase 
Phosphotransacetylase (Pta) is a dimeric enzyme which converts acetyl-CoA to acetyl-
phosphate (AcP) through a transferase reaction between the acetyl group of acetyl-CoA 
and an inorganic phosphate (Brinsmade and Escalante-Semerena, 2007).   
Two different classes of Pta have been discovered possessing each other almost twice 
length of amino acids. The Pta class I (Pta I) has a length of approximately 350 aa while 
the Pta class II (Pta II) is ~700 aa length. The homology of sequences between from both 
classes is the same from the C-terminus side. Different studies have crystallised Pta I and 
determined that the active site is located in the homologous sequences between Pta I and 
Pta II, however, different attempts to crystallised complete Pta II have not been 
successful. Different studies have suggested that the BioD-like N-terminal domain 




enzymatic activity of Pta. The molecules that found a decrease in the activity were ATP, 
ADP and NADH. Interestingly, N. gonorrhoeae possesses a Pta II (NGO0214) and 
neither its structure or function of the BioD-like N-terminal domain have been studied 
(Chittori, Savithri and Murthy, 2012; Yoshida et al., 2019). 
The reaction between acetyl-CoA to AcP is reversible. Pta is eight-fold more active in the 
synthesis of acetyl-CoA, however, pyruvate and phosphoenolpyruvate inhibit this 
reaction and favours the conversion of acetyl-CoA to AcP. Hence, the reaction towards 
synthesis to AcP is favoured at normal physiological concentration of pyruvate (Campos-
Bermudez et al., 2010). In fact, it was observed in a study in E. coli that the intracellular 
concentration of acetyl-CoA was increased during carbon overflow compared to growth 
in glucose (Bennett et al., 2009). This effect is not only due to the reversible enzymatic 
activity of Pta towards acetyl-CoA during carbon overflow but also due to the action of 
the second enzyme of the PTA-AK pathway. 
 Acetate kinase 
The last reaction of the PTA-AK pathway is responsible for the conversion of acetyl-
phosphate (AcP) to acetate. As mention previously, acetate kinase (AckA) is important 
during carbon overflow. This enzyme is responsible to metabolise acetate during carbon 
overflow to compensate the carbon flux. Enjalbert et al., 2017, found in E. coli that AckA 
is responsible for acetate consumption instead of the previous thought enzyme acetate 
synthetase Acs. This was concluded after measuring the flux of carbon molecules 
extracellularly. Interestingly, it was firstly thought that the PTA-AK pathway was 
exclusive of bacteria, however, blast analysis of different organism genomes have 




eukaryotic organisms have incorporated the enzyme as part as other pathways (Ingram-
Smith, Martin and Smith, 2006) 
Structural analysis of AckA crystals from S. enterica serovar Typhimurium and 
Porphyromonas gingivalis showed that AckA showed a dimer conformation of the 
enzyme during native state. Studies have also shown that AckA requires Mg2+ or Mn2+ 
for catalytic activity, and molecules of sulphate and ADP in the active site (Gorrell, 
Lawrence and Ferry, 2005; Chittori, Savithri and Murthy, 2012; Yoshida et al., 2019). 
Several bacteria have shown several copies of AckA in their genomes (Ingram-Smith, 
Martin and Smith, 2006; Chan et al., 2014). N. gonorrhoeae possesses two different 
acetate kinase NGO1521 and NGO0977. Although these two enzymes have not been 
studied, a study in Lactobacillus lactis and Neisseria meningitidis agree that AckAI is 
synthesised at higher concentration than AckAII, and its catalytic activity is favoured to 
produce acetate. While AckAII has a higher affinity to acetate, and in N. meningitidis was 
shown to be more affined to propionate (Catenazzi et al., 2014; Chan et al., 2014). 
1.3 Lysine acetylation  
Lysine acetylation is a post-translational modification (PTM) that involves the acetylation 
of the Nε-lysine residue in proteins. This PTM was firstly observed uniquely in eukaryotic 
cells involved in the regulation of gene expression by the acetylation and deacetylation 
of histones, the reaction mediated by the enzyme lysine acetyltransferase (KAT) and 
deacetylases (KDAC) respectively (Yang and Seto, 2008). Then it was observed that 
acetyl-CoA present in mitochondria at high concentrations could acetylate proteins non-
enzymatically (Wagner and Payne, 2013). Initially thought that lysine acetylation was 
exclusive of eukaryotic cells, it was then discovered that bacteria possessed acetylated 




and E. coli. Later it was shown that lysine acetylation was also performed non-
enzymatically, concluding that acetylation occurs enzymatically and non-enzymatically. 
 Enzymatic lysine acetylation 
Three families of acetyltransferases have been described. The Gcn5-related N-
acetyltransferases (GNAT) family, MYST family, and the p300/CBP family. However, 
only the GNAT are only found in bacteria.  There are around 300,000 different 
acetyltransferases and they are not homologous between each other, hence, the way to 
classify and identify them is by comparing the core GNAT domain. The role of GNAT in 
bacteria has been related to antibiotic resistance, regulation of metabolism and gene 
expression (Thao and Escalante-Semerena, 2011; David G Christensen et al., 2019; 
Burckhardt and Escalante-Semerena, 2020).  
GNATs are formed from the N-terminus by two antiparallel β-strands, two α-helices, 
three antiparallel β-strands, followed by a highly variant central α-helix, a fifth β-strand, 
a fourth α-helix, and a final sixth β-strand. The acetyl-CoA binds between β4 and β5 
strand where the pantothenate interacts with the C-terminal of β4. The enzyme transfer 
the acetyl group by an acid/base mechanism, where a glutamate or aspartate are the base 
to subtract the proton from the amine group (Vetting et al., 2005; Thao and Escalante-
Semerena, 2011; David G Christensen et al., 2019; Burckhardt and Escalante-Semerena, 
2020) 
First discovered in Salmonella enterica, the acetyltransferase (PTA) enzyme showed to 
deactivate the function of the acetyl-CoA synthetase (Acs), an enzyme that catalyses the 
conversion of acetate to acetyl-CoA (CoA), by acetylating the ATP binding region. 




has been assigned to have acetyltransferase activity (Starai et al., 2002; Starai and 
Escalante-Semerena, 2004).  
 Non-enzymatic lysine acetylation 
Interestingly, in 2013, Wagner and Payne found the novelty that lysine acetylation occurs 
non-enzymatically in mitochondria. Isolated liver mitochondria were heated for protein 
denaturation to inhibit the activity of any acetyltransferase. Later incubation with CoA at 
physiological concentration (0.1 to 1.5 mM), which is 3-50 times higher than other 
compartments, showed acetylation of proteins. This proved that at high concentrations of 
CoA, the PTM lysine acetylation occurs non-enzymatically. Although it was thought that 
the process was exclusive of eukaryotic cells, Kuhn et al., (2014), demonstrated that a 
similar process occurs in bacteria. 
In a previous study, it was observed that the acetylation of a RNA transcriptional factor 
in E. coli was altered when the acetate kinase gene was mutated (ΔackA). The enzyme 
AckA catalyses the reaction to convert acetyl-phosphate (AcP) to acetate in the PTA-AK 
pathway. Therefore, the mutation of the enzyme results in an accumulation of AcP. 
Nevertheless, in this study, they created two mutants that possess a contrasting 
concentration of AcP by mutating the two enzymes, Pta and AckA. The analysis of cell 
extract of both mutants by mass spectrometry to identify lysine acetylation, as expected, 
showed an increase of acetylated proteins in ΔackA compared to the wild type (WT). This 
work concluded that the molecule responsible for non-enzymatically lysine acetylation in 
bacteria is AcP. Indeed, further studies have proved that this evolutionary conserved PTM 
is present in several bacteria including Neisseria gonorrhoeae (Kim et al., 2013; Kuhn et 




 Acetyl-phosphate: the novel regulatory molecule in bacteria 
Acetyl-phosphate (AcP) is the intermediate metabolite of the PTA-AK pathway (fig. 1.3). 
Although, it was recently discovered to be involved in lysine acetylation, several studies 
have shown the dual role it possesses in both acetylation and phosphorylation of proteins, 
for the regulation of metabolism, synthesis of virulence factors, and regulation of 
transcription factors (Barak and Eisenbach, 2001; Gueriri et al., 2008; Lima et al., 2011; 
Verdin and Ott, 2013; Castaño‐Cerezo et al., 2014; Liu et al., 2016).  
A study conducted in E.coli showed that the acetylation of the transcriptional factor RcsB 
blocked the transcription of the proteins required for flagella biosynthesis, resulting in an 
effect on motility. Although, the author mutated the acetyltransferase enzyme instead of 
the PTA-AK enzymes and non-enzymatically acetylation is not discussed. The results 
showed that acetylation, which nowadays is well known to be modulated by AcP, 
regulated the transcription of virulence factors (Castaño‐Cerezo et al., 2014). Moreover, 
AcP has also shown to regulate motility in Listeria monocytogenes, and in Bacillus 
amyloliquefaciens regulates the synthesis of antibiotics (Gueriri et al., 2008; Liu et al., 
2016). Recently, it was demonstrated that lysine acetylation is present in Neisseria 
gonorrhoeae. The results obtained by mass spectrometry from a ΔackA, indicate that the 
biosynthesis of the pilus, proteins involved in iron acquisition and several regulatory 
proteins possess regulated sites for acetylation. Furthermore, the gonococcus was unable 
to generate a biofilm and general metabolism was altered (Post et al., 2017). 
Lysine acetylation is increased in carbon overflow. Cells in presence of an augmentation 
of carbon flux are exceeded in the obtainment of energy through the tricarboxylic cycle 
(TCA), therefore, acetyl-CoA is accumulated and it is metabolised by the PTA-AK 




E. coli and the enzymes of the central metabolic pathways show to be regulated by the 
PTM (Schilling et al., 2015).  
AcP has shown to participate in the phosphorylation of proteins. Before the discovery of 
acetylation, it was already described that the pool of AcP was involved in the 
phosphorylation of transcription factors in E. coli (McCleary and Stock, 1994). It was 
later found that, indeed, the concentration present of acetyl phosphate is sufficient for the 
direct phosphorylation of the transcription factor RcsB (Klein et al., 2007). Recently, the 
dual role of AcP was shown in a study in the enterobacteria E. coli. By using site-directed 
mutagenesis, the transcription factor cpxR was mutated in the amino acid that is 
phosphorylated. It was observed that AcP was required for the activation of CpxR. 
Moreover, it was also found that RNA polymerase acetylation is also modulated by the 
intermediate metabolite of the PTA-AK pathway (Lima et al., 2016). 
1.4 Neisseria gonorrhoeae 
In the last decade, gonorrhoea has gained more relevance worldwide because it has 
positioned as the second most common bacterial sexually transmitted infection (STI). In 
2019, the World Health Organisation (WHO) estimated approximately 376 million new 
cases of bacterial STI. In 2016, 86.9 million resided with the disease caused by Neisseria 
gonorrhoeae (Rowley et al., 2019; WHO, 2019b). In England, the number of new cases 
has increased yearly (fig. 1.2). The number increased from 56,232 in 2018 to 70,936 in 
2019, this meant an increase of 26% (Wise, 2020). The isolation of gonococcus strains 
resistant to the current dual treatment, extended-spectrum cephalosporin (ESC) 
ceftriaxone and azithromycin, has arisen and different international organisations classify 
Neisseria gonorrhoeae as a global threat (Fifer, Natarajan and Unemo, 2016). Therefore 




resistant pathogens, the creation of new antibiotics against the gonococcus (Tacconelli 
and Magrini, 2017). The aim of this strategy is to decrease 90% the global incidence of 
gonorrhoea by 2030 (WHO, 2016). 
 
Figure 1.2 Diagnostic rate of gonorrhoea in England from 2012 to 2019. The line shows 
the diagnostic rate of gonorrhoea per 100,000 population. The number next to each point is the 
percentage difference compared to the previous year (Public Health England, 2021). 
Neisseria gonorrhoeae is a pathogen that only infects humans. It colonises the urogenital 
tract causing urethritis in male and cervicitis in the female, although the presence in 
pharynx, conjunctiva and rectal mucosa are also observed. Generally, the STI is 
asymptomatic in women (50-80%) whilst in men, 90% of the cases present the 
characteristic purulent discharge (Unemo and Jensen, 2017). Occasionally, the 
gonococcus disseminates causing septic arthritis, bacteraemia or pustular skin lesion, 
however, the percentage of disseminated gonococcal infection (DGI) from the total cases 
is lower than 3% (Morgan and Decker, 2016).  In order to infect such a specific 
microenvironment, the gonococcus possesses distinct mechanisms for the colonisation 





The microenvironment of Neisseria gonorrhoeae for the development of the infection is 
the urogenital tract. Although the primary site of infection is the urogenital mucosae, the 
gonococcus possesses several proteins for the internalisation within the urethral and 
cervical epithelial cells, and polymorphonuclear cells (PMN) which lead to a systemic 
infection (Edwards and Apicella, 2004).  
 Internalisation into epithelial cells enhances innate immune 
system 
Bacterial colonisation commences by the attachment of the type IV pili to the urogenital 
epithelial cells, where it acts a retractile motor for the motility of the bacteria and as a 
transporter of extracellular DNA (Winther-Larsen et al., 2001; Ramsey, Woodhams and 
Dillard, 2011). This tight gonococcus-cell contact permits the recognition of membrane 
molecules (fig. 1.3). For instance, the gonococcus lipooligosaccharide (LOS), and porins, 
an immunogenic protein that transport water, are recognised by the toll-like receptor 2 
(TLR-2), which lead the release of chemokines and cytokines, necessary for the 
recruitment of PMN. Interestingly, it has been shown that the expression of this 
stimulatory molecules is higher in males than females, explaining the higher rate of 
symptomatic gonorrhoea in men (Massari et al., 2002; Fisette et al., 2003; Edwards and 
Apicella, 2004). 
Once the epithelial cells have triggered the inflammatory response, Neisseria 
gonorrhoeae, in order to survive, internalises into the epithelial cells and PMN. The 
recognition of LOS leads to the endocytosis of gonococci. However, the receptor is 
different depending on the colonised epithelial cell. An asialoglycoprotein receptor 




receptor 3 receptor (CR3) binds to three bacterial proteins: type IV pili, porin and the 
inactivated complement 3 protein (iC3b) which is bound to the lipid A a portion of LOS. 
The binding causes the re-arrangement and ruffling of the plasmatic membrane, and as a 
consequence, bacteria are engulfed by the epithelial cell and internalised within the 
cytosol, this process is named macropinocytosis (Harvey et al., 2001; Edwards and 
Apicella, 2002; Lim and Gleeson, 2011).  
Neisseria gonorrhoeae within the epithelial cells stimulates the innate immune system. 
The microorganism produces phospholipase D within the macropinosome in cervical 
cells. This enzyme causes the displacement of the CR3 in the apical epithelial cells which 
lead to the internalisation of more gonococci, increasing invasion (Edwards, Entz and 
Apicella, 2003). Moreover, gonococci begin to grow releasing fragments of 
peptidoglycan, the main component of bacterial wall. This sugar-peptide polymer is 
recognised by NOD-like receptors (NLR), a family of cytoplasmic receptors that detect 
conserved molecules of bacteria and once stimulated, the receptor triggers a signalling 
cascade for the expression of proinflammatory mediators (Kanneganti, Lamkanfi and 
Núñez, 2007; Mavrogiorgos et al., 2014). The chemokines and cytokines released 





Figure 1.3 Mechanism of adhesion and internalisation of Neisseria gonorrhoeae in 
epithelial cells. 1) The invasion commences with the attachment of type IV pili to the urogenital 
epithelium, causing the binding between lipooligosaccharide (LOS), porin and opacity-associated 
protein (Opa), to toll-like receptor 2 (TLR-2). 2) The binding triggers a molecular cascade that 
activates the transcription factor NF-κB for the synthesis of cytokines. 3) The endocytosis of 
gonococcus is mediated by the recognition of an asialoglycoprotein receptor (ASPG-R) to LOS 
in urethral epithelial cells and in cervical epithelial cells, by the binding between type IV pili, 
porin, and inactivated complement 3 (iC3b), to complement receptor 3 (CR3). 4) In urethral 
epithelial cells, Neisseria gonorrhoeae is internalised and surrounded by clathrin molecules, a 
protein that is involved in the formation of coated vesicles, coupled to ASPG-R. The disruption 
of the clathrin-coated vesicle is led by the decreased of pH, triggering the recycling of clathrin 
and ASPG-R to the apical membrane of the cell. In cervical epithelial cells, the endocytosis is 




mobilisation of CR3 to the membrane. In both cases, the recycling of receptors promotes the 
internalisation of more bacteria. 5) Neisseria gonorrhoeae, start growing within the cytoplasm 
causing the release of peptidoglycan (Pgn) which is recognised by NOD-like receptors (NLR). 
The receptor activates NF-κB and proinflammatory cytokines are synthesised (i.e. IL-1, IL-6, IL-
8). 6-8) Cytokines recruit polymorphonuclear cells (PMN) migrating from the vascular system to 
the lumen of the urethra or cervix recognising the opacity-associated protein (Opa) of gonococci 
by carcinoembryonic antigen cellular adhesion molecules (CEACAM). 
 
PMN are the first line cells of the innate immune response. The recognition of the cells is 
via opsonisation or non-opsonisation. Neisseria gonorrhoeae is opsonised by either 
immunoglobulins G (IgG) and IgA1, or complement proteins. However, higher rates of 
antigenic variation have been observed in the surface molecules of gonococci (i.e. type 
IV pili, LOS and opacity-associated (Opa) proteins) resulting in a low response of the 
adaptive immune system (Haas and Meyer, 1986; Stern et al., 1986; Hedges et al., 1999). 
Therefore, the phagocytosis of gonococci is mainly mediated by non-opsonised 
molecules.  
Gonococcal Opa, is a transmembrane protein of eight β-barrels, and is responsible for the 
internalisation into PMN. This highly genetically variable protein is recognised by 
carcinoembryonic antigen-related cell adhesion molecule (CEACAM) receptors.  
Recently, it was shown that the role of this receptor not only causes the clearance of the 
bacteria but that it also contributes to the pathogenesis of gonorrhoea. The activation of 
CEACAM3, a receptor that characterises from the others by the presence of the 
cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM), leads to the 




which are fundamental for the recruitment of PMN, causing an exacerbation of the 
inflammatory response (Sintsova et al., 2014). 
Although Opa is the most efficient molecule for non-opsonised phagocytosis, PMN 
possess other ways to engulf the gonococcus. As was previously described, in the 
attachment to epithelial cells, the complex of type IV pili, iC3b, and porin, bind to CR3 
located on the PMN membrane. Even though LOS has been observed to promote 
phagocytosis, the binding receptor has not been identified (Virji, 2009; Johnson and Criss, 
2011; Criss and Seifert, 2012; Sintsova et al., 2015). These series of molecular 
recognitions lead to the phagocytosis of the gonococcal bacteria. 
 Survival of gonococcus inside PMN  
The internalisation of bacteria through phagosomes is a process that generally causes the 
death of bacteria. However, Neisseria gonorrhoeae has elucidated the way to escape from 
the two phagocytic mechanisms that exist in PMN to kill bacteria, which are oxygen-
dependent and independent, in order to survive and grow within the cells. Moreover, it 
has been recently shown in gonococci a mechanism that extends the lifespan of PMN 
(Johnson and Criss, 2011). 
The oxygen-dependent mechanism involves the generation of ROS (reactive oxygen 
species) by the NOX2 NADPH-oxidase (nicotinamide adenine dinucleotide phosphate-
oxidase). The enzyme transports electrons from the cytoplasm of the PMN into the 
phagosome causing the production of ROS, such as hydroxyl radical (•OH), hydrogen 
peroxide (H2O2), and superoxide anion (O2
-) (Flannagan, Cosío and Grinstein, 2009; 
Johnson and Criss, 2011). The production of these toxic molecules for bacteria causes an 
augmentation in oxygen consumption by the neutrophil in a process known as oxidative 




isolated from the vagina, produce high concentrations of hydrogen peroxide, giving a 
protection to women against vaginosis (Eschenbach et al., 1989). However, O’Hanlon et 
al. (2010), observed that cervicovaginal fluid and semen inhibit the activity of hydrogen 
peroxide. Although this study proved the ROS produced by lactobacilli bacteria is not 
critical for the control of vaginal infections, a recent study shows that, indeed, 
Lactobacillus inhibits the growth of pathogenic bacteria, such as Neisseria gonorrhoeae, 
but by decreasing pH through the production of lactic acid (Foschi et al., 2017). 
 Neisseria gonorrhoeae averts the oxidative burst by two mechanisms; converting ROS 
into molecules of oxygen and water; and consuming oxygen in presence of lactate. The 
conversion to non-toxic molecules is mediated by peroxidases, such as superoxide 
dismutase (SodB) and cytochrome c peroxidase, and a single cytoplasmic catalase (KatA) 
which also possesses peroxidase activity. Its activity was discovered from a gonococcus 
KatA- strain isolated from a patient treated with penicillin which in the presence of 
hydrogen peroxide the bacteria died (Johnson et al., 1993; Johnson and Criss, 2011). 
Another mechanism to survive from the oxidative burst is the increase of respiration. 
Neisseria gonorrhoeae only metabolises glucose, pyruvate and lactate, the latter the 
carbon source that increases the metabolism of the bacteria. Macrophages in a stress 
condition demonstrate a higher level of lactate which is used by gonococci for respiration. 
Therefore, the level of oxygen which originally is used for the production of ROS is 
decreased by Neisseria gonorrhoeae (Britigan et al., 1988; Smith, Tang and Exley, 2007; 
Johnson and Criss, 2011). Although the oxidative burst is essential in the response against 
microorganisms in macrophages, Criss, Katz and Seifert (2009), showed that the main 
mechanism of gonococcal survival is resistance against non-oxidative killing. By testing 
mutants deficient in enzymes previously detected to participate in the protection against 




survival in PMN of Neisseria gonorrhoeae between wild type and mutants. This finding 
showed that resistance against ROS is non-essential for the survival of gonococcus within 
PMN.  
The non-oxidative killing in PMN is mediated by three types of granules: primary or 
azurophilic, secondary or specific, and tertiary, each one possesses molecules that are 
involved in the disruption of the plasma membrane of bacteria. The two main molecules 
involved in the defence against N. gonorrhoeae are cathepsin G protease and 
permeability-increasing protein (hCAP57) contained in the azurophilic and secondary 
granules, respectively (Johnson and Criss, 2011). The action mechanism of cathepsin G 
was firstly thought to be proteolytic by cleaving proteins from the outer membrane. 
However, its main function is to disrupt the biosynthesis of peptidoglycan (Shafer et al., 
1990). In contrast, hCAP57 is converted by a protein present in azurophilic granules into 
the active form, LL-37. The 37 amino acid residues antimicrobial peptide, is the only 
cathelicidin presents in humans and its role is to disrupt the membrane by forming pores, 
it also functions as a regulator of the immune response (Bucki et al., 2010). It is found in 
PMN and epithelial cells. Interestingly, it was observed a reduction of LL-37 expression 
in cervical cells using immunostaining when infected with N. gonorrhoeae (Bergman et 
al., 2005).  
Neisseria gonorrhoeae counteract the effect of non-oxidative killing using distinct 
mechanisms. The outer membrane proteins type IV pili and porins halt degranulation of 
primary and secondary granules (Bjerknes et al., 1995; Lorenzen et al., 2000). 
Furthermore, enhanced by the presence of lactate, the modification of LOS, by the 
sialylation or substitution of the oligosaccharide, inhibits the binding of cathepsin G 
(Johnson and Criss, 2011; Matthias and Rest, 2014). Another mechanism that the 




This efflux mechanism is composed by trimeric proteins which transport antibiotic and 
host antimicrobials from the cytoplasm to the environment. The pump is composed by 
three genes located within the mtrCDE operon, and it is regulated by a transcriptional 
activator and repressor, MtrA and MtrR, respectively (Zalucki, Dhulipala and Shafer, 
2012; Rouquette-Loughlin et al., 2017a).  Although N. gonorrhoeae has elucidated a 
variety of mechanism to resist the immune response, it has been recently proved that the 
gonococcus has evolved not only to survive but to regulate the immune response. 
 PMN: the route for gonococcal dispersion  
The ability of N. gonorrhoeae to survive within PMN has been well documented. 
However, recent studies showed that the adaptation of the bacteria to the host cells is 
more complex. Once bacteria have been engulfed, a series of mechanisms not only for 
escaping from the antimicrobial action but for the regulation and controlling of immune 
system commence. The induction of immunosuppressive molecules and the regulation of 
apoptosis lead to the increase of the bacterial lifespan within the PMN (Chen and Seifert, 
2011; Zhu et al., 2012; Château and Seifert, 2016). Therefore, gonococci are transported 
through the vessels allowing the dissemination of the infection through the body. 
Apoptosis, programmed cell death mechanism, is a highly regulated process present in 
every single cell. The aim of this genetically encoded process is to maintain an 
equilibrium in tissues and as an immune response to executing cells when an infection or 
damage occur (Buchakjian and Kornbluth, 2010; Tait and Green, 2010; Hongmei, 2012). 
Neisseria gonorrhoeae has shown to be involved in the inhibition of apoptosis, although 
the regulation of apoptosis has also been observed in Mycobacterium tuberculosis, the 
mechanism explained subsequently is exclusively from gonococci (Velmurugan et al., 




Neisserial porin (PorB) prevents apoptosis of PMN and epithelial cells. It was 
demonstrated that purified PorB from Neisseria meningitidis prevented apoptosis in HeLa 
cells (Faherty and Maurelli, 2008). Although a discrepancy was found when N. 
gonorrhoeae was used (Müller et al., 2000). The team that initially reported the anti-
apoptotic mechanism repeated the experiments made by Müller et al. but using their 
protocol and the results found in meningococcus were found in N. gonorrhoeae, 
confirming the inhibition of apoptosis. PorB migrates to the mitochondrial membrane 
preventing the release of cytochrome c, and it also halts caspase-3 activation, both 
required factors for the initiation of apoptosis. Interestingly, this mechanism works even 
if the bacteria is dead (Massari et al., 2003). Chen and Seifert, (2011), studied the 
apoptosis in HL-60 cells, a myeloid leukaemia cell line, and apoptosis in primary PMN. 
Cells were pre-incubated with N. gonorrhoeae and then apoptosis was stimulated using 
staurosporine (STS). The infected PMN incubated with STS showed a decrease of DNA 
fragmentation which corresponds to the last step of apoptosis. This study showed for the 
first time that Neisseria gonorrhoeae inhibits apoptosis in primary cell culture. 
Indeed, the results were confirmed in another work conducted in primary macrophages 
and a differentiated THP-1 cell line. The findings proved that the gonococcal infection 
prevents cells to die by measuring DNA fragmentation. Moreover, infection of primary 
macrophages caused the release of not only pro-inflammatory cytokines (IL-6, IL-8) but 
immunosuppressive (IL-10). Furthermore, PD-L1 (Programmed Death Ligand 1), a 
molecule which acts in the suppression of the immune system, was found upregulated in 
macrophages infected with Neisseria gonorrhoeae. However, the role that these 
immunosuppressive molecules play during infection needs further studies. In both 




expression of the molecules at earlier times will indicate the function of the upregulation 
in the macrophages (Ortiz et al., 2015; Château and Seifert, 2016).  
These findings prove the high adaptation that gonococci have developed to survive and 
regulate the immune response mechanism. The regulation of apoptosis leads to the 
possession of a niche which lifespan is expanded by inhibiting cellular death, moreover, 
the upregulation of immunosuppressive cytokines derive in the mobilisation of Neisseria 
gonorrhoeae through the vessels to colonise new tissues. However, all these events could 
not be possible without the requirement of energy. The gonococcus has evolved to benefit 
from metabolites present when the body is under stress.  
1.5 Lactate: The elect carbon source  
Lactate is one of the metabolites that is found at high concentrations in the body and one 
of the carbon sources that Neisseria gonorrhoeae metabolises. Lactate is found in all the 
body, but especially muscles cells and astrocytes possess the ability to synthesise lactate 
at higher levels. In women, lactobacilli are present in the vagina producing high 
concentrations of lactate. The production of lactate is inversely correlated to the 
concentration of oxygen in the body, and glycolysis is the pathway that from one molecule 
of glucose synthesises two molecules of lactate as a last metabolite. It is converted from 
pyruvate by the enzyme lactate dehydrogenase (LDH) whose reaction leads the oxidation 
of NADH+H+ (nicotinamide adenine dinucleotide reduced) to NAD+ and in a high 
concentration of lactate, the reaction is reversible. In normal conditions, lactate is found 
in blood at 2.0 to 2.5 mmol/L and the concentration is increased in stress conditions (i.e. 
exercise, bacterial infection, after surgery) (Andersen et al., 2013; Bakker, Nijsten and 




As it was mentioned previously, Neisseria gonorrhoeae utilises glucose, pyruvate, and 
lactate, to obtain energy (Stephen A Morse, Stein and Hines, 1974). However, a variety 
of studies have postulated the effects of lactate, in the metabolism of gonococcus and the 
role it has in pathogenesis (Yates et al., 2000; Smith et al., 2001; Exley et al., 2007; Atack 
et al., 2014). The gonococcus metabolises the L-lactate isoform, which is the most 
abundant in the body, by translocating lactate through a lactate permease (LctP). L-lactate 
is then converted to pyruvate by LldD (respiratory L-LDH), thus, the cytosolic LdhA 
(NAD+-linked D-LDH) converts pyruvate into D-lactate and it is converted back to 
pyruvate by LdhD (respiratory D-LDH). The activity of the three LDH results in an 
accumulation of pyruvate (Atack et al., 2014). 
The gonococcus is well known for possessing molecular mimicry, this means that the 
molecules present on the surface of the bacteria imitate the ones found in host cells. 
Sialylation of LOS is the mechanism by which the gonococcus avert phagocytosis. It was 
found that the bacteria presented resistance to complement-mediated killing when 
exposed to serum. The molecule that was found to be involved in the protection of the 
bacteria against the innate immune response was cytidine 5′-monophosphate-N-
acetylneuraminic acid (CMP-NANA). Sialylation is catalysed by the enzyme 
sialyltransferase (Lst) which incorporates the sialyl group on the terminal Galβ1-
4GlcNAc of LOS. The incorporation of the host cell molecule results in a molecular 
mimicry which includes the inhibition of complement deposition on the surface of the 
gonococcus, the avoidance of phagocytosis but also it halts the internalisation into the 
epithelial cells (Gill et al., 1996; Mcgee and Rest, 1996; Parsons et al., 1996; Regan et 
al., 1999). The synthesis of Lst was thought to be mediated in the presence of lactate 
(Mcgee and Rest, 1996). Nevertheless, later studies, by comparing growth between the 




sialylation but the molecule that enhances gonococcus metabolism. Therefore, in 
presence of lactate LOS is synthesised at higher rates resulting in a higher sialylation 
(Parsons et al., 1996; Regan et al., 1999).  
Interestingly, it was recently reported that desialylation of gonococcus in infected women 
contributes to the dispersal of the STI in men. In order to internalise to urethral cells, 
Neisseria gonorrhoeae binds to the surface of the epithelial cells, however, sialylation 
inhibits it. Sialidase is the enzyme that catalyses the desialylation of LOS and 
cervicovaginal microbiome, especially conformed of Lactobacillus sp., produce high 
concentrations of this enzyme (Edwards and Apicella, 2004; Ketterer et al., 2016).  
The concentration of lactate in normal conditions is lower than glucose, however, sites of 
gonococcus colonisation present 2-10 times higher threshold of lactate concentration. In 
stress conditions, the body metabolises high concentrations of oxygen generating a 
hypoxic environment which promotes the anaerobic pathway. Pyruvate which normally 
enters the tricarboxylic cycle (TCA) is converted instead to lactate because the oxidative 
phosphorylation is decreased by the depletion of oxygen (Gao et al., 1998; Bakker, 
Nijsten and Jansen, 2013; Atack et al., 2014). In PMN this phenomenon is observed 
during infection and it is activated during bacterial infection. The recognition of LOS by 
PMN lead to the activation of oxidative burst which requires high concentrations of 
oxygen and ATP, by switching the metabolism from oxidative phosphorylation to 
anaerobic glycolysis, the cell obtains ATP faster by producing lactate, this process is 




Figure 1.4. Warburg effect stimulates gonococcal metabolism. PMN in stress conditions 
such as bacterial infection, the cell switches the metabolism to anaerobic respiration, and the 
tricarboxylic cycle (TCA) and oxidative phosphorylation are inhibited. As consequence, the 
concentration of lactate is increased and it is metabolised by Neisseria gonorrhoeae. Lactate is 
transported through a lactate permease (LctP) and it is metabolised by the phosphotransacetylase-
acetate kinase (PTA-AK) pathway. The high concentration of lactate enhances bacterial growth, 
thus, oxygen used by the PMN for the oxidative burst is depleted. CoA, acetyl-coenzyme A; AcP, 
acetyl-phosphate; LDH, lactate dehydrogenase; PDH, pyruvate dehydrogenase.  
Although this effect has not been described in gonococcal infection, it is known that 
bacteria that survive within PMN  promotes the production of lactate (i.e. Listeria 
monocytogenes, Mycobacterium tuberculosis) (Kelly and O’Neill, 2015; Shi et al., 2015). 
However, it is likely that gonococcus stimulates the Warburg effect. Britigan et al., 
(1988), observed that the concentration of oxygen was depleted in HL-60 cells when 




The possession of three LDHs in Neisseria gonorrhoeae lead to an accumulation of 
pyruvate which is then converted to acetyl-coenzyme A. The conversion of acetyl-CoA 
to acetate through the phosphotransacetylase-acetate kinase (PTA-AK) pathway has 
shown to be a promising route, relevant for the global metabolism of the gonococcus due 




1.6 Aims of the study 
The initial aims of this study was to disrupt the PTA-AK pathway of N. gonorrhoeae to 
observe an alteration in the levels of acetyl-phosphate. This was achieved by constructing 
two isogenic mutants ΔackA and Δpta. However, it was then decided that a strain lacking 
the histone deacetylase-like protein would be interesting to observe possible targets of 
this enzyme, since no studies have been performed to analyse this study. In fact, two of 
the created isogenic mutants are novel Δpta and Δhdac for N. gonorrhoeae. 
These strains were analysed to characterise them phenotypically by growing hem in 
different carbon sources to determine how PTA-AK is involved in the metabolism. Thus, 
the proteome and acetylome of the four strains was analyse to analyse the proteins that 
suffer lysine acetylation. 
The acetylome gave us important information of how this is involved in the metabolism 
and virulence of the bacteria. Interestingly, the isogenic strain Δpta showed less virulence 
than the WT and therefore, it was decided to crystallise the enzyme phosphotransacetylase 











2 Materials and methods 
2.1 Bacterial strains and plasmid constructs 
In this study, twelve strains were used (table 2.1). N. gonorrhoeae MS11 was used to 
create strains with a kanamycin insertion in three different enzymes involved in either 
acetylation or deacetylation. Escherichia coli DH5α, E.coli XL-1 blue and E. coli BL21-
DE3 were used to construct an E. coli strain that overexpresses the protein Pta.  
Table 2.1 Strains of bacteria used and plasmid constructs in this study 
Strain Description and genotype Source 
N. gonorrhoeae MS11 
Wild type, isolated from uncomplicated 
gonorrhoeae, contains gonococcal genetic 
island and it possesses a higher rate 
transformation than N. gonorrhoeae FA1090 
(Jordan, Snyder and Saunders, 2005; Duffin 
and Seifert, 2010). 
J. Sayers 
N. gonorrhoeae MS11 
ΔackA::kanr 
MS11 with disrupted genomic copy of ackA 




N. gonorrhoeae MS11 
Δpta::kanr 
MS11 with disrupted genomic copy of pta by 




N. gonorrhoeae MS11 
Δhdac::kanr 
MS11 with disrupted genomic copy of hdac 
by insertion of kanamycin resistance gene. 
This study 
Escherichia coli DH5α 
F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 




Competent bacterium with high 






Escherichia coli DH5α 
pBHR1-GFP 
E. coli DH5α transformed with a PBHR1 
plasmid, which possesses kanamycin 
resistance and the insert of gfp that encodes 
the green fluorescent protein. 
This work 
Escherichia coli DH5α 
pLES2 
E. coli DH5α transformed with the pLES2 
plasmid, which contains the lacZα gene, and 
ampicillin resistance (ampr) gene. 
This work 
Escherichia coli DH5α 
pLES2-GFP 
E. coli DH5α transformed with the pLES2 




recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F′ proAB lacIqZΔM15 Tn10 
(Tetr)] 








E. coli XL1-blue transformed with the 
expression vector pET28a containing the 




F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 
[lacI lacUV5-T7p07 ind1 sam7 nin5]) 
[malB+]K-12(λ
S) 
Also known as E. coli str. B, contains a λ 
prophage carrying the T7 RNA polymerase 






E. coli str. B transformed with the expression 






2.2 Media and growth conditions 
 Neisseria gonorrhoeae 
Gonococcus is a fastidious bacterium that requires special nutrients for growing. 
Therefore, four different media were used and each medium was employed for a specific 
aim. 
2.2.1.1 Solid medium 
Stocks of N. gonorrhoeae stored at -80 °C were routinely grown on chocolate agar (CHO) 
(E & O Laboratories Limited, Scotland) or Gonococcus agar (GC) (Oxoid, UK) with 1% 
Kellogg’s supplement (glucose, 40.0 g; glutamine, 0.5 g; ferric nitrate, 0.05 g; 
cocarboxylase, 2.0 mg; dissolved in 100 mL distilled water) (Kellogg et al., 1963) at 37 
°C and 5% CO2 atmosphere in a CO2 incubator model MCO-15AC (Sanyo, Osaka, 
Japan). The isogenic mutant strains of the gonococcus were growth on a GC agar 
supplemented with 80 µg/mL kanamycin at the same growing conditions mentioned 
previously. 
2.2.1.2 Liquid medium 
For growth in liquid culture, it was utilised brain heart infusion broth (Oxoid, UK) 
supplemented with 0.5% yeast extract (Oxoid, UK) (BHI-Y). The cultured was incubated 
at 37 °C and with shaking, at 180 rpm for 25 mL tubes in a C25KC incubator shaker (New 
Brunswick Scientific, NJ, USA) and 120 rpm for 500 mL flasks in an Excella E25 
incubator shaker (New Brunswick Scientific, NJ, USA), 10 mM NaHCO3 was added to 




A chemically defined medium for N. gonorrhoeae (CDM-GC) was used to observe the 
utilisation of three different carbon sources, glucose, lactate and pyruvate. This medium 
contains all the necessary nutrients for the gonococcus growth (table 2.2). 
Table 2.2 Composition and preparation of the chemically defined medium (CDM-
GC) for the growth of N. gonorrhoeae 
Solutions and reagents  
Amount  







Potassium sulphate (K2SO4) 
  
10.00 g 














   








H2O (Total volume) 
  
100 mL  
 
Solution III 







































































































   




















Phenol red 0.001%  











Sodium hydrogen carbonate (NaHCO3) 1 M  








Glucose 1 M  








Lactate 1 M  








Pyruvate 1 M  





































Phenol red 0.001% 
  
1.00 





Lactate or pyruvate 1 M    2.00 
H2O   63.40 
NaHCO3 1 M (Freshly made and added before 
bacteria inoculation) 
  1.00 
Adjust to a pH of 7.0 with 5 M NaOH    
 
Media were autoclaved at 121 °C and 15 PSI for 20 min, except for the CDM, which all 
solutions were filter sterilised with a sterile and endotoxin free 0.2 µm PES filter 
PuradiscTM (GE Healthcare, UK). 
 Escherichia coli 
2.2.2.1 Solid medium 
E. coli DH5α was grown in Luria-Bertani (LB) agar (tryptone, 10.0 g; yeast extract, 5.0 
g; NaCl, 10.0 g; bacteriological agar, 15 g; H2O, 1000 mL). Several types of LB agar 
were prepared by adding antibiotics depending on the strain to select in the transformation 
experiments, which will be explained in the next sections. 
2.2.2.2 Liquid medium 
LB broth (same composition but without agar) broth was used to grow the different strains 




2.2.1.2) depending on the volume to employ. This liquid medium was used as a base for 
other experiments that required specific growing conditions for either selection or protein 
expression. 
2.3 Competent cells preparation 
The transformation of the different E. coli strains (E. coli DH5α, E. coli XL1-blue and E. 
coli str. B) required that the bacteria were competent, this means that they were able to 
uptake extracellular DNA. In order to obtain competent cells, the Hanahan method was 
employed (Hanahan, 1983). 
E. coli strains were grown overnight on LB agar plates. Colonies were taken to inoculate 
50 mL LB broth and incubated for 6 h at 37 °C and 180 rpm in a C25KC incubator shaker 
(New Brunswick Scientific, NJ, USA) until the culture reached an optical density (OD600) 
of 0.3. The growth was chilled on ice for 15 min and centrifuged at 3,500 x g for 20 min 
at 4 °C in an Allegra™ X-22R centrifuge (Beckman-Coulter, Krefeld, Germany). The 
bacterial pellet was re-suspended in 16.65 mL RF1 solution (table 2.3), a 1/3 of the 
original volume, and incubated on ice for 15 min. The bacterium was centrifuged again 
at the same conditions and the pellet was re-suspended with 4 mL RF2 solution (table 
2.4), a 1/12.5 of the original volume, and incubated on ice for 15 min. 200 µL aliquots 








Table 2.3. Composition and preparation of 100 mL RF1 solution 
Component Final concentration Amount 
Potassium chloride (KCl) 100 mM 0.75 g 
Manganese (II) chloride (MnCl2 ) 50 mM 0.99 g 
Potassium acetate (CH3CO2K) 30 mM 0.29 g 
Calcium chloride dehydrate 
(CaCl2-2H2O) 
10 mM 0.15 g 
Glycerol 15% (v/v) 15.00 mL 
H2O  85.00 mL 
Adjust to a pH of 5.8 with 10% glacial acetic acid, and filter sterilise through a pre-
rinsed 0.22 micron membrane. 
  
Table 2.4. Composition and preparation of 100 mL RF2 solution 
Component Final concentration Amount 
MOPS (3-(N-morpholino) 
propanesulfonic acid)  
pH 6.8  
10 mM 0.21 g 
Potassium chloride (KCl)  10 mM 0.074 g 
Calcium chloride dehydrate 
(CaCl2-2H2O)  
75 mM 1.1 g 
Glycerol 15 % (v/v) 15.00 mL 
H2O  85.00 mL 





2.4 Cryogenic preservation 
Liquid cultures of BHI-Y and LB for N. gonorrhoeae and E. coli, respectively, were 
grown overnight at 37 °C on a rotary shaker at 180 rpm overnight.  
In a 1.0 mL cryogenic tube (Thermo Scientific™ Nalgene™, Waltham, MA, USA) 500 
µL of culture was mixed with the same volume of 20% glycerol (v/v) and stored in an 
ultra-low-temperature freezer at -80 °C. 
2.5 Mutant construction 
 Neisseria gonorrhoeae MS11  
2.5.1.1 Genomic DNA (gDNA) extraction 
N. gonorrhoeae MS11 was grown overnight on chocolate agar plate as described in 
section 2.2.1.1 and then in 10 mL liquid medium as described in section 2.2.1.2. 1.5 mL 
of culture was centrifuged at 12,000 x g for 2 min and re-suspended in 1 mL PBS.  The 
extraction was performed following the protocol of GenElute™ Bacterial genomic DNA 
kit (Sigma® Life Science, St. Louis, MO, USA). The steps include cell lysis, DNA binding 
to a column, column washing and gDNA elution. The gDNA was eluted in a final volume 
of 80 µL. The quality and concentration of the gDNA were quantified using a NanoDrop® 
ND-1000 spectrophotometer (Thermo Fisher Scientific™, Waltham, MA, USA). The 
extraction was validated with a 260/280 ratio value of ~1.8. 
2.5.1.2 Annealing PCR 
Annealing PCR is a technique to construct DNA fragments by designing primers with a 
complementary sequence of the adjacent fragment of DNA. With this technique, a set of 




For the construction of the N. gonorrhoeae MS11 Δhdac::kanr two fragments of the hdac 
gene (NGFG_00325) and the kanamycin resistant gene (kan) were amplified by PCR. 
The primers were designed to possess the complementary sequence of the adjacent 
fragments, in order to obtain the sequence of the gene hdac with the insertion of the 





Table 2.5. Primers for the construction of N. gonorrhoeae MS11 Δhdac::kanr 













1 467 bp 
hdac1-F TGAAACTCTACGCCCTGTTG 23-42 
hdac1-R TCATTTTAGCCATAACGTTGTTCAGCAG 453-467 
3 501 bp 
hdac2-F TGAATTGTTTTAGTGTTTGAAACCGACCTTTT 620-638 
hdac2-R TTCAGACGGCATTTATATCG 1101-1120 
kan* 2 795 bp 
kan-F CTGAACAACGTTATGGCTAAAATGAGAATATCAC 1-22 




All PCRs were performed using the Q5® High-Fidelity DNA Polymerase ((New England 
BioLabs®, MA, USA)) and a T100™ thermal cycler (Bio-Rad Laboratories, Hercules, 
CA, USA). The parameters for the amplification for each of the three fragment are shown 
in the table 2.6. 
Table 2.6. Reagents and volumes for PCR mix 
Reagent Volume (µL) 
Final 
concentration 
5x Q5® reaction buffer 10.0 1x 
10 mM dNTPs 1.0 200 µM 
10 µM Forward primer 2.0 0.4 µM 
10 µM Reverse primer 2.0 0.4 µM 
Template DNA Variable < 1,000 ng 
5x Q5® high GC enhancer 10 1x 
Q5® High-Fidelity DNA 
polymerase 
0.5 0.02 U/µL 
Nuclease-free water To 50 µL - 
 
Table 2.7. PCR conditions for the amplification of the flanking sequences of hdac 
and the kanamycin resistant gene 
Step Temperature Time 




98 °C 10 s 
Annealing 50.8 °C 30 s 
Extension 72 °C 1:10 min 
Final extension 72 °C 3:00 min 





Finally, the three fragments were used for the PCR (table 2.8) as templates for the final 
construct (hdac1-kan-hdac2) following the PCR conditions shown in the table 2.9. This 
fragment was used to transform the strain of N. gonorrhoeae MS11. 
Table 2.8. PCR mix for the construction of hdac::kan 
Reagent Volume (µL) 
Final 
concentration 
5x Q5® reaction buffer 10.0 1x 
10 mM dNTPs 1.0 200 µM 
10 µM primer (hdac1-F) 2.0 0.4 µM 
10 µM primer (hdac2-R) 2.0 0.4 µM 
Template DNA hdac1 1.0 < 1,000 ng 
Template DNA hdac2 1.0 < 1,000 ng 
Template DNA kan 1.0 < 1,000 ng 
5x Q5® high GC enhancer 10 1x 
Q5® High-Fidelity DNA 
polymerase 
0.5 0.02 U/µL 
Nuclease-free water 21.5 - 
 
Table 2.9. Thermal cycler settings for the construction of hdac::kan 
Step Temperature Time 
Initial denaturation 98 °C 1:00 min 
Denaturation 
30 cycles 
98 °C 10 s 
1st annealing 60 °C 30 s 
2nd annealing 52 °C 30 s 
Extension 72 °C 2:30 min 
Final extension 72 °C 6:00 min 





2.5.1.3 DNA gel extraction 
Amplicons from PCR were extracted from agarose gels whenever secondary amplicons 
were detected by the transilluminator. Samples were run on a 0.6% agarose gel at 110 V 
for 70 min using a PowerPac™ 300 power supply (Bio-Rad Laboratories, CA, USA). The 
DNA product was then purified from the electrophoresis gel following the protocol of 
Monarch® DNA gel extraction kit (New England BioLabs®, MA, USA). The DNA was 
quantified in a NanoDrop 1000 spectrophotometer (Thermo Scientific™, Waltham, MA, 
USA). If the concentration of the sample was low (<40 ng/µL), thus was concentrated 
using a concentrator 5301 (Eppendorf, Hamburg, Germany) and re-suspended in nuclease 
free water to obtain a minimum DNA concentration of 100 ng/µL and a 260/280 ratio of 
at least 1.8.  
2.5.1.4 Agar spot transformation and mutant selection 
The spot transformation on agar plates protocol was followed as described previously by 
Dillard, 2011. On a chocolate agar plate, 12 µL of PCR product (≈ 2 µg DNA) r were 
added on 2 different locations of the plate were the bacteria growth is medium and thin. 
Colonies of N. gonorrhoeae MS11 grown overnight on chocolate agar were streaked on 
the DNA spots once they were dried. The plates were incubated as described in section 
2.2.1.1 for 48 h.  
Colonies that grew were streaked individually on GC agar supplemented with 80 µg/mL 
kanamycin and grew overnight as described in section 2.2.1.1. After 48 h the grown 
colonies were inoculated in liquid medium for PCR, sequencing and cryogenic 
conservation. The colonies that showed the correct sequencing were stored at -80 °C and 




 Neisseria gonorrhoeae with GFP 
N. gonorrhoeae possesses the ability to survive within macrophages (Château and Seifert, 
2016). Therefore, the construction of N. gonorrhoeae with GFP expression could show 
us by microscopy if the acetylation affects the mechanisms that help gonococci to remain 
within immune cells. In order to achieve this, a vector carrying the gfp gene of Aequoria 
victoria able to be transformed into N. gonorrhoeae was constructed. pLES2 is a plasmid 
that has shown to transform strains of both E. coli and N. gonorrhoeae (Stein et al., 1983).  
2.5.2.1 Transformation and plasmid pBHR1-GFP purification  
A vial with 200 µL of competent E. coli DH5α was taken from the -80 °C and thawed on 
ice. 2 µL of pBHR1-GFP was added and incubated on ice for 1 h. Then the 
microcentrifuge tube was hot shocked at 48 °C for 90 s and incubated on ice for 5 min. 
800 µL LB broth were added and the tube was incubated for 1 h at 37 °C with shaking at 
180 rpm. 100 µL of culture were plated on LB agar with 100 µg/mL kanamycin (LB-
Kan100) plate and incubated as described above (section 4.2.1). Colonies grown on the 
agar were streaked on LB-Kan and to verify that the strain was producing GFP the plate 
was located onto a UV transilluminator to observe fluorescence. The plasmid was 
extracted following the protocol of the E.Z.N.A.® Plasmid Mini Kit I (Omega Bio-tek, 
GA, USA) and a 0.6% agarose gel was run at 110 V for 70 min to verified the size of the 
vector.  A set of primers were designed to amplify the gfp gene containing a BamHI 





Table 2.10. Primers for the amplification of the gfp gene from pBHR1-GFP 
 
** Underlined sequence corresponds to the BamHI restriction site. 
 
Table 2.11 PCR mix for amplification of gfp 
Reagent Volume (µL) 
Final 
concentration  
 5x Q5® reaction buffer 10.0 1x 
10 mM dNTPs 1.0 200 µM 
10 µM Forward primer 2.0 0.4 µM 
10 µM Reverse primer 2.0 0.4 µM 
Template DNA Variable < 1,000 ng 
5x Q5® high GC enhancer 10 1x 
Q5® High-Fidelity DNA 
polymerase 
0.5 0.02 U/µL 
Nuclease-free water To 50 µL - 
 Table 2.12. Thermal cycler settings for gfp amplification 
Step Temperature Time 




98 °C 10 s 
Annealing 48 °C 30 s 
Extension 72 °C 1:10 min 
Final extension 72 °C 3:00 min 
Hold 4 °C ∞ 
Strain 
constructed 






gfp 1194 bp 
BamHI** F GGTCAGGGATCCCTCCCTTTTGGTGTCC 1-18 




A PCR for gfp amplification was performed with the Q5® High-Fidelity DNA 
Polymerase (table 2.11) using a T100™ thermal cycler (Bio-Rad Laboratories, Hercules, 
CA, USA) set with the parameters of the table 2.12.  
The PCR sample was run in an agarose gel and the band corresponding to gfp (~ 1.2 kb) 
was extracted from the gel as mentioned previously. The purified product was then ligates 
to the pLES2 plasmid. 
2.5.2.2 pLES2-GFP construction 
E. coli DH5α was transformed with pLES2 as described above, however, for the selection 
of the transformed colonies LB agar with IPTG/X-Gal and 100 µg/mL ampicillin (section 
4.3.2) was used, selecting the blue colonies. The plasmid was then extracted and a 0.6% 
agarose gel was run as described above to confirm the plasmid extraction. pLES2 and gfp 
PCR product were digested with BamHI enzyme (New England BioLabs®, MA, USA) 
using 600-1500 ng of DNA. The digestion was at 37 °C for 1.5 h and the samples were 
run on an agarose gel to check the restriction digestion. 
pLES2 vector and the gfp PCR product were then ligated with a T4 ligase (Thermo 
Scientific™, Waltham, MA, USA) using a DNA to vector ratio of 3:1. The reaction was 
incubated at 22 °C for 15 min and 10 µL of the suspension were dispersed on a LB agar 
with IPTG/X-Gal and 100 µg/mL ampicillin. The plates were incubated at 37 °C 
overnight and white colonies were re-cultured on same agar plates. To prove the 
construction of pLES2-GFP, plasmid extraction was made as described above and a 0.6% 
agarose gel was run.  
E. coli DH5α was then transformed with pLES2-GFP following the protocol mentioned 




ampicillin. The plasmid was extracted and it was stored at -20 °C until used for the 
transformation of N. gonorrhoeae. 
All steps of the construction of the plasmid were verified by DNA sequencing.  
 Construction of E. coli BL21 for Pta overexpression  
In this study, as later will be explained, the enzyme phosphotransacetylase (NGFG00350) 
from N. gonorrhoeae MS11 is proposed as a good target for an antimicrobial molecule. 
However, there is no structure of the enzyme and a crystal was needed. Therefore, the 
enzyme was overexpressed in E. coli BL21. 
2.5.3.1 PCR of pta with polyhistidine tag (pta-his) 
The system his-tag was used to purify the enzyme. This mechanism works through the 
addition of 6 histidine at the N- terminus or C-terminus of the enzyme, in this study was 
used the latter since the cleavage of the histidine tag is not necessary. 
A PCR was performed using gDNA from N. gonorrhoeae MS11 as DNA template. The 
primers (table 2.13) were designed to contain the his-tag, and two different restriction 
sites. The first restriction sequence corresponded to NcoI, this restriction enzyme was 
selected because it codifies for a methionine, amino acid required for the open reading 
frame. The second restriction enzyme was BamHI. The two restrictions sites are present 
in the plasmid pET28 where the pta-his was transformed.  






Table 2.13 Primers for the PCR of pta-his 
 
 
Table 2.14 Thermal cycler settings for pta-his amplification 
Step Temperature Time 




98 °C 10 s 
Annealing 63 °C 30 s 
Extension 72 °C 1:00 min 
Final extension 72 °C 2:00 min 
Hold 4 °C ∞ 
 






pta 1541 bp 
NcoI** F CTGAGTCCATGGCAAAAGTACTCGTCGTAC 1-31 
BamHI** and 
6x his tag 




2.5.3.2 Construction of plasmid pET28-pta-his 
The plasmid pET28 is used for the overexpression of proteins due to the presence of the 
lac promoter that is activated by the addition IPTG in the medium.  
1.1.3.2.1. Plasmid extraction 
E. coli α pET28 was grown overnight on an LB agar supplemented with 50 µg/mL 
kanamycin (LB-Kan50) at 37 °C and then in a liquid medium of LB-Kan50 overnight 
with shaking at 37 °C. The plasmid was extracted following the protocol of the E.Z.N.A.® 
Plasmid Mini Kit I (Omega Bio-tek, GA, USA) and the sample was run in a 0.6% agarose 
gel to check the size and success of extraction. Then it was quantified using a NanoDrop® 
ND-1000 spectrophotometer (Thermo Fisher Scientific™, Waltham, MA, USA). The 
extraction was validated with a 260/280 ratio value of ~1.8 and a concentration higher 
than 100 ng/µL. 
1.1.3.2.2. Restriction enzyme digestion 
For the restriction, 2 µg of plasmid pET28 and pta-his amplicon were enzymatically 
digested with NcoI and BamHI (New England BioLabs®, MA, USA) for 2 h at 37 °C in 
50 µL volume. Each sample was run in a 1.4% agarose gel at 100 V for 80 min using a 
PowerPac™ 300 power supply (Bio-Rad Laboratories, CA, USA) to prove the efficacy of 
the digestion. 
1.1.3.2.3. Ligation and transformation 
In order to construct the pET28-pta-his the PCR product was ligated to the pET28 vector 
using the T4 ligase (Thermo Fisher Scientific™, Waltham, MA, USA). It was used an 
insert-plasmid ratio of 3:1 and it was followed the protocol. Two different ligation 
reactions were set a 16 and 22 °C for 15 min and 1 h, respectively. Then the T4 ligase 




described in section 2.2.6.1 in a strain of E. coli XL-1 blue and the plasmid was then 
extracted for the transformation of E. coli BL21-D3. 
To validate and confirm the correct ligation of the pta-his insert into the pET28 vector, a 
PCR (table 2.16) was performed using universal T7 polymerase primers (table 2.15). 
Table 2.15 Primer for insert validation of the vector pET28 






Table 2.16 Thermal cycler settings for T7 polymerase amplification with pta-his 
insert 
Step Temperature Time 




98 °C 10 s 
Annealing 55 °C 30 s 
Extension 72 °C 1:15 min 
Final extension 72 °C 3:00 min 
Hold 4 °C ∞ 
 
2.5.3.3 Construction of E. coli BL21-DE3 pET28a-pta-his 
E. coli Bl21-D3 is a strain that is widely used in laboratories for the overexpression of 
proteins due to the presence of T7 RNA polymerase and the lactose operon repressor 





E. coli BL21-D3 was transformed with the pET28 pta-his vector following the protocol 
of section 2.2.6.1. The bacteria was grown overnight at 37 °C on LB-Kan50 agar plates 
for the selection of transformed colonies. A screening PCR, described in section 2.2.7.2.3 
was performed to the grown colonies to confirm the successful transformation. The 
amplicon was cleaned up and sent for sequencing. The selected colony was cryogenic 
preserved as described in section 2.4. 
2.6 DNA sequencing 
DNA sequencing was used in order to check if the obtained colonies possessed the correct 
DNA insert. Briefly, PCR products, plasmids, and primers were diluted to 50 ng/µL, 100 
ng/µL, and 1 pmol/µL in a final volume of 10 µL distilled water, respectively. All 
sequencing were performed at the Genomics Core Facility, The Medical School, 
University of Sheffield, UK.  
2.7 Enzymatic assay 
In order to prove that the mutant strains of N. gonorrhoeae MS11 lack of enzymatic 
activity on the mutated genes ackA and pta, an enzymatic assay was assessed for each 
enzyme. 
 Cell free extract (CFE) 
CFE was obtained from the three strains of N. gonorrhoeae, WT, ΔackA and Δpta. Liquid 
cultures of each strains were grown in 30 mL BHI-Y at 37 °C overnight at 180 rpm. The 
culture was transferred to a 500 mL capped flask containing 450 mL BHI-Y and incubated 
overnight at 37 °C at 120 rpm. The culture was centrifuged at 12,000 x g for 15 min in an 
Avanti J-26XP high-speed centrifuge (Beckman-Coulter, Krefeld, Germany) using a Jla 




The supernatant was discarded and the pellet was re-suspended in 20 mL 10 mM Tris/HCl 
buffer (pH 8.0) in a 50 mL tube and it was centrifuged at 12,000 x g for 15 min using a 
Jla 25.50 rotor. The pellet was re-suspended in 2 mL 10 mM Tris/HCl buffer (pH 8.0) in 
a 20 mL capped tube and it was sonicated 7 times during 30 s each at 20 amplitude 
maintaining the tubes on ice during sonication. The suspension was transferred to a 1.5 
mL microcentrifuge tubes and centrifuged at 13,000 x g for 25 min at 4 °C in a Mikro 
220R centrifuge (Hettich, Tuttlingen, Germany). The supernatant was then transferred 
into a 1.5 mL microcentrifuge tubes. The protein concentration was quantified at a 280 
nm wavelength using a NanoDrop 1000 spectrophotometer (Thermo Scientific™, 
Waltham, MA, USA) and stored at -20 °C until use. 
 Acetate kinase (AckA) activity assay 
The quantification of AckA activity was determined using a modified version of a couple 
reaction protocol (Allen et al., 1964). The activity was traced by detecting the formation 
of ADP from ATP and acetate at 340 nm by coupling the reaction with the reduction of 
NAD+ with the enzymes pyruvate kinase and lactate dehydrogenase (fig 4.1). To the 
reaction was added P1, P5-Di(adenosine-5')pentaphosphate (Ap5A) to inhibit the activity 
of adenylate kinase, an enzyme that is involved in the regulation of ATP, ADP and AMP. 
A 1 mL final volume of the reaction mix (table 4.5) was added into quartz SUPRASIL® 
cuvette with a 10 mm light path (Hellma® Analytics, Müllheim, Germany). The cuvette 
was inserted into the spectrophotometer and the reaction was started by the addition of 
the CFE. A BioSpectrometer Kinect spectrophotometer (Eppendorf, Hamburg, Germany) 
was used for the enzymatic assay and it was set to a 340 nm wavelength at 37 °C and 
interval readings of 15 s during 60 m. All the reactions were standardised with the same 









1.5 M Tris/HCl buffer (pH 8.0) 100 mM 66.7 
0.1 M MgCl2 
. H2O 2 mM 20 
0.1 M Phosphoenolpyruvate (PEP) 2 mM 20 
5 mM NADH 0.1 mM 20 
3 U/µL Pyruvate kinase 9 U 3 
7 U/µL malate dehydrogenase 26 U 3.7 
10 mM Ap5A 0.2 mM 20 
100 mM Acetate 2 mM 20 
75 mM ATP 1.5 mM 20 
CFE 8-15 mg/mL  Variable 
H2O  to 1 mL 
 
Lactate Pyruvate









Figure 2.1. Couple reactions for the determination of AckA activity. The reaction was 
linked with the activity of lactate dehydrogenase (LDH) and pyruvate kinase (PK) in order to 
determine the activity of acetate kinase (AK). PEP, phosphoenolpyruvate. (Adapted from: Allen 





 Phosphotransacetylase (Pta) activity assay 
The determination of Pta activity was performed using a modified couple reaction 
protocol (Pickett, Williamson and Kelly, 1994). Pta activity was traced by coupling three 
reactions which are involved in the acetyl-CoA dependent synthesis of citrate. NADH 
formation was measured at 340 nm whereas its formation by malate dehydrogenase is 
negligible in the absence of acetyl-CoA (fig. 2.2).  
A 1 mL final volume of the reaction mix (table 2.18) was added into quartz SUPRASIL® 
cuvette with a 10 mm light path (Hellma® Analytics, Müllheim, Germany). The cuvette 
was inserted into the spectrophotometer and when a baseline was observed, acetyl-
phosphate was added to start the reaction. A BioSpectrometer Kinect spectrophotometer 
(Eppendorf, Hamburg, Germany) was used for the enzymatic assay and it was set to a 
340 nm wavelength at 37 °C and interval readings of 15 s during 60 min. All the reactions 
were standardised with the same amount of protein and a reaction mix containing no CFE 
was used as blank. 





1.5 M Tris/HCl buffer (pH 8.0) 100 mM 66.7 
0.1 M MgCl2 
. H2O 2 mM 20 
50 mM NAD+ 1 mM 20 
5 mM CoA-SH 0.2 mM 40 
250 mM D/L malic acid 5 mM 20 
6 U/µL malate dehydrogenase 12 U 2 
3 U/µL citrate synthase 25 U 8 




H2O  to 1 mL 
200 mM AcP 10 mM 50 
 
Malate Oxaloacetate












Figure 2.2. Coupled reactions for the determination of Pta activity. Pta activity was 
determined by tracing the formation of acetyl-CoA reaction coupled to citrate synthase and malate 
dehydrogenase that produces NADH which can be measure at 340 nm (Adapted from: Whiteley 
and Pelroy, 1972). 
 





Where the enzyme activity (Δc) is derived from the change in absorbance per minute 
(ΔA), divided by the mM absorptivity of the product (ε) which is NADH (6.22 mM-1 cm-
1) and the path length of light through the sample which was 1 cm. 
The activity is expressed in nano moles of product synthesise per minute per mg of protein 




2.8 Acetyl-phosphate (AcP) quantification 
The different strains of N. gonorrhoeae MS11 were thought to have varying 
concentrations of AcP. Therefore, it was used a method that quantifies the amount of AcP 
by determining the ATP released in the reaction of AcP to acetate performed by acetate 
kinase. The assay was followed as previously (Ramos-Montañez et al., 2010; Weinert et 
al., 2013) with the following modifications. 
35 mL of BHI-Y cultured were grown for 10 h from an initial OD 600 0.5. The culture was 
centrifuged at 3,500 rpm x g for 20 min at 4 °C in an Allegra™ X-22R centrifuge 
(Beckman-Coulter, Krefeld, Germany). The pellet was washed twice with 500 µL ice-
cold assay buffer (10 mM sodium phosphate [Na3PO4] pH 7.5; 10 mM MgCl2; 1 mM 
EDTA) and centrifuge at 13,000 x g for 2 min in 5415 D centrifuge (Eppendorf, Hamburg, 
Germany). 20 µL were set aside for protein quantification reading the sample at OD280. 
Protein concentration was used to normalise AcP measurements. Cell suspensions were 
extracted by addition of 100 µL 3 M HClO4 (perchloric acid) and incubated on ice for 30 
min. The suspensions were clarified by centrifugation at 10,000 x g for 2 min at 4 °C and 
the supernatant neutralised with 100 µL saturated KHCO3 (potassium bicarbonate). The 
samples were then clarified by the same centrifugation conditions and the supernatant 
was transferred to a new 1.5 mL microcentrifuge tube with 30 mg activated charcoal to 
remove ATP. Lysates were incubated on ice for 15 min and then filtered to remove the 
charcoal using a sterile and endotoxin free 0.2 µm PES filter PuradiscTM (GE Healthcare, 
UK). 
The lysates were divided in three groups; ATP conversion assays for AcP measurements; 
control reactions without acetate kinase and ATP measurement for efficiency of ATP 




MgCl2, 4 µL 300 mM ADP, and 4 µL 0.4 U/µL acetate kinase. The assay was performed 
in triplicates and the control reaction contained the same reagents except ice-cold buffer 
was used instead of the enzyme, the control assay was performed in duplicates. The tubes 
were mixed and incubated at 37 °C for 90 min. ATP was determined by mixing 50 µL of 
the reaction with 50 µL CellTiter-Glo® reagent (Promega, Madison, WI, USA), which is 
a luminescent viability assay that quantifies the amount of ATP by the reaction of 
luciferase that converts luciferin to oxyluciferin with the release of light. ATP 
measurement was performed to determine the level of ATP contamination of the sample 
by mixing 50 µL of the filtrated lysate with 50 µL CellTiter-Glo® reagent.  
To validate the results, a control for the recovery of AcP was performed. This control was 
done by adding known samples of AcP (1, 5, 10, 25, and 50 µM) to the reaction mix 
instead of the sample at the beginning of the procedure. ATP concentrations were 
determined by comparing the results to an ATP standard curve (1, 5, 10, 25, and 50 µM). 
A specific concentration of ATP was added into the reaction and the procedure was 
followed as described above but without the addition of charcoal and the posterior 
filtering. As with the samples, the control and the ATP standard curve, were mixed 1:1 
with the CellTiter-Glo® reagent in triplicates.  
The samples were read on a Varioskan™ Flash multimode reader (Thermo Scientific™ 
Nalgene™, Waltham, MA, USA), instrument that can detect luminescence released by 
the luciferase. The samples were loaded on a Microfluor® 1 black 96-well microplate with 
flat bottom (Thermo Scientific™, Waltham, MA, USA). The concentration of AcP and 




2.9 Carbon source utilisation 
N. gonorrhoeae can only metabolise three molecules as carbon and energy sources 
(Mcgee and Rest, 1996). The four different strains of gonococci were grown on the CDM-
GC supplemented with glucose, lactate or pyruvate, in order to determine if the mutations 
in the ackA, pta, and hdac genes affected the metabolism of these three carbon sources.  
 Growth conditions 
The four strains of N. gonorrhoeae MS11, WT, Δhdac, ΔackA and Δpta, were grown on 
CHO agar for 18 h as described in section 2.2.1.1. Colonies were taken from the agar 
plates and inoculated each strain in two 25 mL capped tubes (Sarstedt, Nümbrecht, 
Germany) containing 10 mL CDM-GC supplemented with glucose section 2.2.1.2. The 
tubes were incubated at 37 °C with shaking at 180 rpm for 16 h. Then they were 
centrifuged at 4,000 x g for 10 min, and the pellets were re-suspended with 10 mL CDM-
GC with the carbon source to test, either lactate or pyruvate. The growth was measured 
using an Ultrospec III spectrophotometer (Pharmacia, Sweden) at 600 nm in disposable 
1.5 mL polystyrene cuvettes with a 10 mm light path (Sarstedt, Nümbrecht, Germany). 
The culture was adjusted to a final 0.05 OD600 with the bacterial culture and the CDM-
GC with the supplemented carbon source to test. The amount of culture to use for the 
adjustment of optical density was calculated using the formula: 
Volume of culture =
0.75
OD600 of stock culture
 
An initial OD600 was measured and the tubes were incubated at 37 °C with shaking at 180 




2.10 Detection of lysine acetylated proteins 
The constructed mutants are involved in the production of acetyl phosphate and in the 
deacetylation. In order to compare a difference in the acetylation of proteins between the 
four strains of N. gonorrhoeae MS11, an anti-acetyllysine antibody was used to screen 
the acetylated proteins. 
 Sample preparation 
Samples collected from the growth curves (section 4.8) were thawed and centrifuged at 
13,000 x g for 3 min in a 5415 D centrifuge (Eppendorf, Hamburg, Germany). Then the 
pellet was re-suspended in 100 µL modified Laemmli buffer (240 mM Tris-HCl pH 6.8, 
10% glycerol (v/v), 2% SDS (w/v)) and heated at 95 °C for 10 min. The concentration of 
total proteins was quantified in a NanoDrop 1000 spectrophotometer (Thermo 
Scientific™, Waltham, MA, USA). The samples were stored at -20 °C until use. 
 Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
The SDS-PAGE gel was prepared as described in table 2.19. The samples were loaded at 
a normalised concentration in two different gels, used for Coomassie staining and western 
blot. The samples were loaded using 4x Laemmli buffer (1 M Tris-HCl, 8% SDS (w/v), 
40% glycerol (v/v), 10% β-mercapto ethanol (v/v), 0.04% bromophenol blue (w/v)). The 
gels were run in a denaturing buffer (0.25 M Tris, 1.9 M glycine, 0.03 M SDS) at 100 V 
for 45 min and then at 150 V for 1.5 h using a PowerPac™ 300 power supply (Bio-Rad 





Table 2.19. Preparation of 12% SDS-PAGE 
Reagent Resolving gel Stacking gel 
Acrylamide 3 mL 0.63 mL 
H2O 4.3 mL 3.2 mL 
10% APS 100 µL 50 µL 
10% SDS 100 µL 50 µL 
Tris-HCl 1.5 M pH 8.8 2.5 mL - 
Stacking buffer - 0.63 mL 
TEMED 10 µL 4 µL 
 
For the observation of total proteins, one of the gels was stained during 3 h in Coomassie 
blue solution (50% methanol (v/v), 10% glacial acetic acid (v/v), 0.25% Coomassie blue 
(w/v)) and then detained until the protein bands were observed with a destaining solution 
(40% methanol (v/v), 10% glacial acetic acid (v/v)). 
 Western immunoblot 
To detect the lysine acetylated proteins, a western blot was performed using SDS-PAGE 
gel. The proteins were transferred to an Amersham™ Protran™ nitrocellulose blotting 
membrane (GE Healthcare Life Science®, Piscataway, NJ, USA) in a transfer buffer (25 
mM Tris, 190 mM glycine, 20% (v/v) methanol) at 120 V for 2 h using a PowerPac™ 300 
power supply (Bio-Rad Laboratories, Hercules, CA, USA). The blot was then blocked in 
PBST (PBS with 0.1% Tween® 20 (v/v)) with 5% skimmed milk (w/v) for 1 h. The blot 
was located into a 50 mL falcon tube (Sarstedt, Nümbrecht, Germany) containing 10 mL 
PBST with 5% skimmed milk. An anti-acetyllysine monoclonal rabbit antibody (9441 
Cell Signaling Technology®, MA, USA) was added (1:1,000) and the tube was incubated 
at 4 °C on a shaker overnight. The blot was washed three times with PBST with shaking 




antibody (Cell Signaling Technology®, Danvers, MA, USA) was used at a 1:5,000 
dilution in PBST with 5% (w/v) skimmed milk for 1 h with gentle shaking at room 
temperature. The membrane was washed as described above. To reveal the blot 4 mL of 
the chemiluminescence substrate (Amersham™ ECL™ GE Healthcare Life Science®, 
Piscataway, NJ, USA) were added and a ChemiDoc™ XRS+ System imager (Bio-Rad 
Laboratories, Hercules, CA, USA) was used to image the bands. The software was set to 
take images every 3 min during 15 min. 
2.11 Acetylome 
The acetylome is the study of all the protein lysine acetylation sites of an organism. In 
this study, we used a sensitive immune-affinity purification and high-resolution LC-
MS/MS to identify all the acetylation sites of the four different strains of N. gonorrhoeae 
MS11. 
 Cell free extract (CFE) 
The four strains of N. gonorrhoeae MS11, WT, Δhdac, ΔackA and Δpta, were grown in 
different steps to amplify the biomass to have a final culture of 1 L. For each strain, four 
replicates were prepared. The strains were streaked on  CHO agar at 37 °C for 18 h. 
Capped tubes of 25 mL (Sarstedt, Nümbrecht, Germany) containing 15 mL CDM-GC 
supplemented with glucose each were inoculated with the bacteria and incubated at 37 °C 
with shaking at 180 rpm in a C25KC incubator shaker (New Brunswick Scientific, NJ, 
USA) for 18 h. The growth was measured using an Ultrospec 2100 pro spectrophotometer 
(Biochrom, Cambridge, UK). Falcon tubes of 50 mL (Sarstedt, Nümbrecht, Germany) 
were inoculated and adjusted to an OD600 0.05 with the growth and CDM-GC with 
glucose in a final volume of 40 mL. The tubes were then incubated at 37 °C and with 




supplemented with glucose divided in 50 mL falcon tubes, adjusting the culture to an 
OD600 0.1. The tubes were incubated as previously described for 7 h to reach the 
logarithmic bacterial growth. The culture was transferred into two 1 L bottles (Thermo 
Scientific™ Fiberlite™, Waltham, MA, USA) and centrifuged at 15,500 x g for 40 min 
at 4 °C in a Sorvall Lynx 6000 ultracentrifuge (Thermo Scientific™, Waltham, MA, 
USA). The pellet was then re-suspended with 19 mL PBS, previously filtered with an 
endotoxin free 0.2 µm PES filter PuradiscTM (GE Healthcare, UK) and transferred to a 25 
mL capped tube. The tube was centrifuged at 4 °C and 3,900 x g for 35 min in an Allegra™ 
X-22R centrifuge (Beckman-Coulter, Krefeld, Germany). The pellet was then re-
suspended with 2.5 mL denaturation buffer (denaturation buffer composition). The 
sample was then sonicated on ice ten times using a Vibracell sonicator (Sonics & 
Materials, Danbury, CT, USA) at ~20 A for 30 s. The sample was transferred to 1.5 mL 
microcentrifuge tubes and centrifuged at 30,000 x g for 20 min at 4 °C in a Mikro 220R 
centrifuge (Hettich, Tuttlingen, Germany). The supernatant was transferred to a new 2.5 
mL microcentrifuge tube and stored at – 20 °C. A 50 µL aliquot was taken for protein 
quantification using the Pierce BCA protein assay kit (Thermo Scientific™, Rockford, 
IL, USA) and a Varioskan™ Flash multimode reader (Thermo Scientific™ Nalgene™, 
Waltham, MA, USA) to read the absorbance of the solution at 562 nm. Each sample was 
expected to contain at least 10 mg of protein for a good resolution in the mass 
spectrometry. 
 Sample preparation for LC-MS/MS 
The preparation of the sample comprises reduction, alkylation, peptide digestion, 
desalting, and immunoaffinity purification. This protocol was performed in the Biological 





2.11.2.1 Reduction and alkylation 
The proteins prior to analysis have to be in a denaturalised conformation. Therefore, the 
disulphide bonds are cleaved using an oxidising reagent, then the reduced sulphur groups 
are alkylated in order to  avoid the oxidation and re bonding of the disulphide bonds 
(Müller and Winter, 2017). 
The samples were reduced using 0.5 M tris-2(-carboxyethyl)-phosphine (TCEP) to a final 
concentration of 10 mM and incubated at 37 °C for 15 min. Then it was alkylated with 
0.5 M iodoacetamide to a final concentration of 20 mM, and incubated at 37 °C for 15 
min, covering from light. The sample was then diluted eight folds with 50 mM ammonium 
bicarbonate in order to dilute the urea from 8 M to 1 M. 
2.11.2.2 Trypsin digestion 
Trypsin is a serine protease that cleaves the carboxyl side of arginine and lysine residues. 
This protease is used for acetylome analysis since lysine acetylated residues are not 
cleaved by the enzyme.  
Trypsin-TPCK (Cell Signaling Technology®, MA, USA) was diluted in 0.1% 
trifluoroacetic acid (TFA) and 300 µg were added to the sample and incubated overnight 
at 37 °C and shaking at 150 rpm. 
2.11.2.3 Desalting 
The next step of the sample preparation is the depletion of salts that could affect the 
electrospray ionisation (ESI). This is achieved by using a column with a hydrophobic 
material, this leads to the binding of the peptides and the elution of salts, DNA/RNA, and 




The sample was first acidified, in order to remove fatty acids, with 100% TFA until a pH 
3.0 was reached measuring with pH strips. The sample was centrifuged at room 
temperature at 4,150 x g for 5 min, this to remove any precipitation as consequence of the 
addition of TFA. The supernatant was transferred to a new 50 mL falcon tubes. 
Before loading the sample, the column was connected to a 20 mL syringe. Using a 
Preppy™ 12-Port vacuum manifold (Sigma Aldrick, Oakville, Canada) the column was 
first conditioned with 10 mL of 100% acetonitrile (ACN) followed by 5 mL of 50% ACN 
and 0.1% TFA. Then the cartridge was equilibrated with 10 mL of 0.1% TFA. The 
acidified sample was slowly loaded three times on an empty syringe connected to a 360 
mg silica Sep-Pak® C18 column (Waters, Ireland). The cartridge was then washed with 10 
mL of 0.1% TFA and it was slowly eluted with 4 mL of 50% ACN and collected in two 
2 mL microcentrifuge tubes. The sample was dried down in a concentrator 5301 
(Eppendorf, Hamburg, Germany), before fully dried the sample was re-suspended with 
1.4 mL of 1X immunoaffinity purification buffer (PTMScan® IAP buffer 10X, 9993 Cell 
Signaling Technology®, MA, USA). 
2.11.2.4 Immunoaffinity purification (IAP) 
The purification of peptides with the PTM of acetylation requires the enrichment of this 
type of peptides with an antibody that binds to lysine acetyl residues. A kit from Cell 
signalling containing beads covered with anti-acetyllysine antibodies was used to purify 
the acetylated peptides from the solution. 
The beads were washed with 1 mL of PBS and centrifuged at 4 °C for 30 s at 2,000 x g, 
this step was repeated four times. Afterwards, the beads were re-suspended in 40 µL of 
PBS. Before the addition of the samples, the pH was measured and adjusted with 1 M 




incubated at 4 °C for 2 h on a rotor. The tube was then centrifuged at 2,000 g for 30 s at 
4 °C and the supernatant was transferred to a new tube and saved at -20 °C. The following 
steps were performed at 4 °C. 1 mL of IAP buffer was added and the tube was inverted 
five times to mix the beads. Then it was centrifuged at 2,000 x g for 30s and the 
supernatant removed, the wash and centrifugation were repeated one more time. 1 mL of 
HPLC water was added and mixed by inverting the tube five time. The tube was then 
centrifuged at 2,000 x g for 30s. The last two steps were repeated two more times. The 
remained water was removed using a gel loading tip. Then 55 µL of 0.15% TFA were 
added to the beads and incubated at room temperature for 10 min with shaking at 800 
rpm. The supernatant was transferred to a microcentrifuge tube and the beads were 
washed once again with 50 µL of 0.15% TFA and centrifuged as previously described. 
2.11.2.5 Concentration and purification of peptides for LC-MS/MS  
A last purification was performed using 200 µL C18 stage tips (Thermo Scientific™, 
Waltham, MA, USA).  The stage tip was washed with 100 µL of 0.1% TFA/50% ACN 
followed by 100 µL 0.1% TFA. The sample was passes through the stage tip three times 
and it was then washed 3 times with 100 µL of 0.1% TFA. The sample as then slowly 
eluted with 100 µL of 0.1% TFA/50% ACN. The sample was then dry in vacuum 
concentrator and re-suspended in 20 µL of HPLC water. 
2.12 LC-MS/MS 
The samples were processed by the bIOMICS facility in the University of Sheffield. The 
samples were loaded in a Orbitrap Elite™ Hybrid Ion Trap-Orbitrap (Thermo 
Scientific™ , Waltham, MA, USA) coupled to a Dionex Ultimate 3000 HPLC system 




EASY-Spray™ Ion Source (Thermo Scientific™ , Waltham, MA, USA) for ease of 
sample delivery and improved sensitivity through nanolitre flow rates. 
 Data analysis of MS 
Raw data was analysed using MaxQuant software version 1.6.5.0 (Tyanova, Temu and 
Cox, 2016). The peptides were analysed against N. gonorrhoeae FA1090 proteomic 
database. Trypsin was set as the enzyme with a maximum of three missed cleavages. The 
precursor ion tolerance was set to 20 ppm and the fragment ion tolerance was set to 0.5 
Da. Carbamidomethylation in cysteine was set as a fixed modification, while oxidation 
in methionine, acetyl (protein N-term) and acetyl in lysine were used as variable 
modifications. All peptides were used for quantification studies, but to find significantly 
acetylated peptides only those found in two or more replicates and with a FDR < 0.05 
were used (t-test adjusted for multiple testing using permutation-based FDR). Data 
filtering was carried out using the following parameters: Peptide false discovery rate 
(FDR) was set to 1%; minimum peptide length was set to 8; peptides used for protein 
quantification was set to razor and unique peptides. Further data processing was 
performed using the Perseus tool (version 1.6.7.0) and R version 3.6.3. 
2.13 Killing larvae assay 
Galleria mellonella (greater wax moth) larvae have been used as an in vivo model for the 
study of bacterial virulence (i.e. Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus) due to the similarities in the innate immune system with 
mammals and the ability to grow at 37 °C. G. mellonella possesses at least 8 different 
types of hemocytes, the innate immune cells of insects, each playing a specific role in the 
innate immune system. However, one of the hemocytes has the ability to phagocytose as 




ROS (i.e. O2−, H2O2, NO
−) (Jander, Rahme and Frederick, 2000; Peleg et al., 2009; 
Browne, Heelan and Kavanagh, 2013; Tsai, Loh and Proft, 2016). Therefore, this in vivo 
model was selected to test if larvae could be infected and killed by N. gonorrhoeae MS11 
and to observe if the acetylation of proteins is involved in the virulence of the bacteria.  
In order to determine if the gonococcus infects larvae a modified protocol of killing larvae 
assay was performed (Wand et al., 2011). N. gonorrhoeae MS11 WT was cultured on 
CHO agar overnight. 15 mL BHI-Y broth were inoculated and incubated overnight as 
described above (section 2.2.1.2). 5 mL BHI-Y were inoculated with the overnight culture 
and adjusted to an OD600 0.1. The tube was incubated at 37 °C for 4 h, time to reach mid-
exponential phase, on a rotary shaker at 180 rpm. The culture was centrifuged at 3,900 x 
g for 10 min in an Allegra™ X-22R centrifuge (Beckman-Coulter, Krefeld, Germany). 
The pellet was re-suspended with 2 mL sterile PBS and the suspension was adjusted to 
an OD600 of 0.5 equating to approximately 4x10
8 CFU/mL. Eight 10-fold serial dilutions 
were prepared using sterile PBS. Groups of 20 larvae were injected into the haemocoel 
via the hindmost left proleg of the larva (fig. 2.3) with 10 µL of the dilutions (102, 103, 
104, 105, 106, 107, 108) each using a semi-automatically PB-600-1 repeating dispenser 
(Hamilton®, NV, USA) affixed to a to a Gastight 500μl Hamilton syringe (Model 1750 
RN large hub SYR, with a 22 gauge, large hub RN NDL, 2 inch, point style 2 needle). 
Control groups were injected with 10 µL sterile PBS, or 10 µL heat killed bacteria boiled 
for 15 min at 95 °C. Another group was left untreated. The larvae were located in plastic 
Petri dishes and incubated at 37 °C in a CO2 incubator. Larvae were check at different 






Figure 2.3. Inoculation of G. mellonella with N. gonorrhoeae. The larvae was inoculated 
with N. gonorrhoeae into the haemocoel in the zone indicated with a black arrow.  
To calculate the number of inoculated bacteria Miles and Misra method was followed 
(Miles, Misra and Irwin, 1938), 10 μL of each dilution were spotted by triplicates onto a 
CHO agar and the plates were incubated as described in section 4.2.1. The colonies grown 
on the agar were counted and the CFU injected into larvae was calculated. 
To compare the virulence between the WT, ΔackA and Δpta strains of N. gonorrhoeae, it 
was followed the protocol as mentioned above with minor alterations. 15 larvae per strain 
were infected with the dilution 105 to 108. The dead/alive number of larvae were 
monitored at different time points. 
2.14 Macrophage killing assay 
This assay was performed to observe the capacity of intracellular survival of the four 
different strains of N. gonorrhoeae.  
 Blood samples 
The blood samples were obtained from volunteers after informed consent. The study was 
approved by the South Sheffield Research Ethics Committee with number 07-Q2305/7.  
 Monocyte-derived macrophage (MDM) differentiation  
Human monocytes were obtained from normal blood donor buffy coats by two-step 
gradient centrifugation. The monocytes differentiate after 14 days seeded in a 24 wells 





1 mL of RPMI 1640 supplemented with 10% of heated inactivated foetal bovine serum 
(HIFBS) and 2 mM L-glutamine to a final cell number of 2x105 cells/mL. The media 
culture was changed every 4 days and the cells were incubated at 37 °C in a 5% CO2 
atmosphere.  
 Killing assay 
The four strains of N. gonorrhoeae were cultured in 15 mL of BHI-Y for 18 h at 37 °C 
with shaking at 180 rpm. The OD was read on an Ultrospec 2100 pro spectrophotometer 
(Biochrom, Cambridge, UK) at 600 nm and 15 mL of BHI-Y were inoculated with 
bacteria to a final OD600 of 0.05 and incubated as previously mentioned for 4 h to reach 
the exponential phase. The tubes were centrifuged at 3,900 x g for 8 min at room 
temperature. The pellet was re-suspended with 1 mL of filtered PBS and transferred to a 
1.7 mL microcentrifuge tube for centrifugation at 12,000 x g for 2 min at room 
temperature the pellet was washed and centrifuged again. The pellet was re-suspended in 
2 mL of RPMI 1640 supplemented with 10% of HIFBS and 2 mM L-glutamine and the 
OD was read at 600 nm. 5 mL of RPMI were inoculated with the bacterial suspension at 
an OD of 0.01 which equivalents to a MOI of 5 and incubated at 37 °C for 30 min. The 
Miles-Misra method was performed on GC agar plates and incubated as mentioned in 
section 2.2.1. 
The medium from the plate with the MDM was removed and washed with 1 mL of cold 
sterile PBS. The PBS was removed and the bacterial suspension was added in triplicates 
for each strain. Three wells were inoculated only with the medium to be the negative 
control. The plates were centrifuged at 150 x g and 4 °C for 5 min. The two plates were 
incubated at 37 °C and 5% CO2 for 2 and 3 h. After incubation 100 µL of each well was 




of the last three dilutions were plated and incubated at 37 °C overnight to determine the 
bacterial CFU in the medium. The medium from the wells was removed and the wells 
were washed twice with 2 mL of ice cold sterile PBS. Then 1.5 mL of RPMI medium 
with 100 µg/mL of gentamicin were added to the wells. This step is too killed all the 
bacteria that are extracellular. The plates were incubated for 50 min at 37 °C in a CO2 
incubator. 
The wells were washed twice with 2 mL of ice cold sterile PBS and 250 µL of 1.5% 
saponin was added and the plates were incubated at 37 °C for 15 min in a CO2 incubator. 
Using 1 mL tips the wells were scrapped and the wells were washed with 750 µL of sterile 
PBS and the suspension was mixed with the pipette. Miles-Misra technique was 
performed as previously mentioned using the 100 and 10-1 to inoculate 10 µL on GC agar 
plates. The CFU colonies were counted after 48 h of incubation. 
2.15 Microscopy for in vitro killing assay 
The microscopy was performed using a Leica AF6000LX inverted microscope. It is fitted 
with an environmental chamber maintained at 37°C and equipped with a gas mixer for 
the supply of CO2. The microscopy was set to take pictures every 5 min during 9 h. The 
areas were chosen in the centre of the well with 10 pictures taken from three different 
wells for each strain.  
 Cell and bacteria staining 
The MDMs were obtained as mentioned in section 2.15 and dyed each well with 2 drops 
of NucBlue™ Live ReadyProbes™ Reagent (Thermo Fisher Scientific™, Waltham, MA, 
USA) 30 minutes before infection with the different isogenic strains of N. gonorrhoeae. 
Meanwhile the gonococcal strain were grown overnight at 37 °C in BHI medium as 




suspended with 1.6 mL PBS. The suspension was transferred and centrifuged at 12,000 x 
g for 2 min and re-suspended with 500 µL PBS. 200 µL of bacterial suspension were 
transferred to a microcentrifuge tube and 0.5 µL of pHrodo red succinimidyl ester 
(Thermo Fisher Scientific) was added. The tube was vortexed and incubated for 30 min 
and 37 °C on a shaker. The suspension was re-suspended in 1 mL Tris (2.5 mM; pH 8.4) 
and incubated for 1 min in dark. The tube was centrifuged at 12,000 x g and re-suspended 
with 1mL PBS. The OD was read in a spectrophotometre and the suspension was adjusted 
to a final OD600 of 0.005 in 1 mL RPMI. The MDMs were inoculated with a MOI of 5 
with the bacterial suspension.  
 Image analysis 
The image files were analysed in software ImageJ. The file was loaded in split channels 
and the channel 1 and 2 were used to quantify the number of bacteria and cells present in 
the image, respectively. The threshold to identify bacteria and cells was adjusted at a 
minimum of 22 and 24, respectively and a maximum of 255 for both channels. Then the 
images were converted to mask and finally, processed for analysis of particles (fig. 2.4). 
The measurements to analyse were number of bacteria or cells, area, total area and 





Figure 2.4 Image analysis process in ImageJ. Images obtained from fluorescence 
microscopy were analysed to quantify different parameters. In this figure is shown the process to 
analyse the file from the channel 2 which corresponds to the nuclei of the MDM. a) The image is 
loaded to the software; b) then a threshold is set to determine the best values to identify only the 
cells; c) the image is converted to mask; d) to be processed for the analysis of particles that 
quantifies the number of cells, size, area and total area. At the bottom right is a 50 µm bar scale. 
2.16 Gene expression quantification by RT-qPCR 
Several genes involved in the virulence of N. gonorrhoeae were analysed using RT-
qPCR. This technique quantifies the mRNA present within bacteria.  
 RNA extraction 
The four strain of N. gonorrhoeae were grown in 15 mL of BHI-Y medium for 18 h with 
shaking at 180 rpm. The OD600 was measured using a spectrophotometer 15 mL of BHI-
Y were inoculated with the bacterial suspension and adjusted to an OD600 of 0.1. The 




centrifuged at 3,900 x g for 8 min at 4 °C and the pellet was re-suspended with 1 mL of 
molecular grade water and transferred to a microcentrifuge tube. The tube was centrifuge 
at 12,000 x g for 2 min at room temperature. The RNA was extracted using the Monarch® 
total RNA miniprep kit (New England BioLabs®, MA, USA) with some modifications 
the sample two times through the gDNA removal column, incubating the sample 30 min 
with the DNase; washing thrice and eluting the sample with 80 µL of water. The RNA 
concentration was quantified with a NanoDrop® ND-1000 spectrophotometer (Thermo 
Fisher Scientific™, Waltham, MA, USA). The sample required a 280/260 ratio higher 
than 1.8 and a concentration higher than 50 ng/µL. 
 Genes and primers 
A total of 24 genes were analysed (table 2.20). Including genes involve in pili 
biosynthesis, two component system, transcriptional regulator, iron acquisition genes and 
metabolic genes. The primers were designed with Primer Blast website having as 
parameters; a product size between 140 and 180 bp; a primer melting temperature (Tm) 
between 60 and 62 °C; and a primer GC content of between 48 and 51%. This parameter 
were chosen in order to do the qPCR using the same settings for all the genes. Previous 
RT-qPCR the primers were validated by PCR of the gDNA of N. gonorrhoeae. 
Table 2.20 Genes and primer used for RT-qPCR 




AATTCCGATTAACGCTCGCACC 22 61.87 
149 
AAGGCCTTCGGGTTGTAAAGGA 22 61.89 
ackA  
GATCTTGGTTTTGAACTGCGGC 22 60.92 
162 
GCGGACAGATCGACTTTGTGTT 22 61.43 
hdac 
GGTTTGGAGGTGCTGCCAAATA 22 61.41 
180 
TTCCTGAAACTCTACGCCCTGT 22 61.35 
aceE E2 
GGAGATTTTGTCGCCGACTTTG 22 60.41 
154 
CGACATCATCGCCGTAGAAGTT 22 60.79 
fnr 
GGATGGCAAAGAGCGAGGTAAA 22 60.94 
153 
CTTCCTGTTCTTTGCGGGAACT 22 61.07 
hemO 
ATCAACCGCTTTGTGGAACACG 22 62.20 
160 





CACCAAGTCTTTGTTGTCGCGT 22 62.13 
179 
GCAGTATTTTCGGCAATCCGGT 22 61.83 
katA 
GTTGCCGACAATCAAAACAGCC 22 61.43 
160 
TTACGGTAAACGTACCGAACGC 22 61.23 
lst 
TCAGCACCACATAAAACCGCTC 22 61.45 
162 
TAAATCAGGGGGAAAGGAACGC 22 60.62 
misR 
ATCCAAGCCGTTCATTTTGGGC 22 62.31 
149 
TGACCGAACTGCTGACCGAATA 22 61.72 
misS 
AGACGGGGCTGTTTTTCCATTC 22 61.40 
156 
CTTTTTGGCTGGTGCAGAACAC 22 61.05 
mtrC 
TTGTTTACTGATGGCATCGGCG 22 61.82 
148 
GCTGTATCAGATCGACAGTTCCAC 24 61.26 
mtrD 
CAAACCTTCCACGCCGTTCATA 22 61.45 
165 
GCGGCAGGTATTTTCGGCATTA 22 61.89 
mtrE 
GTGCGATGTCGATCAGCTTTTG 22 60.79 
178 
GTTGCAGCAGCCTTTGCATT 20 60.60 
mtrR 
TGCCGCCTTGGAAACCTTTT 20 61.05 
142 
ACGTTGGAACAACGCGTCAA 20 61.36 
narL 
GTCAGCATAATGACTGCCTGCT 22 61.00 
140 
GGACTCTCGGGCATCAAAATGA 22 60.68 
narX 
GGATGGCATCGCTTTGGGAAAT 22 61.86 
173 
TTCTTTCCGCCTGGAAAATGCC 22 61.98 
ntrX 
CAGCAGCTTTTGCAGGGAAATC 22 60.93 
165 
GATTGCGACGGTATCACCCTTT 22 61.00 
ntrY 
GGAAATGCCGAACAGGAACAAG 22 60.35 
179 
GGATAGTCTCGTTCAGCGCAAT 22 60.80 
pilE 
TCCGCAGAACCATTTTACCGAAC 23 61.66 
169 
CGTGGCATCCGCTTCAAAAATC 22 61.29 
pilQ 
GGTTTGTTCAAAGTCCAAGGCG 22 60.80 
151 
GGCATCGGCAGGAAACATTACA 22 61.52 
pilS2 
GTCCGCAGAACCATTTTACCGA 22 61.19 
160 
CCCACCGACATCAAAGGCAAAT 22 61.73 
pta 
TCGAACCAGTCGTCGCTTTT 20 60.25 
151 
CAAAAGTACTCGTCGTACCCGT 22 60.35 
tbpA 
AGGGTGTTGAATCGAGCTGGTA 22 61.41 
156 
ACTTTGCGTATGGACAGCCAAC 22 61.71 
 
 RT-qPCR 
The RNA from the four strains of N. gonorrhoeae MS11 were analysed for the detection 
of the genes previously mentioned. Three biological and three to five technical 
experiments were performed for each gene. Triplicates of each gene were run on plates 
of 96 wells (Applied Biosystems, Life Technologies Corp., Carlsbad, CA, USA) with a 
final volume of 10 µL. The Luna® Universal One-Step TR-qPCR Kit (Monarch, New 
England BioLabs®, MA, USA) was used due to the efficiency in doing the reverse 




Table 2.21 Reaction mix for RT-qPCR 
Reagent Volume (µL) Final concentration 
Luna Universal One-Step 
Reaction Mix (2X) 
5.0 1x 
Luna WarmStart® RT 
Enzyme Mix (20X) 
0.5 200 µM 
10 µM Forward primer 0.4 0.4 µM 
10 µM Reverse primer 0.4 0.4 µM 
Template RNA Variable 0.1 ng 
Nuclease-free water to 10 µL - 
 
The reaction was performed in a QuantStudio 5 Real-Time PCR Systems (Applied 
Biosystems, Life Technologies Corp., Carlsbad, CA, USA). The settings for the RT-
qPCR are shown in table 2.22. 
Table 2.22 Settings for RT-qPCR 
Step Temperature Time 
RT 55 °C 10:00 min 




95 °C 10 s 
Annealing, extension 
and read 
61.5 °C 1:15 min 
Melt curve 95-60 °C 0.1 °C/s 
The gene expression was calculated by comparing the CT delta of each gene compared 
to the CT of the 16S rRNA housekeeping gene. 
2.17 Protein overexpression, purification and crystallisation 
 Growth and CFE  
The protein Pta from N. gonorrhoeae MS11 was overexpressed using the strain 
constructed in section 2.5.3. Escherichia coli BL21-DE3 pET28a-pta-his was grown 




°C. Six 50 mL falcon tubes with 30 mL of LB-Kan50 were inoculated with the bacteria 
and incubated at 37 °C with shaking at 180 rpm for 18 h. The OD600 was read and five 
2.5 L flasks with 600 mL of LB were inoculated with the culture and adjusted to an OD600 
of 0.03. The flasks were incubated at 37 °C and shaking at 260 rpm for 2:30 h or until an 
OD600 of between 0.8 and 1.0 was reached. 1 M of IPTG (Isopropyl-β-D-thiogalactoside) 
was added to a final concentration of 250 mM and incubated at 18 °C and shaking at 260 
rpm for 20 h. The cultured was transferred to 1 L bottles (Thermo Scientific™ Fiberlite™, 
Waltham, MA, USA) and centrifuged at 15,000 x g and 4 °C for 35 min in a Sorvall Lynx 
6000 ultracentrifuge (Thermo Scientific™, Waltham, MA, USA). The pellet was re-
suspended with 100 mL sterile PBS and the suspension was centrifuge in a 250 mL bottle 
(Thermo Scientific™ Fiberlite™, Waltham, MA, USA) at 15,000 x g and 4 °C for 20 
min. The pellet was re-suspended in 30 mL of binding buffer (50 mM phosphate buffer, 
0.5 M NaCl, 30 mM imidazole). The suspension was divided in three tubes of 25 mL and 
the suspension was sonicated on ice ten times at 20 A for 30 s each time waiting 30 s 
between each sonication. The suspension from the three tubes was collected in a 50 mL 
tube and it was centrifuged at 30,000 x g and 4 °C for 25 min. The supernatant was 
collected and stored at 4 °C until purification. 
 His-Trap column 
Columns of 5 mL with nickel sepharoseTM were used as first step for the purification of 
the protein. The protein binds to the column by immobilised metal ion affinity (IMAC). 
The column was washed five column volumes (CV) with water and then five CV with 
binding buffer previously mentioned. The samples was slowly loaded and the column 
was washed ten CV with the binding buffer. The sample was eluted with four CV of 




 Buffer exchange for gel filtration 
The sample was concentrated in a 10,000 MW cut off tube (Amicon®, Millipore, Billerica, 
MA, USA) by centrifugation at 3,900 x g and 4 °C for 20 min. The column was washed 
two times with gel filtration buffer (25 mM Tris-HCl; 200 mM NaCl; pH 7.6) and 
centrifuged as described previously. The sample was re-suspended with 1.5 mL of gel 
filtration buffer. 
 Gel filtration 
A final purification step consisted in the separation of the pta protein from the rest by gel 
filtration. This method allows the separation by size exclusion. Fast-protein liquid 
chromatography (FPLC) was performed using an ÄKTA-Purifier 10 FPLC (GE 
Healthcare Life bioscience) and Superdex High-performance column (GE Healthcare 
Life bioscience) with a bead volume of 120 mL. The column was washed overnight with 
70% of ethanol overnight at a flowrate of 0.2 mL/min and it was then loaded with gel 
filtration buffer until a stable was observed in the plot. The sample was loaded in a 5 mL 
loop with a flow rate of 0.4 mL/min and fractions of 2 mL were collected in 
microcentrifuge tubes. The eluted fraction were then run in a SDS-PAGE gel as 
mentioned in section 2.10.2. The samples was then concentrated using a 10,000 MW cut 
off tube and centrifuged at 3,900 x g and 4 °C for 20 min and the sample was then re-
suspended with 40 µL gel filtration. 
 Crystallisation 
The crystallisation of protein was performed by testing different conditions. Four 
different were tested for the crystallisation. Using a buffer, a salt, and a precipitant; using 
an organic molecule and a precipitant; organic molecule, precipitant, and seeding; and 





Table 2.23 Conditions for sitting drop crystallisation of Pta 
Condition 
Buffer/Organic molecule Salt Precipitant Silver 
bullet 
Seeding pH 
[M] Molecule [M] Molecule [%] Molecule 
1 0.1 Sodium cacodylate 1-4  Ammonium sulfate - - No No 5.5-8.0 
2 0.2 Ammonium tartrate dibasic - - 12-18 PEG 3350 No No 5.5-8.0 
3 0.1 HEPES 0.1-0.4  Magnesium chloride hexahydrate 16-22 PEG 6000 No No 5.5-8.0 
4 0.1 Bis-Tris 0.1-0.4   Lithium sulfate 21-27 PEG 3350 No No 6.0-8.0 
5 0.1 Bis-Tris 0.2  Lithium sulfate 12-18 PEG 3350 No No 5.5-8.0 
6 0.2 Ammonium tartrate dibasic - - 12-18 PEG 3350 No No 5.5-8.0 
7 0.1 -0.5 Malic acid - - 18-22 PEG 3350 No No 5.5-8.0 




96 deep well plates were used for the preparation of the buffer as shown in the figure 2.5, 
depending on the utilisation of the number of components of the buffer.  
 
Figure 2.5 Preparation of the buffers for the crystallisation of Pta. Volume used of each 
component for the preparation of buffers in 96 deep well plates. The organic molecule volume 
are considered for a 1 M stock solution. a) Preparation of buffer with organic molecule and 
precipitant. b) Preparation of plate with buffer, salt and precipitant. The buffer volume are 
considered for a 1 M stock solution. 
The buffer was then transfer to 96 wells plate used for sitting drop crystallisation. This 




the buffer and two small wells for the addition of the concentrated protein and the buffer 
(fig 2.6).  
 
Figure 2.6 Diagram of sitting drop crystallisation plate. The 96 well plate contains a 
reservoir of 150 µL and a sitting drop for 10 nL - 5 µL. 
 
The plates were set with 50 µL of the buffer in the reservoir and using the liquid handler 
Mosquito® crystal robot (TTP Labtech, Melbourne, UK), 150 nL of buffer and protein 
were disposed on the sitting drop. For seeded plates 20 nL of the suspension of crystals 
with buffer was added to the sitting drop. The plates were incubated at 17 °C until the 











and histone deacetylase family enzyme 




3 Acetylome of Neisseria gonorrhoeae MS11 
3.1 Introduction 
N. gonorrhoeae MS11 is a clinically isolated strain from an uncomplicated case of 
gonorrhoea. This strain is used worldwide for its ability to uptake DNA and for the 96.5% 
similarity to the reference strain N. gonorrhoeae FA 1090 genome (Jordan, Snyder and 
Saunders, 2005). 
In order to understand the role of acetyl-phosphate in protein acetylation, the 
phosphotransacetylase-acetate kinase (PTA-AK) pathway was disrupted. As a 
consequence, two mutant strains were constructed, N. gonorrhoeae MS11 Δpta::kanr and 
N. gonorrhoeae ΔackA::kanr, one with a lower acetyl-phosphate concentration and 
another with a higher concentration, respectively.  
The pta gene (NGFG00350, NGO0214) catalyses the reversible reaction of acetyl-CoA 
to acetyl-phosphate. By mutating this gene, the synthesis of acetyl-phosphate is inhibited 
and the intracellular concentration decreases. Contrary, the mutant ΔackA (NGFG00758, 
NGO1521) causes an increase of the intracellular acetyl-phosphate concentration since 
this enzyme catalyses the reversible reaction of acetyl-phosphate to acetate (Verdin and 
Ott, 2013). 
Acetylation is a reversible post-translational modification, and deacetylation is either 
non-enzymatic or enzymatic. The first deacetylases were found in eukaryotic cells for the 
deacetylation of histones and are divided in classes according to their cofactor molecule, 
zinc or NAD (Grabiec and Potempa, 2018; Narita, Weinert and Choudhary, 2019). In 
bacteria, the classification is the same, histone-family like deacetylases (HDAC) and 
sirtuin CobB, respectively. Studies have preferred the study of CobB and have found that 




Patel and Amador-Noguez, 2015; Ren et al., 2016; Macek et al., 2019; Parks and 
Escalante-Semerena, 2020; Wang et al., 2020). In this study, I studied the role of the not 
explored HDAC and analysed for the first time the acetylome of an isogenic strain Δhdac. 
A gonococcus mutant of the histone deacetylase-like (hdac) gene (NGFG00325, 
NGO0187) was constructed. This enzyme reverses acetylation by removing the acetyl 
group, and has shown to be important in the bacterial virulence and pathogenesis due to 
epigenetic modifications of the host cells (Grabiec and Potempa, 2018; Zughaier, 
Rouquette-Loughlin and Shafer, 2020). 
The mutants were constructed by disrupting the genes with a kanamycin resistance gene 
(kanr). PCR and DNA sequencing were performed to prove the mutant construction. 
The N. gonorrhoeae MS11 Δpta::kanr and N. gonorrhoeae ΔackA::kanr strains were 
obtained as part of my MSc. Molecular Medicine project when the project was started 
(Felix-Diaz Parga, 2017). 
A previous study performed a similar approach by analysing the acetylome of N. 
gonorrhoeae MS11 ΔackA, however, the acetylome coverage showed in the study was 
lower compared to ours (Post et al., 2017). Moreover, this was the first study in N. 






 Characterisation of N. gonorrhoeae MS11 Δpta and ΔackA 
The characterisation of the three strains of N. gonorrhoeae MS11 was conducted by 
assessing the enzymatic activity of phosphotransacetylase (Pta) and acetate kinase 
(AckA), and by determining the concentration of acetyl-phosphate (AcP). This was done 
in order to prove that the mutation on the pta and ackA genes provoked biological effect 
on the enzymatic activity and as consequence, a disruption of the acetyl-phosphate 
concentration. 
The mutated strains showed no enzymatic activity with respect to their mutated proteins. 
The AckA activity of the Δpta strain decreased 45% than the WT, while the Pta activity 
of the ΔackA strain decreased 78% compared to the WT strain (table 3.1).  






N. gonorrhoeae MS11 WT 1789.43 ± 267.38 9.78 ± 5.64 
N. gonorrhoeae MS11 Δpta 0 5.41 ± 3.86 
N. gonorrhoeae MS11 ΔackA 396.56 ± 87.94 0 
n=3. 
Since the activity of the enzymes was null, a change on the AcP production was expected. 
Therefore, the concentration of AcP was quantified as mention in section 2.8. N. 
gonorrhoeae MS11 Δpta showed a significant 0.7 fold decrease, while the ΔackA strain 
resulted in a significant 1.3 fold increase (fig. 3.1). Even though, the concentration of AcP 
was lower in the Δpta it was not fully depleted, this could have been due to the sensitivity 
of the assay that also detects ATP molecules and if the samples preparation is not fully 
































p <  0 .0 0 0 1
p =  0 .0 3 0 1
* * * *
 
Figure 3.1 PTA-AK pathway controls the concentration of acetyl-phosphate. The 
concentration was quantified from cell free extracts obtained from each strain of N. gonorrhoeae 
MS11 grown on BHI broth for 10 h. A standard curve of AcP was used to calculate the 
concentration of AcP in pmoles per cell. The number of cells was measured by the OD600 of the 
WT, Δpta, and ΔackA strains with values of 0.332, 0.170 and 0.244, respectively, being an OD600 
of 1.0 equal to 8x108 cells/ml. Measurements were performed by triplicate. ΔackA strain showed 
a significant higher concentration of AcP and Δpta a significant lower concentration, both 
compared to the WT. 
Due to the change of AcP concentration in the two strains, a western blot using anti-
acetyllysine antibodies was performed. This antibody binds to the lysine residue of 
proteins that are acetylated. Since AcP was described as the molecule involved in the non-
enzymatically acetylation (Klein et al., 2007; Wolfe, 2016) a different pattern of 
acetylation was expected. The immunoblot loaded with normalised concentrations of 
proteins (fig 3.2b), showed that the ΔackA had an increase of 16.5 fold in the intensity of 
the bands compare to the WT and the Δpta showed a decreased of band intensity of 0.9 





Figure 3.2 Immunoblot for acetylated proteins using an anti-acetyllysine antibody. 
Strains of N. gonorrhoeae MS11 were grown in BHI-Y for 24 h and protein extract was quantified 
and loaded on SDS-PAGE gels. a) SDS-PAGE with 10 µg of proteins; b) immunoblot with 45 
µg of protein. The bands correspond to the acetylated proteins screened with the antibody; c) the 
immunoblot was analysed with the Image Lab software to calculate the number of bands and 
intensity, each point correspond to a band on the immunoblot (7, 13, 1) for each strain (WT, 




These three experiments confirmed that the two mutants led to a change in the levels of 
acetyl-phosphate and the level of protein lysine acetylation. Hence, the strains were 
analysed to identify the sites of the proteins that are acetylated by acetyl-phosphate. 
 Construction of Neisseria gonorrhoeae MS11 Δhdac::kanr  
The gene hdac (NGFG00325, NGO0187) of the gonococcus was mutated by inserting 
the kanamycin resistance gene (kanr) by annealing PCR, inserting the resistance marker 
at the nucleotide position 468. The primers were designed to overlap 25 and 26 bp 
between the hdac segments and kanr. Additionally, once base pair was added to the hdac2-
R primer in order to complete the DNA uptake sequence (DUS). In total, hdac possesses 
two of these sequences, however, the second DUS has one base pair that is out of the 
translating sequence (fig. 3.3). The homologous recombination frequency following 
transformation of the bacteria is increased with the presence of complete a DUS 
(Hamilton and Dillard, 2006; Duffin and Seifert, 2010; Spencer-Smith et al., 2016).  
The three fragments were gel purified due to the amplification of other amplicons (fig. 
3.3b). The fragments were then used for the annealing PCR. This amplicon was further 
gel purified in order to avoid any unspecific amplicons, sequenced and then used for the 
transformation of N. gonorrhoeae MS11. 
Several mutants were obtained after the agar spot transformation but only five colonies 
were selected for DNA sequencing, confirming the construction of the mutant isogenic 





Figure 3.3 Design and construction of N. gonorrhoeae MS11 Δhdac::kanr. a) The hdac 
gene was amplified in two different sections (yellow bars) of 467 and 501 bp, respectively. The 
first segment starts at position 23 and ends at position 489, while the second segment starts in the 
position 620 and ends at position 1120. The kanamycin resistance gene (green bar) was amplified 
from a gonococcus strain possessing the marker. The three amplicons were used as template for 
the annealing PCR. Four primers from six used, shown in magenta colour, were designed with 
overlapping sequences to obtain the construct.  At the bottom of the mutant gene diagram are 
shown the location of the two DUS in blue colour. b) 1.5% agarose gel loaded with the three 
segments. c) 1% agarose gel loaded with the hdac and Δhdac::kanr amplicons showing a band 
size of 1220 and 1763 bp, respectively. Two different temperatures were used for the annealing 




 Acetylome of Neisseria gonorrhoeae MS11 
The acetylome of the wild type strain was analysed first before the determination of the 
acetyl-phosphate dependant acetylation sites. The acetylome of N. gonorrhoeae MS11 
was determined by LC-MS/MS. Using mass spectrometry 1,254 proteins were identified, 
representing the 59% coverage of the proteome that possesses 2,106 proteins, higher than 
the average coverage of 21% calculated from 9 studies. From the identified proteins, 
3,752 acetylation sites were identified in 1,017 proteins corresponding to the 48.3% of 
the proteome (fig. 3.4). 
Figure 3.4 Number of identified proteins of N. gonorrhoeae MS11 by mass 
spectrometry. Protein extracts enriched with anti-acetyl lysine antibodies were analysed in 
quadruplicates by LC-MS/MS. The spectra of N. gonorrhoeae MS11 was analysed with the 
software MaxQuant using the proteome database downloaded from UniProt and 1,254 proteins 
were identified. The parameters of the software Perseus to localise class I acetylation sites were 
set to a localisation probability of > 0.75 and a score difference >5, identifying 3,752 class I 
acetylation sites in 1,017 proteins. 
The 50% of acetylated proteins had a length of 186-436 amino acids and possessed 













the number of acetylation sites (fig. 3.4b). However, the fitness of the correlation between 
the length and number of acetylation sites was low (fig. 3c). 
 
Figure 3.5 Distribution of acetylated proteins.  a) Distribution of acetylated proteins 
according to the number of acetylation sites. b) Distribution of proteins with 1 to 10 acetylation 
sites. Lines within the plot show the median size of the proteins. c) Correlation between the length 
of proteins and number of acetylation sites. The plot shows the distribution for each variable. A 
linear regression model showed a fitness of 0.1612 and a correlation of 0.401. 
The number of lysines/acetylation sites ratio showed that 21% of proteins are acetylated 
in 10% of the total lysines (fig. 3.5a). Further analysis to determine the correlation 




correlation. In order to analyse this, a correlation between acetylated lysines, number of 
total lysines and protein length showed an R2 of 0.007 (fig. 3.5b). 
 
 
Figure 3.6 Correlation of acetylation sites and protein length. a) Distribution of 
acetylated lysines ratio. The ratio was calculated by dividing the number of acetylated lysines to 
the number of total lysines. The data was obtained using the UniProt entry to download the protein 
sequences by data mining. b) Correlation between acetylated lysines/number of total lysines, and 
number of lysines/protein length ratios. A linear regression model is shown in red line and the 
distribution of both axis are shown. The correlation value was 0.083. 
The distribution of the 3,752 acetylation sites within the protein showed that the density 
of acetylation occurs at a higher rate by the middle of the sequence with the highest peak 






Figure 3.7 Relative location of acetylation sites. The plot shows the density of the 
acetylation sites in the relative location to the protein length. The plot is divided in three regions 
of highest density of acetylation. The first is in the N-terminus (left) area from the relative location 
of 0 to 0.38; the second, by the middle of the sequence from the relative location 0.38 to 0.73 
where it shows a constant density; and the third region corresponding to the C-terminus (right), 
where the highest density is observed.  The values were obtained by dividing the position of 
acetylation to the length of the protein. The parameters used for the analysis were a Gaussian 
method for the kernel density estimate with and adjust value of 0.5. The dashed lines intercept the 
two sites with the lowest density. The 3,752 sites are shown at the bottom of the plot. 
The 3,752 sequence windows, which are the sequence of peptides detected by the mass 
spectrometer flanking the acetylation sites on each side, were analysed to determine the 
sequence motif of the acetylation sites. The acetylation site is considered the position 0 
and the analysis of the 4 amino acids flanking the acetylated lysine on each side, showed 
that the most probable amino acids to flank the acetylation site are leucine and glutamic 
acid, both at the position -1 (fig. 3.6a-b).  
Interestingly, the probability to find more negative charged amino acids for the first 4 




probability is higher for the positive charged amino acids. Downstream the probability 
for negative and positive charged amino acids is 0.1695 and 0.072. Upstream the 
probability for negative and positive charged amino acids is 0.1095 and 0.1775 (fig 3.7b). 
 
Figure 3.8 Flanking amino acids of the acetylation site. a) Sequence motif of the 3,752 
acetylation sites. The logo shows the probability of the 4 amino acids flanking the acetylated 
lysine. The sequence motif was generated with the ggseqlogo package of R. b) Probability of each 
amino acid for each position flanking the acetylated lysine. The minus side showed a higher 







3.2.3.1 Enrichment analysis 
All of the proteins that were identified with an acetylation site were analysed for 
enrichment of pathways using the DAVID bioinformatics tool. The enrichment analysis 
showed that the PTM acetylation was found in several metabolic processes (fig 3.9).  
A figure of 55 biological processes were identified as significantly enriched. The areas 
with the highest enrichment scores were metabolic processes related to pyruvate, 
pyrimidines, aspartic acid, and translation. These processes contained 18, 16, 18, and 80 
proteins, respectively. The area with the highest number of proteins was metabolic 
processes with 503. 
For the molecular function annotations, 39 terms were enriched and interestingly, 28 of 
them were related to binding functions. rRNA binding was the term with the highest 
enrichment score.  
Finally, 17 terms were enriched for cellular components. The three terms with the highest 







Figure 3.9 Enrichment of gene ontology annotations of N. gonorrhoeae MS11 acetylome. The enrichment was performed using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) v6.8. From the 1,017 protein entries, 591, 426 and 730 were found for biological process (BP), molecular function (MF) and cellular 





An interaction network of the KEGG pathways was analysed in order to observe clusters 
where acetylation could be involved. The network shows a cluster that includes 
glycolysis, TCA cycle, and propanoate metabolism; and in the centre of the cluster is the 
pyruvate metabolism pathway. Out of this cluster we found pathways involved in 
translation, purine metabolism, pentose phosphate pathway and interestingly, pili 
biosynthesis labelled as flagellar assembly by the software (fig 3.10). 
Figure 3.10 KEGG pathways network of the N. gonorrhoeae MS11 acetylome. At the 
top of the network is shown a cluster composed by the central metabolic pathways whereas the 
TCA cycle, pyruvate metabolism, glycolysis/gluconeogenesis and carbon metabolism have the 
highest number of edges. Surrounding the cluster are shown pathways that are not sharing 
proteins. Each pathway is coloured depending on the p value which shows the significance 
according to the times the protein appears in the acetylome and the size correspond to the number 
of proteins. The edges connect to each pathway when proteins are shared and the thickness 
increases with the number of shared proteins. 




Acetylation has shown to modify the activity of some enzymes and their conformational 
structure (Xiong and Guan, 2012; Šoštarić et al., 2018). Therefore, proteins with 10 or 
more acetylation sites were filtered from the data set to observe to which pathways they 
correspond. In fig. 3.11 are shown the 44 proteins that are involved in 45 different 
pathways which correlate to the cluster observed in fig. 3.10. Showing that proteins in 
common among these pathways that contain a high number of acetylation sites. 
The enzymes with the highest number of acetylation sites were the chaperonin protein 
DNA K, pyruvate dehydrogenase E1 component, DNA-directed RNA polymerase 
subunit beta, 60 kDa chaperonin, alanine t-RNA ligase and 2-oxoglutarate dehydrogenase 
with 32, 30, 23, 20, 19 and 18 acetylation sites, respectively.  
Interestingly, 5 different t-RNA ligases possessed high number of acetylation involved 
aminoacyl-tRNA biosynthesis. In addition, the other pathways that shown proteins with 
high acetylation sites were the ones in carbon metabolism (TCA cycle, 
glycolysis/gluconeogenesis and pyruvate metabolism), and nucleotide metabolism 
(purine and pyrimidine). 
A table showing proteins with 5 or more acetylation sites and the pathways they 
participate are shown in the supplement table 8.1. 
Once the acetylome was analysed in the WT, the next step was to analyse the different 
constructed mutants to see the role of acetyl-phosphate and the histone deacetylase family 





Figure 3.11 Correlation between proteins with high acetylation sites number and pathways in N. gonorrhoeae MS11. Proteins with 10 or more 
acetylation sites are sorted in descending order according to the number of KEGG pathways they are involved and the pathways are sorted in descending order 




 Acetylome of isogenic mutants of N. gonorrhoeae MS11 
In this section the validation of the mass spectrometry and the analysis of the acetylome 
of the three isogenic mutant strains of the gonococcus is described. N. gonorrhoeae MS11 
ΔackA and Δpta were used to identify the acetyl-phosphate-dependent acetylation sites 
and the strain of N. gonorrhoeae MS11 Δhdac was studied to determine possible targets 
of this deacetylase enzyme. As mention previously, this study involved the investigation 
of two novel mutant constructs of N. gonorrhoeae, Δpta and Δhdac the two latter strains 
were constructed for the first time for this study 
3.2.4.1 Validation of mass spectrometry experiment 
The four strains of N. gonorrhoeae MS11, WT, Δhdac, ΔackA and Δpta, were grown in 
chemical defined medium supplemented with 10 mM glucose until mid-logarithmic phase 
was reached. Four independent replicate cell free extracts (CFE) were obtained for each 
strain, counting the WT strain as well, 16 CFE were analysed through mass spectrometry. 
In order to validate the experiment, before the CFEs were enriched with the antibody, the 
proteome of the samples were analysed to determine the expression of the proteins among 
the 16 CFEs and identify any difference.  
The 16 replicates were evaluated by doing a correlation of the values of intensity to 
determine if any replicate had to be excluded. A correlation value lower than 0.75 was set 
to exclude a sample. However, all the replicates showed a correlation value higher than 
0.75. The samples that showed the lowest correlation value were the replicates 1 from the 
isogenic strains Δpta and Δhdac. The rest of the replicates showed a correlation value 






Figure 3.12 Correlation of CFE for sample validation. The CFE from the 4 replicates of 
the 4 N. gonorrhoeae strains were processed for mass spectrometry to determine the acetylome. 
Before the enrichment of acetylated peptides, aliquots were taken to determine the proteome and 
compare the correlation between samples. The 16 samples were correlated by a Pearson 
correlation analysis using the intensity values. On the left side of the plot are the correlation plots, 
in the middle arranged in diagonal are the distributions of the proteins on each sample and on the 






3.2.4.2 Descriptive analysis of the acetylome 
The samples after validation were analysed to determine the acetylome. The CFE were 
enriched using anti-acetyllysine antibodies that identify the acetylated peptides. The 
intensity given for each acetylation site for the 16 samples were analysed with the 
Student´s t-test. This is a two-tailed test that compares the means between samples taking 
the WT strain as the reference value to determine if the acetylated peptide was 
significantly increased or decreased. To discard type I errors, a t-test adjusted for multiple 
sample comparison was calculated using a permutation-based FDR of 1%. Applying this 
FDR we filtered potential false positive acetylation sites. 
A volcano plot in figure 3.13 shows the significant different acetylation sites according 
to the fold change difference to the WT. The plot correlates the negative logarithm of the 
p -value and the fold change of acetylation. 
 
Figure 3.13 Volcano plot for acetylation sites in N. gonorrhoeae MS11. The plot shows 
the acetylation sites that are significantly decreased (left side) or increased (right side) compared 
to the WT strain determined by the two-tailed Student´s test. The S0 parameter was set to 0.1 and 
the false discovery rate to 0.05. Acetylation sites that showed a significant difference are blue 




In table 3.2 are shown the number of proteins that showed significant different acetylation 
sites compared to the common acetylation profile of the WT strain that considers the 
abundance of proteins. This acetylation sites were classified by the number of proteins 
which showed significant increased and decreased acetylation sites. The total number of 
significant acetylation sites was 3,752. From these sites, we observed sites with 
significant increase and decrease in acetylation. As expected, the isogenic strain ΔackA 
showed a higher number of significant increased acetylation sites as in the Δhdac strain, 
and in the Δpta strain more acetylation sites were found significantly decreased. The table 
with the proteins with two or more significant different acetylation sites are found on the 
supplement table 8.2. 
The significant different acetylation sites were used through the rest of the study for the 
analysis and determination of the sites potentially regulated by acetyl-phosphate. 
Table 3.2 Number of significant proteins and acetylation sites in the isogenic mutant 
strains of N. gonorrhoeae MS11. The percentage next to the total number of proteins and 
acetylation sites is compared to the total number found in the three strains. The percentage of the 
other values are respective to the total number from each strain. 
Strain 







ΔackA 638 (62.7%) 531 (83.2%) 235 (36.8%) 1,369 (36.5%) 1369 (77.7%) 305 (22.3%) 
Δpta 527 (51.8%) 277 (52.6%) 330 (62.6%) 847 (22.6%) 387 (45.7%) 460 (53.3%) 
Δhdac 184 (18.1%) 164 (89.1%) 26 (14.1%) 235 (6.3%) 209 (88.9%) 26 (11.1%) 
 
The median fold change of acetylation in the three isogenic mutant strains is 2.24, -1.09 




acetylation sites are divided into the type of fold change (increased or decreased) the 
median values are similar among the strains (fig. 3.14c). 
 
Figure 3.14 Distribution and median of acetylation sites in the isogenic mutant 
strains of N. gonorrhoeae MS11. a) Distribution of the acetylation sites according to the fold 
change. b) Boxplot of all the significant sites from the three isogenic mutant strains. ΔackA and 
Δhdac have a median of fold change on the positive side, while Δpta on the negative side. c) The 
distribution of the acetylation sites showed that the significant sites are divided in two by 
increased and decreased acetylation. Therefore, the median size was calculated for each division 
considering increased when the fold changed was higher than 0 and decreased when lower than 
0. The median fold changes are shown for the three strains. 
In order to analyse the location of acetylation in the protein. The site of acetylation was 
calculated relatively to the length of the protein, being 0 the N-terminus and 1 the C-
terminus (fig. 3.15). The location of acetylation between strains showed a different pattern 
of acetylation compared to the WT (fig. 3.7). Suggesting that acetylation by acetyl-




The ΔackA isogenic strain showed a different pattern of distribution of the location. The 
middle part corresponding from 0.385 to 0.73 showed lower density than the WT in that 
area but the final section (0.73-1.0) showed the highest region of density with the highest 
density of 1.23. Analysis of the sequence motifs of the three sections, showed that in all 
the sections, the two amino acids that had the highest probability at position -1 were 
leucine (L) and glutamic acid (E), a hydrophobic and a negative charged amino acid, 
respectively. Overall, the probability of the arginine increases the closer to the C-terminus 
of the protein (fig. 3.15). 
Contrary to ΔackA, the two lowest points in Δpta were at a similar location to the WT 
strain, however, the densities were different. In the middle section, the highest density in 
the decreased acetylation of Δpta was 1.30 and in the increased was 1.24. The sequence 
motifs in the decreased acetylation of Δpta, opposite to ΔackA, showed that the two amino 
acids at position -1 with the highest probability were E and L in three sections. On the 
increased acetylation of Δpta, the sequence motifs changed on the three sections and the 
amino acids with the highest probability at postion-1 were arginine, leucine and alanine. 
However, at the third section arginine is the third most probable (fig 3.15). 
The density of increased acetylation sites in Δhdac showed the highest density in the N-
terminus of 1.23. In the middle section a peak is observed however is lower that the first 
section with a density of 1.08. As in the first two cases the two most probable amino acids 
at position -1 were L and E. However, in the second and third sections it is observed that 





Figure 3.15 Analysis of the sequence motifs for the acetylation sites in the three isogenic strains of N. gonorrhoeae MS11. The plot shows the 
density of the significant acetylation sites in the relative location to the protein length. The plots are divided in three regions as in the WT. The values were 
obtained by dividing the position of the acetylation site to the length of the protein. The parameters used for the analysis were a Gaussian method for the kernel 
density estimate with and adjust value of 0.5. The dashed lines intercept the two sites with the lowest density. The significant different acetylation sites are 
shown at the bottom of the plot. The sequence motifs were generated with the ggseqlogo package of R by filtering the data to select the sequence windows of 




 Acetyl-phosphate dependent acetylation in N. gonorrhoeae MS11 
In nature, two types of acetylation occur as post-translational modifications on protein. 
The first is enzymatically, by the action of acetyltransferases an acetyl group binds to the 
Nε-lysine residue using acetyl-CoA as donor. The second is non-enzymatically, the acetyl 
group is donated by the high energy molecule acetyl-phosphate (Verdin and Ott, 2013; 
Ouidir, Kentache and Hardouin, 2016; Wolfe, 2016). In this section, utilising the data 
obtained from the acetylome of the isogenic mutant ΔackA and Δpta, we determined the 
acetylation sites dependent of acetyl-phosphate. 
In this study, the acetyl-phosphate dependent acetylation sites were defined as the unique 
acetylation sites found in both ΔackA and Δpta that showed a significant (p value <0.05) 
increased and decreased of fold change, respectively, in at least three of the four 
biological replicates. 
The proteins and acetylation sites of both strains were analysed by a Venn diagram, 
identifying 409 and 424, respectively (fig. 3.16a-b). The selection of highly regulated 
acetylation sites by acetyl-phosphate was determined by analysing the increased and 
decreased acetylation sites from ΔackA and Δpta, respectively. From this classification, 





Figure 3.16 Identification of unique acetyl-phosphate-dependent acetylation sites in 
N. gonorrhoeae MS11. Venn diagrams of proteins and acetylation sites from the strains ΔackA 
and Δpta. a) 409 unique proteins were shared between both strains, and b) 424 acetylation. c) 
Acetylation sites were divided in increased and decreased depending on the fold difference. The 
overlapping acetylation sites from ΔackA with an increased fold difference and the decreased 
from Δpta are the highly regulated acetyl-phosphate dependent sites. A total of 117 unique 
acetylation sites were found in 102 proteins. 
The sequence windows from the 117 acetylation sites were analysed to determine the 
sequence motif. This sequence motif shows the amino acids that are flanking the acetyl-
phosphate dependent acetylation site.  
At the position -1, the amino acid with the highest probability was glutamic acid with 
0.198 and at position +1 was arginine with 0.178. At position +3 and +4, lysine has the 





Figure 3.17 Sequence motif of acetyl-phosphate dependent acetylation sites. a) 
Sequence motif generated from the 117 unique sequence windows of the classified acetylation 
sites. The sequence motif shows the first 4 amino acids flanking the acetylation site and the size 
correspond to the probability to be in that position. The sequence motif was generated using the 
ggseqlogo package of R. b) Probability of each amino acid for the positions flanking the 





From 102 proteins, 88 showed one acetyl-phosphate dependent sites and 14 two. The 
mean fold change was 2.02 and -2.23, and the median was 1.52 and -1.99, in ΔackA and 
Δpta, respectively (fig. 3.18a-b).  
The analysis of gene ontologies showed that the molecular function term with the highest 
number of proteins with acetyl-phosphate dependent sites was ATP binding with 38 
proteins. However, seven more terms were related to molecule binding function. The 
KEGG pathways with the highest number of protein were pyruvate metabolism and 
methane metabolism with 7 proteins each. Other carbon metabolism pathways with five 
proteins were glycolysis and gluconeogenesis. Thirty four of the proteins are found in the 
cytoplasm, 11 are integral components of membrane (fig. 3.18c). The only biological 
process with more than 5 proteins was translation. A table with the terms with more than 
two proteins is find in the supplement table 8.3. 
An enrichment analysis of the identified proteins with an AcP-dependent site was 
performed. The biological process with the highest enrichment score were processes 
related to tRNA aminoacylation. Five of the terms were related to metabolic processes. 
For the molecular function we found that 65% of the terms were related to binding 






Figure 3.18 Acetyl-phosphate dependent sites. a) Proteins classified as acetyl-phosphate 
dependent for acetylation. The same acetylation site was found on both strains with a significant 
difference of the fold change. b) Boxplot showing the fold change of each acetylation site. An 
ANOVA test shows a significant difference between the fold changes in both strains. c) Gene 
ontology analysis showing the terms with more than five proteins in molecular function (MF), 





Figure 3.19 Enrichment analysis of the gene ontologies for the proteins with acetyl-phosphate- dependent sites. The analysis was performed 
using the DAVID website which identifies the annotations and perform a statistical analysis to identify the enriched terms. In the plot are shown the significant 





3.2.5.1 Determination of targets for the gonococcal histone deacetylase-like 
protein 
Histone deacetylase-like proteins (HDAC) are a family of enzymes that removes the 
acetyl group from the N-ε-lysine residue. These enzymes were first discovered in 
eukaryotic cells and classified in different classes (Grabiec and Potempa, 2018). Their 
main target are histones to block the transcription of genes. Recently, several HDACs 
have been found in prokaryotes and a 2020 study in N. gonorrhoeae, found that the 
gonococcal HDAC NGO0187, same gene that was used in this study, plays a role in the 
regulation of the host gene expression (Jiang et al., 2017; Zughaier, Rouquette-Loughlin 
and Shafer, 2020) 
For the identification of the possible targets of HDAC, all the acetylation sites with a 
significant fold change were classified according to the difference, increased or 
decreased. Since the action of the HDAC is to deacetylate proteins, the possible targets 
were classified as the unique acetylation sites that showed a significant increase in the 
isogenic mutant strain Δhdac. Thirty four unique acetylation sites in 34 proteins were 





Figure 3.20 Identification of the possible targets of HDAC. The acetylation sites found 
in the three isogenic mutant strains ΔackA, Δpta, and Δhdac were classified according to the fold 
change difference. From the 2,451 acetylation sites (blue), 34 (green) were unique for Δhdac. 
The sequence windows of the 34 acetylation sites showed a similar sequence motif as the 
acetyl-phosphate dependent sites. At the position -1 the amino acid with the highest 
probability was glutamic acid with 0.28 and at position +1 was isoleucine with 0.24 
probability. Different to the acetyl-phosphate dependent sites, the HDAC targets 
sequence motifs also present a negative charge amino acid at position -2. The amino acid 





Figure 3.21 Sequence motif and probability for the HDAC targets. a) Sequence motif 
generated from 25 unique sequence windows. The sequence motif shows the first 4 amino acids 
flanking the acetylation site and the size correspond to the probability to be in that position. The 
sequence motif was generated using the ggseqlogo package of R. b) Probability of each amino 
acid for the positions flanking the acetylation sites. 
From the identified proteins with an acetylation site susceptible to HDAC (fig. 3.22a) 
three tRNA ligases are involved in translation, both ribosomes (50S and 30S) showed one 
target site in one subunit. Interestingly, the enzyme phosphotransacetylase showed higher 
acetylation in K450, furthermore, the porin B, a protein involved in the virulence of the 




The gene ontologies of the identified proteins showed a diversity of functions, however, 
the term translation was the only biological process with two proteins the rest showed 
only one. The molecular function with the highest number of proteins was ATP binding 
with eleven proteins followed by zinc ion binding, tRNA binding and magnesium ion 
binding. Purine and pyrimidine metabolism presented three proteins. The complete heat 
map with all the enzymes and terms is found in the supplement fig 8.1. 
A network analysis of the KEGG pathways and biological processes showed a cluster for 
processes related to translation and tRNA metabolism, including the tRNA ligases for 
valine (valS), alanine (alaS), and glutamate (gltX). Pyruvate metabolism and TCA cycle, 
contained one enzyme each biotin carboxylase and 2-oxoglutarate dehydrogenase, 
respectively (fig. 3.22b). 
The enrichment analysis showed 4 biological process terms with metabolic and 
biosynthetic metabolic processes. All the molecular functions are binding related except 
for one which has ATPase activity. tRNA binding showed the highest enrichment score. 





Figure 3.22 Protein targets of HDAC and network analysis. a) List of the possible deacetylation sites of the protein HDAC in N. gonorrhoeae MS11. 
The list shows the protein name and the gene name. The tiles are filled according the fold change difference and the deacetylation position site is found inside 
of the tile. b) A network of the identified enzymes was created using ClueGo on the software Cytoscape. The network shows the biological processes in black 






Figure 3.23 Enrichment analysis of the gene ontologies for the HDAC targets. The analysis was performed using the DAVID website which identifies 
the annotations and perform a statistical analysis to identify the enriched terms. In the plot are shown the significant terms (p value <0.05) for biological process 





From the discovery of the first histone deacetylase in 1996, to the discovery of the non-
enzymatic acetylation in both eukaryotic and prokaryotic cells, a door was opened to 
explore new types of enzymatic regulations (Verdin and Ott, 2013, 2015; Wagner and 
Payne, 2013; David G Christensen et al., 2019). The development of new technologies 
such as mass spectrometry, has made that studies like proteomics be more affordable and 
with better resolution. For instance, two studies of acetylation in E.coli in 2008 and 2013, 
identified 125 and 1,070 acetylation, respectively (Yu et al., 2008; Zhang et al., 2013). 
In this study, the acetylome of the wild type strain and three isogenic mutants of N. 
gonorrhoeae MS11 was analysed. The coverage of identified proteins and acetylation 
sites overtakes the acetylome of the last acetylome study made by Post et al., 2017. The 
total coverage of identified proteins increased by 55% and 40% for acetylation sites (fig. 
3.24). Post study and this study share in common 444 and 1,345, proteins and acetylation 
sites, respectively, corresponding to the 43.7% and 35.8%, respectively. Moreover, in this 
study we analysed four samples for each strain, including Δpta and Δhdac, one more 
biological replicate than Post study. 
Comparing data from the most recent papers that made 
immunoaffinity enrichment and mass spectrometry, we 
observed that this study shows the highest coverage and 
the number of biological replicates is as high as one 
more study (table. 3.3). This difference in coverage was 
possible due to the high number of biological replicates, 
the number of strains analysed and the protocol 
established at the BIOMICS facilities of the University of Sheffield. 
Figure 3.24 Comparison of identified 
proteins and acetylation sites. The data 
correspond to three and four biological 
replicates from the Post, et al. paper 








Proteins Coverage Growth medium Growth phase Replicates Reference 
Clostridium 
acetobutylicum 





3 biological Xu et al., 2018 
Salmonella 
Typhimurium 
1,259 631 13.30% LB broth Early 
logarithmic 
1 biological Li et al., 2018 
Bacillus subtilis 1,355 629 15.03% Fresh minimal medium 
supplemented with glucose 
Logarithmic 4 biological Kosono et al., 2015 
Brenneria nigrifluens 1,866 737 17.30% Tryptic soy broth Stationary 6 technical Li et al., 2020 
Streptococcus 
pneumoniae 
653 392 20.50% Toddy-Hewitt broth with 
0.5% yeast extract medium 
Stationary 2 biological Liu et al., 2018 
Escherichia coli 
BW25113 
3,840 978 23.87% M9 minimal medium 0.4% 
Glucose 
Stationary 3 biological Schilling et al., 2019 
Vibrio alginolyticus 2,883 1,178 27.17% LB broth Logarithmic NA Pang et al., 2020 
Neisseria 
gonorrhoeae MS11 
2,686 656 31.15% GC broth supplemented 
with 1% IsoVitaleX and 
Kellogg’s supplement 
Stationary 3 biological Post et al., 2017 
Vibrio cholerae V52 3,402 1,240 34.67% LB broth Mid-logarithmic 
and stationary 
2 biological Jers et al., 2018 
Neisseria 
gonorrhoeae MS11 
3,752 1,017 48.29% Chemically defined with 
glucose 





Comparing the data from the Post study, 1213 acetylation sites in 444 proteins are in both 
acetylomes. From this 689 were significantly different in 327 proteins. From the 1,017 
proteins, the 70% showed more than 1 acetylation site analogous to other study, where 
they found 72%. The proteins with >20 acetylation were six, chaperone protein DnaK 
(DnaK), pyruvate dehydrogenase E1 component (AceE),  DNA-directed RNA 
polymerase subunit beta (RpoB), chaperone protein ClpB (ClpB),  DNA-directed RNA 
polymerase subunit beta (RpoC) and 60 kDa chaperonin (GroEL), which four of these 
proteins have been also identified with a high number of acetylation sites (Yu et al., 2008; 
Kuhn et al., 2014; Post et al., 2017). 
DnaK and GroEL are chaperones which function is to fold proteins, these proteins are 
specially synthesised during a heat shock that causes the denaturation of proteins and that 
the chaperones refold to their native conformation. The two chaperones have shown to be 
regulated by levels of acetyl phosphate. In two studies made on a ΔackAΔpta mutant of 
E. coli they found increased transcription levels, however, their activity was reduced. The 
idea that ATP was affecting their activity was discarded when they found that the levels 
between the WT and the mutants were not significantly different (Mizrahi, Biran and Ron, 
2006, 2009).  
The enrichment analysis showed similar results as in other bacteria species. The 
biological processes with the highest enrichment score were metabolic process for 
pyruvate, pyrimidine and aspartate followed by translation. The first two terms were also 
found in S. enterica serovar Typhimurium, although in their study they only analysed one 
biological repetition, the protein extract was also collected during exponential growth (Li 
et al., 2018). In V. cholerae translation was also one of the terms with the highest 





The 78% of molecular function terms were related to the binding of molecules, which has 
been also shown in several bacterial acetylomes (Liu et al., 2016, 2018; Jers et al., 2018). 
Acetylation has shown to be involved in the regulation of gene transcription by inhibiting 
the binding of transcription gene regulators to their gene targets. Some examples are the 
inhibition of the regulator of the two-components system in S. enterica Typhimurium by 
the acetylation of K102 and K201 (Ren et al., 2016; Koo et al., 2020); acetylation of the 
nucleoid-associated protein HU, which helps in the DNA compaction, decreases the 
interaction with the DNA in Mycobacterium tuberculosis (Ghosh et al., 2016); and in a 
recent study in E.coli, acetylation showed to be involved in the synthesis of proteins. The 
threonine aminoacyl tRNA synthetase was mutated to have a specific lysine acetylated, 
this enzyme produced mischarged amino acids which affect the synthesis of the peptide 
chain (Chen et al., 2019). Acetylation of aminoacyl-tRNA ligases has also shown an 
inhibition of their activity in E. coli (Barnoy et al., 2017; Ye et al., 2017; Chen et al., 
2019) 
In this study, we identified the 20 amino acids tRNA ligases but only 18 showed 
significant different acetylation sites (supplement table 8.4) and from 53 ribosomal 
proteins from both subunits, 44 possessed significant acetylation sites. This explains the 
high enrichment score of the cellular component for ribosomes which in total showed 250 
and acetylation sites. 
Acetylation is present in the central metabolism of N. gonorrhoeae MS11. The interaction 
network of KEGG pathways showed a cluster with pathways of the central metabolism. 
This means that enzymes with acetylation sites are shared among pathways. The analysis 
of 3 pathways (TCA cycle, glycolysis, and pyruvate metabolism) showed that almost all 
of the proteins belonging to these pathways were identified in the acetylome of the 




from the central metabolism controls the metabolic flux. In Salmonella enterica  and E. 
coli the enzymes of the central metabolism were all acetylated and found that it regulates 
the carbon flux and the enzymatic activity (Wang et al., 2010; Zhang et al., 2013; 
Pisithkul, Patel and Amador-Noguez, 2015).  
 Acetylation affects chemical properties of proteins 
Acetylation has shown to regulate the activity of metabolic enzymes by either changing 
the conformational structure of the protein, modifying net charges or inhibiting the 
interaction with the substrate (Xiong and Guan, 2012; Lin et al., 2013; Baeza, Smallegan 
and Denu, 2015; Ghosh et al., 2016; Bontemps-Gallo et al., 2018; Chen et al., 2019; 
Barbosa Leite et al., 2020). The general approach to determine if an acetyl-phosphate 
dependent site regulates the activity of an enzyme is by mutating the lysine to another 
amino acid usually non-charged or by site directed acetylation (Venkat, Gregory, Gan, et 
al., 2017; Barbosa Leite et al., 2020). In a study of Trypanosoma brucei, the parasite that 
causes sleeping sickness in human, the activity of the glycolysis enzyme aldolase was 
shown to be decreased in the mutants where lysine was mutated to the polar uncharged 
amino acid glutamine in the positions K157Q and K163Q. They found a change in the 
pocket where the substrate binds, and a change on the surface net charge to the negative 
side (Barbosa Leite et al., 2020).  
In N. gonorrhoeae, we observed a changed to a more negative charge net on all the 
identified proteins. The positive and negative charged amino acids were quantified in all 
the sequences from the identified proteins in the acetylome, since lysine is a positive 
charged amino acid when acetylated it is neutralised and a negative charge is added to the 
net protein charge.  In fig 3.25, we observe that the linear regression model shifts to the 




charge is neutralised. Studies have shown that this changes caused by acetylation stabilise 
proteins and increase the interaction protein-protein (Lin et al., 2013; Ree, Varland and 
Arnesen, 2018). 
 
Figure 3.25 Acetylation decreases the charge of a protein by neutralising positive 
residues. Protein sequences were obtained and the amino acids with negative and positive charge 
were counted and plot. The blue and red dots are the number of charged amino acids before and 
after acetylation, respectively. Linear regression and the r square are shown for each condition. 
In this study, we analysed the distribution of the acetylation location in the proteins. We 
observed that the distribution was divided in 3 regions, the extreme regions showed a 
higher number of acetylation sites than in the middle, supporting the hypothesis that non-
enzymatic acetylation is a PTM where the access to enzyme is limited (Kuhn et al., 2014; 
Baeza, Smallegan and Denu, 2015; David G Christensen et al., 2019). Indeed, we 
observed that in ΔackA the increased acetylation is in all regions, while in Δpta the 
majority of the decreased acetylation is in the middle region of the protein presumably 
where the access for acetylation is difficult to access. Similar, the acetylation sites of 




where the enzyme might be acting because in the middle it cannot access for 
deacetylation. 
The specific mechanism of non-enzymatic acetylation still unrevealed, however, there is 
a proposal that acetyl-phosphate dependent acetylation occurs in lysines that are located 
close to acidic amino acid (Kuhn et al., 2014; Carabetta and Cristea, 2017). Indeed, we 
found that approximately 20% of acetyl-phosphate dependant sites were next to a residue 
of glutamic acid. 
 Neisserial histone- deacetylase like protein 
We identified from mass spectrometry 34 unique sites with a significant increase 
acetylation in Δhdac. The logo sequence of the amino acids flanking the acetylation 
showed a similar distribution and probability of the amino acids found in ΔackA and Δpta, 
with a glutamic acid next to the lysine. These lysine acetylation sites could be possible 
targets of HDAC. Enzymes involved in tRNA binding was the molecular function to be 
enriched suggesting that tRNA proteins are regulated by Hdac. In E. coli it was found that 
lecucyl-tRNA and arginyl-tRNA were negatively regulated by AcP-dependent 
acetylation and that the deacetylase CobB was responsible of removing the acetyl to 
activate the tRNAs (Ye et al., 2017). Venkat showed in two studies that acetylation of 
tyrosil-tRNA, and threonyl-tRNA impairs their enzymatic activity and suggests that 
CobB deacetylates the enzymes to activate them (Venkat, Gregory, Gan, et al., 2017; 
Chen et al., 2019). In N. gonorrhoeae glutamate, alanine, and valine-tRNA ligase 
acetylation was increased in the isogenic strain Δhdac. 
Other relevant proteins that suggest to be deacetylated by Hdac were biotin carboxylase, 
2-oxoglutarate dehydrogenase and phosphotransacetylase. The three enzymes are 




pathway, respectively. In Mycobacterium tuberculosis, isocitrate lyase, the enzyme of the 
glyoxylate shunt, showed to be positively regulated by the deacetylase CobB (Bi et al., 
2017). In E. coli, malate dehydrogenase and isocitrate dehydrogenase, both enzymes from 
TCA, also showed an increase of activity when deacetylated by CobB (Venkat, Gregory, 
Sturges, et al., 2017; Venkat et al., 2018). 
Phosphotransacetylase (Pta), the protein that produces acetyl-phosphate, showed an 
increase of acetylation in the lysine site K450 in the isogenic strain Δhdac. This site is 
located in the active site of the protein. This result is discuss in the next chapter where a 
regulation of Pta by the deacetylase HDAC is proposed. 







Role of acetyl-phosphate in the 





4 Role of acetyl phosphate in the metabolism of N. 
gonorrhoeae MS11 
4.1 Introduction 
Bacterial metabolism is known to be regulated by post-translational modifications (PTM), 
including, glycosylation, phosphorylation, and acetylation among others (Duan and 
Walther, 2015; Pisithkul, Patel and Amador-Noguez, 2015). The interest in bacterial 
lysine acetylation has increased during the last 20 years (fig. 1) and studies have shown 
interesting findings suggesting that acetyl-phosphate is the precursor molecule for ATP, 
acetylation of metabolic enzymes is conserved among different bacterial species, acetyl 
phosphate has a dual role for acetylation and phosphorylation of proteins, lysine 
acetylation regulates the metabolic flux and bacterial virulence (Wanner and Wilmes-
Riesenberg, 1992; Wang et al., 2010; Pisithkul, Patel and Amador-Noguez, 2015; 
Nakayasu et al., 2017; Ren et al., 2017; Camprubi et al., 2018) 
 
Figure 4.1 Number of publications related to bacterial lysine acetylation. The data 
corresponds to the search on PubMed from the period 1974-2020 using acetyl-phosphate, 





Acetyl-phosphate is the intermediate metabolite from the phosphotransacetylase-acetate 
kinase pathway (PTA-AK) metabolite that is synthesised by the enzyme phosphate 
acetyltransferase which converts Acetyl-CoA to acetyl-phosphate, using inorganic 
phosphate and realising CoA-SH, acetyl-phosphate is then metabolised to acetate by 
acetate kinase realising ATP (fig. 4.2) (Kuhn et al., 2014; Wolfe, 2016; David G 
Christensen et al., 2019). 
 
Figure 4.2 Reactions in the PTA-AK pathway. a) Reaction metabolised by 
phosphotransacetylase (NGO0214) synthesising acetyl-phosphate, b) and then converted to 
acetate by acetate kinase (NGO0977). 
Acetyl-phosphate is a high energy molecule that has shown a balance between stability 
and reactivity. A study shown that acetyl-phosphate is more stable at cooler temperatures 
and hydrolysis increases when temperature is increased. Also they have shown that it has 
a dual role as an acetyl donor, and phosphate donor especially to nucleotides (Camprubi 
et al., 2018). Due to its high free energy it reacts with residues of lysines where it can 
acetylate in two ways; the Nα and Nε, being the latter reversible and the most common 





Figure 4.3 Types of lysine acetylation. The acetylation of residues of lysine occurs in the Nα 
(bottom) and Nε (top).  
The majority of acetylated enzymes have been identified to be involved in metabolic 
processes in E. coli, S. enterica, B. subtilis, M. tuberculosis and  S. aureus (Wang et al., 
2010; Sadykov et al., 2013; Hentchel and Escalante-Semerena, 2015; Schilling et al., 
2015). The acetylation leads to changes on the surface charge and in the conformation of 
the binding pocket to substrates and ligand, inhibiting the activity of the enzymes 
(Nakayasu et al., 2017; Barbosa Leite et al., 2020). 
N. gonorrhoeae is an obligate human pathogen that mainly colonises the genito-urinary 
tract. N. gonorrhoeae has adapted to survive in this niche, which is characterised by 
limited nutrient sources, and the organism metabolises the carbon sources that are 
available. It is a fastidious microorganism that grows in microaerobic conditions. 
However, it also grows in anaerobic conditions using the nitrite and nitric oxide reductase 
to metabolise nitrite to nitrous oxide (N2O) by a denitrification pathway (Knapp and 
Clark, 1984; Overton et al., 2006; Quillin and Seifert, 2018). Glucose, pyruvate, and 




to influence the pathogenicity and virulence of N. gonorrhoeae (Stephen A. Morse, Stein 
and Hines, 1974; Yates et al., 2000; Smith, Tang and Exley, 2007; Li et al., 2010; Atack 
et al., 2014).  
In this chapter, we analysed the effect of acetylation by acetyl-phosphate in the 
metabolism of N. gonorrhoeae. We found that PTA-AK pathway is a possible escape 
pathway during overflow metabolism. We determined, that the consumption of lactate 
increases acetylation compared to other carbon sources. Structural and docking analysis 
of enzymes, showed a possible regulation of the central metabolic pathways by the 





 Acetyl-phosphate dependent acetylation is enriched in central 
metabolic pathways 
In this chapter, the analysis to determine the effect of lysine acetylation in the metabolism 
of N. gonorrhoeae MS11 was based on the data obtained from mass spectrometry. The 
enzymes with acetylation sites that showed a significantly difference in fold change of 
acetylation were selected for this chapter. Since the level of acetyl-phosphate was 
different in the mutants ΔackA and Δpta we could determine the role of these two 
enzymes in the regulation of the metabolism. 
An enrichment analysis of metabolic pathways was performed using the data of fold 
change in the acetylation. The analysis was performed using the package BiocManager 
on R. The package uses the database of KEGG pathways and performs an enrichment 
analysis utilising the values from levels of acetylation.  
The analysis showed an enrichment of the carbon metabolism in the mutants ΔackA and 
Δpta, from these the central metabolic pathways were found. Entner-Doudoroff, 
gluconeogenesis, pyruvate metabolism and TCA cycle were enriched. The mutant ΔackA 
showed an increased enrichment of pyruvate metabolism, and gluconeogenesis was both 
increased and decreased, this is due to the mutant showed sites that were significantly 
increased and decreased in acetylation. The mutant Δpta showed an increase in 
gluconeogenesis, pyruvate metabolism and TCA cycle. The mutant Δhdac showed an 






Figure 4.4 Enrichment analysis of KEGG pathways for the acetylated enzymes in N. 
gonorrhoeae MS11. The enzymes with significantly different acetylation were divided in 
increased and decreased depending the level of fold change in the acetylation. The enrichment of 
the WT strain was determined using all the identified acetylation sites. 
Different studies have shown an alteration of central metabolism pathways and in the 
metabolism flux due to the disruption of the PTA-AK pathway (D. G. Christensen et al., 
2019; Schütze et al., 2020), therefore, the isogenic mutant strains were grown in glucose, 
lactate and pyruvate, reported to be the only carbon sources that the gonococcus 
metabolises (Stephen A. Morse, Stein and Hines, 1974). The strains were cultured 
overnight on a chemically defined medium with 10 mM glucose and then transferred to 
the same medium supplemented with the carbon sources to test their growth during 10 h. 





Figure 4.5 Growth curves of N. gonorrhoeae MS11 in glucose, lactate, and pyruvate. 
Strains of N. gonorrhoeae MS11 were grown for 10 h at 37 °C with shaking in a chemically 
defined medium supplemented with a carbon source. Samples were taken every hour and read in 
a spectrophotometer. a) Growth curves of the 4 strains growing on the three different carbon 
sources. The plot shows the standard deviation of the curves. b) The growth of the isogenic strains 
were compared to the WT growth and a T test was performed. The ANOVA test demonstrated if 
the carbon source showed a significance difference among all the data. ns, no significance; **** 




The growth of the strains was compared to the WT growth in the three different carbon 
sources. In glucose, no significant difference was shown overall, however, a significance 
difference in all the strains was observed at 2 and 3 h of growth (supplement table 2.4). 
Δhdac showed an increased growth, contrary to ΔackA and Δpta. In lactate and pyruvate, 
only the growth of ΔackA and Δpta was significantly different with a reduction of the growth 
(fig 4.5 a-b). 
The growth rates on every carbon source were calculated for each strain. The doubling 
time of all strains were significantly different to the WT on all the carbon sources.   
In glucose, the doubling time of the WT was 1.13 h. The isogenic strain Δhdac reduced 
the doubling time by 1.04 fold, while the doubling time was increased by 1.25 and 1.3 
fold by the isogenic strains ΔackA and Δpta, respectively, all compared to the WT 
doubling time (fig. 4.6a) .  
The doubling time in lactate was 1.19 h in the WT, the doubling time of Δhdac showed 
no significance difference, however, the doubling time of ΔackA and Δpta was 
significantly slower (fig. 4.6a). 
The doubling time in pyruvate by the WT strain was 2.06 h, and all isogenic strains 
showed a significance difference on the doubling time. Δhdac increased the doubling time 
by 1.07 fold, and Δpta in 6.66 fold. Interestingly, ΔackA showed a negative doubling 
time, meaning that the bacteria were not growing, presenting a doubling time of -24.02 h 





Figure 4.6 Doubling time of N. gonorrhoeae MS11 and the isogenic strains in three 
carbon sources. The exponential phase (EP) was different for each strain due to the growth 
patterns showed in each carbon source. Therefore, for WT and Δhdac the EP was considered from 
2 to 4 h in all carbon sources. However, for ΔackA and Δpta the EP was different in lactate and 
pyruvate. The EP was account from 6 to 8 h of growth, and in glucose from 2 to 4 h of growth. 
The doubling time was calculated using the generation time formula G= t/n. a) The times were 
compared between strains and b) by carbon source. ns, no significance; * p value < 0.05; ** p 




The doubling time of each strain was compared to the growth on each carbon source. The 
WT and Δhdac strains showed no significance difference in the doubling time growing 
in glucose and lactate, however, the doubling time was significantly increased when 
growing in pyruvate by 1.82 and 2.17 fold, respectively (fig. 4.6b).  
The strain ΔackA significantly increased the doubling time in lactate compared to the 
growth in glucose by 3.28 fold and in pyruvate no growth was observed. The Δpta strain 
showed a significant increase in doubling time in both lactate and pyruvate compared to 
glucose, by 1.87 and 9.33 fold, respectively (fig. 4.6b). 
In previous studies, bacteria was grown in different carbon sources and concluded that 
glucose stimulates the acetylation in E. coli and S. enterica and that the acetylation is 
increased in the central metabolic pathways controlling the activity of the enzymes (Wang 
et al., 2010; Pisithkul, Patel and Amador-Noguez, 2015). Therefore, a western blot using 
the anti-acetyllysine antibody was used to observe if acetylation is modified in the growth 
of the three different carbon sources. 
Samples of bacteria were taken after 10 h growing in the different carbon sources and a 
western blot was performed (fig. 4.7a). The intensity of the bands was analysed and then 
compared by a t-test. The Δpta strain showed no bands after growing in each carbon 
source. The Δhdac and ΔackA strains showed no significant difference in the intensity of 
the bands when grown in glucose, however, it is shown a tendency to increase the 
intensity of the bands in both strains being ΔackA the strain with higher intensity of the 
bands. Growth in lactate and pyruvate showed no significance difference between WT 
and Δhdac although with a tendency to increase the intensity in the Δhdac strain. 
Interestingly, the intensity of the bands was significantly increased in the ΔackA strain. 
This means that both carbon sources increased acetylation compared to the growth in 





Figure 4.7 Acetylation of proteins in N. gonorrhoeae MS11 in different carbon 
sources. Samples of bacteria growing at 37 °C in a chemically defined medium supplemented 
with 10 mM glucose, 20 mM lactate or 20 mM pyruvate was taken for protein extraction. a) 100 
µg of proteins was loaded in a SDS-PAGE for western blot using an anti-acetyllysine antibody to 
detect acetylated proteins. b) The intensity of the bands was analyse with the ImageLab® software 
and the intensities were compared between strains in the three different carbon sources with a t-




The intensities were then compared between each carbon to determine if the growing in 
different carbon sources modifies the acetylation on each strain. Overall, acetylation is 
not affected by the carbon source, however, a tendency to decrease acetylation is observed 
when the strains were grown in pyruvate. The only strain that showed a significant 
difference in the intensity of acetylation was ΔackA. The growth in lactate increased the 
acetylation compared when grown in glucose (table 4.1). 
Table 4.1 Comparison in the acetylation of isogenic strains of N. gonorrhoeae MS11 
growing in different carbon sources. A western blot with 100 µg of proteins was analysed 
to determine the intensity of the bands. The values were compared among carbon sources for each 
strain using t-test. 
Strain 
Comparison 
p  value Significance 
Carbon 1 Carbon 2 
WT 
Glucose Lactate 0.594 ns 
Glucose Pyruvate 0.268 ns 
Lactate Pyruvate 0.176 ns 
Δhdac 
Glucose Lactate 0.119 ns 
Glucose Pyruvate 0.479 ns 
Lactate Pyruvate 0.069 ns 
ΔackA 
Glucose Lactate 0.017 * 
Glucose Pyruvate 0.194 ns 
Lactate Pyruvate 0.287 ns 
  ns, no significance. 
 The difference of acetylation in the ΔackA follows the hypothesis that lactate increases 
acetylation due to the presence of three different lactate dehydrogenases in N. 
gonorrhoeae which metabolise lactate to pyruvate and then to acetyl-CoA, the precursor 
for acetyl-phosphate (Atack et al., 2014). During infection lactate is increased by the 
Warburg effect, where anaerobic glycolysis is stimulated synthesising a higher level of 
lactate that N. gonorrhoeae could use as carbon source. In fact, some bacteria have shown 




shown a depletion of oxygen within HL-60 cells due to lactate metabolism, furthermore, 
growth of N. gonorrhoeae is increased when grown in glucose supplemented with lactate 
(Britigan et al., 1988; Regan et al., 1999; Kelly and O’Neill, 2015; Shi et al., 2015). 
The alteration to the metabolism of the three carbon sources in the different isogenic 
strains showed that the level of acetyl-phosphate is altering in the activity of the enzymes 
from the central metabolic pathways. Therefore, the enzymes from Entner-Doudoroff, 
gluconeogenesis, pyruvate metabolism, and TCA cycle enzymes were analysed in the 




 PTA-AK pathway is a metabolic flux escape for carbon overflow 
Enzymes from the central metabolic pathways are susceptible to acetylation and it is now 
recognised that it regulates the activity of the enzymes, but also the flux of the metabolism 
(Wang et al., 2010; Pisithkul, Patel and Amador-Noguez, 2015; Schilling et al., 2015, 
2019; Bernal, Castaño-Cerezo and Cánovas, 2016; Venkat, Gregory, Sturges, et al., 2017; 
Venkat et al., 2018; D. G. Christensen et al., 2019; Macek et al., 2019; VanDrisse and 
Escalante-Semerena, 2019; Schütze et al., 2020). Although it is not fully understood, it 
has been shown that the regulation of enzymes by acetylation is driven by a difference in 
the protein surface charge and changes in the conformational structure of the pockets were 
the substrates or cofactors bind. 
Lysine is a positively charged amino acid that is susceptible to the nucleophilic attack of 
acetyl-phosphate to its charged amine group. As consequence, the positive charge is 
neutralised and interactions with surrounding amino acid residues is altered, furthermore, 
the addition of the acetyl group to lysine changes the conformation of the surface of the 
enzyme (Kuhn et al., 2014; Nakayasu et al., 2017). Barbosa Leite et al., 2020, shown that 
the aldolase of Trypanosoma brucei is inhibited by the acetylation of K157 due to changes 
on the surface charge and conformation of the cavity pocket where the substrate binds. 
In this section, enzymes of the central metabolic pathways were analysed for alterations 
in the conformation of the catalytic site and the interactions with the substrates and 
cofactors. We found that 96% of the enzymes from gluconeogenesis, pentose phosphate, 
Entner-Doudoroff, pyruvate metabolism, and TCA cycle pathways shown acetylation 
sites dependent on acetyl-phosphate. 
The central metabolic pathways were obtained from the KEGG pathway database website 




acetylation sites from mass spectrometry were mapped for each enzyme. Protein models 
of the enzymes were searched in the PDB database (https://www.rcsb.org/) and the 
acetylation sites detected by mass spectrometry were mapped on the 3D model of the 
enzymes to analyse any modification on the conformation of the enzyme or on the 
interaction with the substrates. 
4.2.2.1 Gluconeogenesis 
Neisseria gonorrhoeae process glucose through the Entner-Doudoroff pathway because 
the glycolysis pathway is not complete due to the lack of phosphofructokinase, however, 
gluconeogenesis is found in the gonococcus (Baart et al., 2010). The gluconeogenesis 
pathway shown that all enzymes, except triosephosphate isomerase, possessed acetylation 
sites dependent to acetyl-phosphate. The enzymes with the highest number of significant 
different acetylation sites were 2, 3-bisphosphoglycerate dependent phosphoglycerate 
mutase (GMPA) and phosphoenolpyruvate synthase (NGO0200). The enzymes fructose-
1,6-bisphosphate aldolase (NGO0034), GMPA, and phosphoenolpyruvate synthase 
(NGO0200) shown acetylation sites that are highly regulated by the PTA-AK pathways, 
this means, that in the ΔackA and the Δpta strains, the acetylation fold change was 









Figure 4.8 Acetylation of the gluconeogenesis enzymes. Gluconeogenesis pathway of 
N. gonorrhoeae was downloaded from KEGG pathway website with entry number 
ngo00010. The acetylation sites with a significant different fold change to the WT were 
mapped to each enzyme. The acetyl-phosphate regulated sites (square shape) were 
considered if it was found in both ΔackA and Δpta, and presenting a high and low fold 
change in acetylation,   respectively, Thus, highly regulated sites were plotted to map 
them on the relative location of the protein, N-terminus, middle and C-terminus. Enzymes 




The only enzymes that have been crystallised for N. gonorrhoeae in this pathway are 
fructose-1, 6-bisphosphate aldolase (FBA) and GPMA, the crystals were obtained from 
the protein bank database (PDB) with the accession numbers, 5U4N and 5UM0, 
respectively. The acetylation sites were identified and the binding sites of the substrates 
were analysed by docking the enzymes. Both enzymes shown that lysine acetylation 
modified the substrate binding and the conformation of the pocket cavity. 
The enzyme fructose-1,6-bisphosphate aldolase (FBA) catalyses the reversible 
conversion of fructose 1, 6 biphosphate to dihydroxyacetone phosphate and 
glyceraldehyde 3-phosphate and it is essential for gluconeogenesis and it plays an 
important role in pathogenic bacteria (Pegan et al., 2013; Ziveri et al., 2017; Barbosa 
Leite et al., 2020). The acetylation sites of FBA were mapped on the protein and the 
acetylation site K202 was located in the active site. Although this acetylation site was 
found in the N. gonorrhoeae WT and no significant differences were found in the isogenic 
mutants, it is relevant to show how acetylation affects the interactions of the enzyme when 
it is acetylated. Three residues from the active site form hydrogen bonds with K202, 
however, when the lysine is acetylated, only one hydrogen bond remains. Furthermore, 





Figure 4.9 K202 acetylation of fructose-1, 6-bisphosphate aldolase changes the 
surface area and hydrogen bonds of catalytic sites. a) FBA crystal with a resolution of 
1.6 Å downloaded from the PDB with an accession number 5U4N. The active site was 
located (cyan, box) and the acetylation sites were identified for the WT (yellow), ΔackA 
(red), and AcP regulated (orange). b) K202 site (yellow) in the active site interacts by 
hydrogen bonds (yellow dashed lines) with G199, S197 and G233. c) The acetylation of 
K202 (green) causes the loss of two hydrogen bonds and a change of the pocket cavity 




The enzyme 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase (GPMA) 
catalyses the reversible reaction of 3-phosphoglycerate to 2-phospho-D-glycerate. 
Studies have shown that the activity of GPMA is regulated by acetylation (Hallows, Yu 
and Denu, 2012; Xu et al., 2014). The crystal model of the neisserial protein was obtained 
from PDB and analysed. The acetylation in K97 was shown to be affected by the PTA-
AK pathway since the fold change of acetylation was significantly increased and 
decreased in the isogenic strains ΔackA and Δpta, respectively. 
The acetylation of K97 modifies the conformation of the pocket cavity and the 
interactions with the substrate 3-phosphoglycerate. The in silico analysis showed that the 
substrate binds to the enzyme by nine hydrogen bonds to 6 amino acids residues , 
including K97. When the lysine residue is acetylated, the cavity pocket changed the 





Figure 4.10 Acetylation of K97 is acetyl-phosphate regulated in GPMA. a) The model 
of the GPMA enzyme was downloaded from PDB with the accession code 5UM0 in the tetramer 
conformation. b) A monomer unit was isolated and the active site was located (blue, box) and 
the acetylation sites were identified for the WT (yellow), ΔackA (red), and AcP regulated 
(orange). c) The substrate 3-phosphoglycerate was docked to the enzyme by in silico 
analysis showing nine hydrogen bonds including K97. d) The acetylation of K97 shows 
the same interactions with the six residues. e) The cavity pocket of the catalytic site, (f) 




The analysis of electrostatic potential surface (EPS) showed that acetylation is found in a 
cluster with a positive EPS. The acetylation of K97 also altered the EPS charge by 
neutralising the positive of the lysine and modifying the pocket cavity (fig 4.11). 
 
Figure 4.11 Acetylation of K97 changes the electrostatic potential surface of GPMA. 
The model of the GPMA enzyme was downloaded from PDB with the accession code 5UM0. 
The EPS was calculated with PyMOL. The scale bar represents the charges on the surface of the 
protein. GPMA shows a cavity pocket with a positive charge (left) and the acetylation of K97 
(green) causes a modification on the conformation on the pocket and the neutralisation of the 




Since the acetylation site was located in a cluster that showed a highly positive 
electrostatic potential surface, this suggested that acetylation could regulate the activity 
of enzymes that possess areas of highly positive electrostatic potential surface.  
Therefore, the enzymes of all the gluconeogenesis pathway were analysed to determine 
the site whereas acetyl-phosphate dependant acetylation occurs depending on the 
electrostatic potential surface. 
The protein models were obtained using PHYRE2, except FBA and GPMA, and showed 
that more than 90% of the residues possessed a modelling confidence higher than 90%. 
The significant different acetylation sites were located and determined if the location of 
acetylation was in the active site and if the lysine residue is a conserved site among 
different homologue sequences (fig 4.12). 
The models showed that acetyl-phosphate dependant acetylation occurs on areas with a 
positive electrostatic potential. The sites that were close to the active site were analysed 
to determine if they are conserved in several species and to determine if the acetylation 
modified the pocket cavity of the active site (fig. 4.12). 
The enzymes that showed acetylation in the active site were fructose 1, 6-biphosphate 
aldolase (FBA), phosphoglycerate kinase (PGK), 2, 3-bisphosphoglycerate-dependent 
phosphoglycerate mutase (GPMA), and pyruvate kinase (PK). All the acetylation sites 
were significantly increased in the ΔackA strain (fig. 4.12). 
The other enzymes showed a negative electrostatic potential in the active site and 
therefore, no acetylation was found in the active site of those enzymes (fig. 4.12). 
The relation found on the electrostatic potential surface and acetylation among the 
gluconeogenesis enzymes, led that this analysis was used on all the next pathways to 








Figure 4.12 Electrostatic potential surface (EPS) of enzymes from the 
gluconeogenesis pathway in N. gonorrhoeae. The enzymes were modelled using 
PHYRE2 and the EPS was determined using PyMOL. The significant different 
acetylation sites were mapped for ΔackA (green), Δpta (yellow) and found in both strain 
with a higher and lower acetylation, respectively (orange). The modification to the active 
site was considered if the acetylation site was located within cavity pocket of the active 
site. On the table at the bottom it is shown the abbreviation of the protein name, the 
molecular weight in Daltons (Da), if the acetylation is found in the active site and the 
position of the residue, the ratio of acetylated lysines to total number of lysines found in 




4.2.2.2 Pentose phosphate pathway 
The pentose phosphate pathway (PPP) runs parallel to glycolysis and it shares reactions 
with the Entner-Doudoroff pathway. PPP synthesises precursors for the synthesis of 
nucleotides and amino acids. It also produces pyruvate from fructose 6 phosphate. This 
pathway is important in N. gonorrhoeae because the glucose catabolism occurs through 
the Entner-Doudoroff pathway (Stephen A. Morse, Stein and Hines, 1974; Stincone et 
al., 2015). 
The acetylation sites of the PPP enzymes were analysed and the enzymes related to the 
Entner Doudoroff pathway showed levels of acetylation significantly higher. The 
enzymes glucose 6-phosphate 1-dehydrogenase (NGO0715), 6-
phosphogluconolactonase (NGO0716), and phosphogluconate dehydratase (NGO0714) 
are involved in the biosynthesis of pyruvate and they presented a fold change of 
acetylation from 1.24 to 5.17 (fig 4.13). 
For the enzymes that are involved in the biosynthesis of the nucleotide precursor 
phosphoribosyl pyrophosphate (PRPP) (Hove-Jensen et al., 2017). All enzymes showed 
acetylation levels altered by acetyl-phosphate for exemption of ribulose-phosphate 3-
epimerase (NGO0758). The enzyme that showed the highest level of acetylation was the 
ribose-phosphate pyrophosphokinase (NGO0441) with the sites K185 and K195 with fold 








Figure 4.13 Acetylation of the pentose phosphate pathway enzymes. PPP of N. 
gonorrhoeae was obtained from KEGG pathway website with entry number ngo00030. 
The acetylation sites with a significant different fold change from the WT were mapped 
to each enzyme. The final metabolites of the pathway are phosphoribosyl pyrophosphate 
(PRPP), ribose 1-phosphate and pyruvate (blue box). This pathway is connected to 
gluconeogenesis, nucleotide biosynthesis and pyruvate metabolism. Thus, highly 
regulated sites were plotted to map them on the relative location of the protein, N-
terminus, middle and C-terminus. Enzymes (yellow box); metabolites (yellow circles); 




The EPS analysis showed that six out nine enzymes presented significant levels of 
acetylation in areas with positive electrostatic potential and that are located within the 
active site pocket. From the non-oxidative branch, the enzymes with an acetylation site 
within the active site were ribose-5-phosphate isomerase A (RPIA), phosphoglucomutase 
(PGM), and ribose-phosphate pyrophosphokinase (PRPS). These enzymes contribute to 
the biosynthesis of PRPP which it is used as a precursor for the synthesis of nucleotides 
and amino acids (fig. 4.14).  
All the enzymes of oxidative branch, Entner-Doudoroff pathway, showed acetyl-
phosphate dependent acetylation present in the active site. The enzymes were glucose-6-
phosphate 1-dehydrogenase (G6PDH), 6-phosphogluconolactonase (PGLS), and 









Figure 4.14 Electrostatic potential surface (EPS) of enzymes from the pentose 
phosphate pathway in N. gonorrhoeae. The enzymes were modelled using PHYRE2 
and the EPS was determined using PyMOL. The significant different acetylation sites 
were mapped for ΔackA (green), and Δpta (yellow). The modification to the active site 
was considered if the acetylation site was located within cavity pocket of the active site. 
On the table at the bottom it is shown the abbreviation of the protein name, the molecular 
weight in Daltons (Da), if the acetylation is found in the active site and the position of the 





The crystals of two enzymes of the PPP were found on the PDB. These enzymes were 
transaldolase (NGO1610) and 6-phosphogluconolactonase (NGO0716), with the 
accession numbers 3CLM and 3HLI, respectively.  
The transaldolase converts the glyceraldehyde 3-phosphate (G3P) and sedoheptulose 7-
phosphate (S7P) to D-erythrose 4-phosphate (E4P) and beta D-fructose 6-phosphate 
(F6P) with the formation of a Schiff intermediate helped by the action of  lysine (Samland 
and Sprenger, 2009). The active site was identified and a molecular docking for both 
substrates G3P and S7P was performed. By locating the binding sites of the two 
molecules, it was observed that any of the acetylation sites that are acetyl-phosphate 
dependent (K65 and K337) interacted with the substrates (fig 4.13). 
 
Figure 4.15 Acetylation of K65 and K337 are outside the active site of the enzyme 
transaldolase in N. gonorrhoeae. The model of enzyme transaldolase was downloaded from 
PDB with the access number 3CLM. The model has a resolution of 1.14 Å. The substrates 
glyceraldehyde 3-phosphate and sedoheptulose 7-phosphate were modelled and the energy was 
decreased to 0 kJ/mol. The molecular docking was selected to the lowest affinity energy. The 
acetylation sites with an increased found in the ΔackA strain acetylation are located outside of the 






Contrary, the active site of the enzyme 6-phosphogluconolactonase (NGO0716) showed 
to be affected by acetylation. 6-phosphogluconolactonase (PGLS) catalyses the second 
reaction of the PPP, which it is also involved in the Entner Doudoroff pathway. This 
reaction converts the 6-phospho D-glucono-1,5-lactone (6PGL) to 6-phospho D-
gluconate (6PG) by an  hydrolysis reaction (Miclet et al., 2001).  
The molecular docking showed that the substrate 6GPL possessed an affinity of -7.8 
kcal/mol and that it interacts with 5 residues (G41, S44, D68, M134, and K197) by eight 
hydrogen bonds. Two of these bonds interact with a lysine residue K197 that showed 
higher acetylation in the isogenic strain ΔackA by 3.54 fold change.  
Interestingly, a conservation analysis of the site showed that from 447 homologue 
sequence, 407 contained the lysine K197 meaning a 91% conservation. The lysine K197 
was acetylated in silico and showed the loss of two hydrogen bonds with the substrate 
6GPL. Furthermore, the conformation of the pocket cavity of the active site was altered. 





Figure 4.16 Acetylation of the residue K197 in 6-phosphogluconolactonase in N. 
gonorrhoeae modifies the interaction and conformation of the active site. a) The model 
of GPLS enzyme was downloaded from PDB with the accession code 3CLM. The catalytic residues 
were located (cyan) and the lysine residues that were acetylated were identified for the WT 
(yellow), and ΔackA (red). b) The substrate 6-phospho D-glucono-1, 5-lactone (6PGL) was docked 
to the enzyme by in silico analysis showing eight hydrogen bonds including K197. c) The 
acetylation in silico of K97 showed a loss of two hydrogen bonds with K197. d) The cavity pocket 





4.2.2.3 Pyruvate metabolism 
The pyruvate metabolism is the core of the central metabolism, it is the connection 
between glycolysis and TCA cycle. In this pathway pyruvate is oxidative decarboxylated 
to form the metabolite acetyl-coenzyme A (acetyl-CoA), CO2, and NADH (H
+). This 
transformation is catalysed by a complex of three different enzymes, known as pyruvate 
dehydrogenase complex (PDC) (De Kok et al., 1998; Sauer and Eikmanns, 2005; Patel et 
al., 2014).  
The PDC is integrated by pyruvate dehydrogenase (E1) (aceE), dihydrolipoamide 
acetyltransferase (E2) (NGO0564), and dihydrolipoamide dehydrogenase (NGO0562). 
Each component has a specific role in the reaction. E1 decarboxylates pyruvate to form 
an enamine that then will acetylate a lipoyl residue in E2; then E2 transfers the acetyl 
group to the coenzyme A to form acetyl-CoA, and finally, the E3 transfers the electrons 
to produce NADH (H+). In previous studies, the pyruvate dehydrogenase E1 has shown 
to have a great number of acetylation sites (Post et al., 2017; Pang et al., 2020). 
In this pathway is also included the conversion of lactate to pyruvate. N. gonorrhoeae 
possesses three different lactate dehydrogenase that catalyses this reaction. Two are found 
on the membrane, and one in the cytosol. These enzymes are of particular interest due to 
the influence that lactate have shown in the pathogenesis and metabolism of N. 
gonorrhoeae (Parsons et al., 1996; Atack et al., 2014; Sigurlásdóttir et al., 2017). 
Furthermore, the PTA-AK pathway is found in pyruvate metabolism. Therefore, the study 
of these pathways are key to understand the role of acetyl-phosphate in the metabolism 




All the enzymes of pyruvate metabolism pathway showed acetyl-phosphate dependent 
acetylation, except acetate kinase that showed a significantly decreased acetylation which 
it was due to the knocking out of the gene (fig. 4.15).  
The enzyme that presented more acetylation sites altered by acetyl-phosphate was 
pyruvate dehydrogenase E1 with sixteen different acetylation sites. Two of those sites are 
highly regulated by the PTA-AK pathway because the level of acetylation was higher in 
the isogenic strain ΔackA and lower in Δpta. From the three lactate dehydrogenases, only 
the respiratory L-lactate dehydrogenase (NGO0639) showed a highly regulated 
acetylation site by PTA-AK pathway (fig. 4.15).  
From the enzymes of the PTA-AK pathway only the phosphate acetyltransferase 
(NGO0214) showed acetylation sites dependent on acetyl-phosphate. Although acetate 
kinase (NGO0977) showed significant decreased acetylation on the sites K169 and K195, 
these are not relevant because the gene was knocked out therefore, the peptides were 










Figure 4.17 Acetylation of the pyruvate metabolism enzymes. The pyruvate 
metabolism of N. gonorrhoeae was obtained from KEGG pathway website with entry 
number ngo00620. The acetylation sites with a significant different fold change to the 
WT were mapped to each enzyme. The acetyl-phosphate regulated sites (square shape) 
were considered if it was found in both ΔackA and Δpta, and presenting a high and low 
fold change in acetylation, respectively. Thus, highly regulated sites were plotted to map 
them on the relative location of the protein, divided by N-terminus, middle and C-
terminus. The pathway shows the name of the gene by either the abbreviation or the locus 
(yellow box), the metabolites (yellow circles) and the carbon source used by N. 
gonorrhoeae (blue box). The intermediate metabolite of the PTA-AK pathway, acetyl-




The EPS analysis of the enzymes from the pyruvate metabolism showed that six enzymes 
possessed acetyl-phosphate dependent acetylation sites in the active site. Some of them 
with a percentage of conservation. However, all these sites found in the active site showed 
a positive electrostatic surface charge (fig. 4.18). 
The enzymes that presented these acetylation sites were LdhA, NAD-linked D-LDH 
(LDHA), quinone-dependent D-lactate dehydrogenase (LDHD), pyruvate dehydrogenase 
E1 component (PDE1), dihydrolipoamide dehydrogenase (DLD), acetyltransferase 
component of pyruvate dehydrogenase complex (DLAT), and phosphate 
acetyltransferase (PTA) (fig. 4.18).  
The ratio of acetylated lysines to the total number of lysines in the enzymes of this 
pathway was 27.7%. However, the enzyme PDE1 showed a ratio of 62.5%, and 
interestingly, all of the pyruvate dehydrogenase complex showed in total 191 acetylated 
lysine residues from which 72 showed a significant different fold change of acetylation 
in the different strains (fig. 4.18). 
The lysine residues identified to be conserved were found in DLAT and PTA, with a 
conservation percentage of 35 and 81% among 1001 and 429 different sequences, 
respectively. The acetylation sites that suggest to be altering the active site and therefore, 
the interaction with the substrate were K357 and K450, respectively. K357 was found 
with a significant increase acetylation in ΔackA, Δpta, and Δhdac with a fold change of 
1.56, 1.57 and 1.32, respectively. Since DLAT mechanism action is complex due to the 
involvement of the enzymes of the pyruvate dehydrogenase complex, the prediction of 
acetylation in the binding interaction was not performed (fig. 4.18).  
However, the two enzymes LDHA and PTA were modelled and analysed for the binding 









Figure 4.18 Electrostatic potential surface (EPS) of enzymes from the pyruvate 
metabolism in N. gonorrhoeae. The enzymes were modelled using PHYRE2 and the 
EPS was determined using PyMOL. The significant different acetylation sites were 
mapped for ΔackA (green), and Δpta (yellow). The modification to the active site was 
considered if the acetylation site was located within cavity pocket of the active site. On 
the table at the bottom it is shown the abbreviation of the protein name, the molecular 
weight in Daltons (Da), if the acetylation is found in the active site and the position of the 
residue, the ratio of acetylated lysines to total number of lysines found in the enzyme and 





The location of the acetylation sites showed that the enzymes NAD+-linked D-LDH 
(LDHA) and phosphate transacetylase (PTA) were affected on the active site by 
acetylation. The proteins were modelled with PHYRE2 with a confidence modelling 
higher than 90% in the 99 (fig. 4.16a) and 65% (fig. 4.18a) of the sequence residues, 
respectively. 
The enzyme LDHA is a cytosolic lactate dehydrogenase that catalyses the reversible 
reaction of D-lactate to pyruvate with the reduction of NAD+ (Atack et al., 2014). 
Contrary to the previous enzymes where the acetylation inhibited the binding to the 
substrate, the structure prediction an in silico analysis suggests that acetylation increases 
the binding to the substrate. The enzyme showed a significant reduction of acetylation in 
the residue K154 by 1.54 fold in the ΔackA strain (fig. 4.16).  
The substrates NAD+ and lactate were docked in the active site of the enzyme and NAD+ 
showed five hydrogen bonds to four residues (G153, K154, I155 and S233). One of the 
hydrogen bonds interacts with K154 and when the lysine was acetylated in silico, the 
hydrogen bond was replaced by two bonds, increasing the number of hydrogen bonds 





Figure 4.19 Acetylation of K154 interacts with the substrate of LDHA in N. 
gonorrhoeae. a) The modelling of LDHA was created using PHYRE2. The catalytic residues 
were located (cyan) and the lysine residues that were acetylated were identified for the 
WT (yellow), increased acetylation in Δpta (blue), decreased acetylation in ΔackA 
(salmon), and increased acetylation in ΔackA (red,). b) The substrates NAD (magenta) and 
lactate (yellow) were docked to the enzyme by in silico analysis showing five hydrogen 
bonds including K154. c) The acetylation in silico of K154 showed interaction with 
NAD+. d) The cavity pocket of the catalytic site, e) when acetylated showed a change in 




The enzyme PTA is part of the short pathway PTA-AK that catalyses the conversion of 
acetyl-CoA to pyruvate with the generation of the intermediate metabolite acetyl-
phosphate and the release of CoA. Acetyl-phosphate is the responsible molecule of non-
enzymatic acetylation (Verdin and Ott, 2013; Wolfe, 2016). 
The predictive model of PTA was analysed to find possible interactions with the substrate. 
The model presented a percentage confidence of 65% of residues modelled higher than 
90% due to the presence of 175 amino acids in the N-terminus that have not been 
modelled from a crystal. However, discarding the first 175 amino acids, the modelling 
confidence increases to more than 90% compared with 429 homologue sequences. 
 
Figure 4.20 Alignment of PTA with different bacterial species. The sequence of 
phosphate transacetylase (PTA) from N. gonorrhoeae MS11 was aligned to the sequence of PTA 
from 6 species of different bacteria. The sequence of the gonococcus contains 175 amino acids 
additional to the other sequences.  
The enzyme showed a significant increase of acetylation in the lysine residue K450, 
located the active site, in the isogenic strain ΔackA. The molecular docking of the 
substrate acetyl-CoA showed interactions with seven residues (T302, N446, Y449, K450, 
G462, S476, and G478) forming seven hydrogen bonds. One of the hydrogen bonds is 
with K450 which showed an 81% conservation among 429 homologue sequences. 
Acetylation of the lysine residue in silico showed the depletion of the hydrogen bond and 
a change in the conformation of the pocket of the active site by decreasing the surface 
area for solvent molecules by 11.26 Å2. The increase of acetylation was 2.65 fold in the 
strain ΔackA, however, this same site was significantly increased by 3.15 fold in the 








Figure 4.21 Acetylation of K450 residue of phosphate transacetylase is predicted to 
alter the interaction with the substrate and the conformation of the active site. a) 
Predictive model of PTA using PHYRE2. The active site was located (cyan, box) and the 
acetylation sites were identified for the WT (yellow), and ΔackA (red). b) The substrate 
acetyl-CoA was docked to the enzyme by in silico analysis, showing seven hydrogen 
bonds including the residue K450. c) The acetylation in silico of K450 showed a loss of 
a hydrogen bond to K450. d) Aerial view of the cavity pocket of the catalytic site, e) 
showed a decreased of the surface area when K197 was acetylated (green). f) Lateral view 
of the active site with substrate, and g) after acetylation of K450 showing a decrease of 




The second enzyme of the PTA-AK pathway is acetate kinase (AK). The enzyme 
catalyses the reversible conversion of acetyl-phosphate to acetate with the production of 
one molecule of ATP (Verdin and Ott, 2013). The predictive model of the enzyme 
possessed a 100% of residues modelled at >90% confidence. The active site was located 
and by molecular docking the predictive binding sites of the substrates acetyl-phosphate 
and ADP were identified. 
The acetylation sites of the enzyme were located, which only were found in the WT strain. 
Two sites of acetylation (K169 and K197) showed a significant lower acetylation, 
however, these sites were decreased due to the sequence of the mutant that some parts 
were deleted from the WT sequence. The rest of the acetylation sites found in the WT 
strain are located outside of the active site and K47 is located near the acetylation site but 
the data from mass spectrometry showed no acetylation difference in any of the isogenic 
strains (fig. 4.19). 
 
Figure 4.22Acetate kinase model of N. gonorrhoeae. The model was constructed with 
PHYRE2 and the active site (cyan) was used to the molecular docking of the substrates ADP 
(magenta) and acetyl-phosphate (yellow). Then the acetylation sites were located for the WT 




4.2.2.4 TCA cycle 
The TCA cycle is the final pathway of the central metabolic pathway. In this pathway 
merges the oxidation of carbohydrates, amino acids and lipids and it is the pathway where 
the highest number of ATP molecules for the obtainment of energy. The pathway starts 
with a molecule of acetyl-CoA that will suffer a number of steps to be finally 
decarboxylated into CO2 (Akram, 2014). 
The analysis of acetylation of the TCA cycle enzymes showed that all presented 
significant different levels of acetylation in the isogenic strains. Aconitate hydratase B 
(NGO1231), isocitrate dehydrogenase (NGO1082), and 2-oxoglutarate dehydrogenase 
(SUCA) were the enzymes that presented the highest number of acetyl-phosphate 
dependent sites with 18, 10, and 19 sites, respectively (fig. 4.23). 
2-oxoglutarate and malate quinone reductase showed that the acetylation site K563 and 
K218, respectively, are regulated by the PTA-AK pathway, since the fold change of 








Figure 4.23 Acetylation of the TCA cycle enzymes. The TCA cycle of N. gonorrhoeae 
was obtained from KEGG pathway website with entry number ngo00020. The acetylation 
sites with a significant different fold change to the WT were mapped to each enzyme. The 
acetyl-phosphate regulated sites (square shape) were considered if it was found in both 
ΔackA and Δpta, and presenting a high and low fold change in acetylation, respectively, 
Thus, highly regulated sites were plotted to map them on the relative location of the 
protein, divided by N-terminus, middle and C-terminus. The pathway shows the name of 
the gene by either the abbreviation or the locus (yellow box), the metabolites (yellow 




The electrostatic potential surface analysis demonstrated that citrate synthase (CS) and 
dihydrolipoyllysine residue succinyltransferase component of 2-oxoglutarate 
dehydrogenase complex (DLST) possessed a positive EPS cluster where acetylation 
could have occurred. However, only DLST showed that the site K214 was in this cluster. 
This cluster suggests to be an active site of the enzyme, but the conserved amino acids 
were found in another area which possesses a negative EPS (fig. 4.24). 
Contrary to the previous pathways where enzymes showed acetylation sites in the active 
site, none of the enzymes from the TCA cycle showed acetylation sites that were 








Figure 4.24 Electrostatic potential surface (EPS) of enzymes from the TCA cycle in 
N. gonorrhoeae. The enzymes were modelled using PHYRE2 and the EPS was 
determined using PyMOL. The significant different acetylation sites were mapped for 
ΔackA (green), and Δpta (yellow). The modification to the active site was considered if 
the acetylation site was located within cavity pocket of the active site. On the table at the 
bottom it is shown the abbreviation of the protein name, the molecular weight in Daltons 
(Da), if the acetylation is found in the active site and the position of the residue, the ratio 
of acetylated lysines to total number of lysines found in the enzyme and the Kollman 





In this chapter the role of acetyl-phosphate in the acetylation of the enzymes from the 
central metabolic pathways (CMP) and the effect acetylation possesses in growth and 
carbon utilisation was described. 
The general approach was to identify the pathways where acetylation was increased and 
decreased by an enrichment analysis in the three isogenic strains. From the enriched 
pathways we found that all the CMP were found at least in one mutant, which corresponds 
to a phenomena that has been described previously in other studies (Zhang et al., 2008; 
Xiong and Guan, 2012; Schilling et al., 2015, 2019; Reverdy et al., 2018; David G 
Christensen et al., 2019). In fact, a study analysed the acetylation of 48 different bacterial 
species and determined that acetylation is highly conserved among bacteria for the 
regulation of the enzymes from the CMP (Nakayasu et al., 2017). 
In this study, we found that 96% of the total enzymes corresponding to the CMP presented 
acetyl-phosphate dependent acetylation sites. This supports the idea presented by Nakayasu 
et al., 2017, that acetylation was one of the first regulation system for the enzymes 
belonging to the metabolic pathways. Interestingly, it was determined that acetyl-
phosphate is the ancestor of ATP for the obtainment of energy. The molecule acetyl-
phosphate was synthesised non-biologically and it showed to phosphorylate proteins just 
in the presence of water. In the study also, acetyl-phosphate was able to phosphorylate 
ADP to ATP (Camprubi et al., 2018). Duan and Walther, 2015, proposed that each post 
translational modification (PTM) has a specific role in the cell. By the analysis of networks 
and enrichment of biological processes for each PTM they showed that proteins that have 
more phosphorylation sites, are more prone to interact with other proteins. This would 




metabolic pathways, as described previously in several studies (Castaño-Cerezo et al., 
2009a, 2015; Wang et al., 2010; Kim et al., 2013; Sadykov et al., 2013; Choudhary et al., 
2014; Venkat, Gregory, Sturges, et al., 2017; Venkat et al., 2018). This hypothesis is 
supported by the results found in the analysis of acetylation of the enzymes from each 
pathway from CMP. 
The growth in different carbon sources showed a changed in the phenotype in N. 
gonorrhoeae and revealed that acetylation is important in the control of carbon metabolism. 
Furthermore, this is the first time that PTA-AK mutants were grown in lactate and pyruvate. 
In glucose, although all the strains grew, the isogenic strains ΔackA and Δpta presented a 
significant lower growth during the first 3 and 4 h, respectively. Therefore, the doubling 
time was significantly slower. This effect has been observed in other studies where the pta 
gene was mutated in E. coli and observed a slower growth in glucose compared to the WT 
(Chang et al., 1999; Mizrahi, Biran and Ron, 2006). While in the strain Δhdac the doubling 
time was significantly faster. In a study of a deacetylase mutant of Mycobacterium 
tuberculosis the growth was faster in fatty acids suggesting that the deacetylation of 
isocitrate lyase increased the metabolism and therefore the speed of growth (Bi et al., 
2017).  
However, the growth phenotype changed radically when these two isogenic strains were 
grown in lactate and pyruvate. In bacteria, the oxidation of glucose leads to the formation 
of pyruvate and finally to acetyl-CoA. The unbalance of carbon catabolism and respiration 
leads to the accumulation of products, and this is known as carbon overflow (Castaño-
Cerezo et al., 2009b, 2015; Schilling et al., 2015; Bernal, Castaño-Cerezo and Cánovas, 
2016; De Mets, Van Melderen and Gottesman, 2019). The accumulation of products is 
found in the pyruvate node where pyruvate is converted to acetyl-CoA. Since acetyl-CoA 




pyruvate causing the intracellular accumulation and extracellular release of pyruvate 
(Wolfe, 2005). 
PTA-AK pathway plays an important role in metabolism as the escape valve to handle the 
carbon overflow by producing and releasing acetate extracellularly, a phenomenon known 
as the acetate switch (Chang et al., 1999; Wolfe, 2005; Bernal, Castaño-Cerezo and 
Cánovas, 2016; Schütze et al., 2020). This switch in bacteria has been extensively studied 
and it has been related to the pathogenicity, virulence, biofilm formation, and response to 
stress. However, when the PTA-AK pathway has been altered by constructing mutants, the 
bacteria have shown a difference in their phenotypes. For instance, bacterial growth is 
decreased and there is a presence of secretion of lactate, pyruvate and formate instead of 
acetate (Holms, 1996; Dittrich, Bennett and San, 2008; Niu et al., 2014; Castaño-Cerezo 
et al., 2015; Bernal, Castaño-Cerezo and Cánovas, 2016). Indeed, a slower growth was 
observed in both the ΔackA and Δpta isogenic strains. 
Although, the acetate switch has been longer studied, the reason for this change of 
metabolism has not been fully understood. However, in this study I proposed a mechanism 
that regulates the acetate switch by the acetylation of the first enzyme of the PTA-AK 
pathway.  
As mention previously, the acetate switch occurs when there is carbon overflow due to an 
increase of substrates to be oxidised which leads to the secretion of other by products 
including pyruvate and lactate. This occurs in the pyruvate node, where the pyruvate is 
converted into acetyl-CoA through a series of reactions catalysed by the pyruvate 
dehydrogenase complex (PDC). This complex is encoded in an operon formed by the 
enzymes pyruvate dehydrogenase, dehydrolipoyl acetyltransferase, and dehydrolipoyl 




transcriptionally regulated by the repressor PdhR, which activity is inhibited in presence of 
pyruvate (Ogasawara et al., 2007). Interestingly, in an E. coli Δpta strain, the levels of 
PdhR were decreased by 10 fold compared to the WT but the PDC activity was increased. 
In this study, the researchers proposed a post translational modification as the regulatory 
mechanism of PdhR (Castaño-Cerezo et al., 2009a). Contrary to E. coli, N. gonorrhoeae 
lacks the gene pdhR upstream to the PDC operon and the regulation of the PDC 
transcription has not been described (fig 4.25). However, the analysis of the upstream 
sequence of the gonococcus operon showed the palindromic sequences where PdhR binds 
the PDC promoter in E. coli. This could suggest that a different inhibition for the 
transcription of the aceEF-lpd operon occurs in N. gonorrhoeae or that the regulation of 
the activity of the PDC is directly on the enzymes by post translational modifications.  
Interestingly, in the proteome of N. gonorrhoeae Δpta we found a decrease in the 
expression of the dehydrolipoyl acetyltransferase, the component E2 of the PDC. Thus, the 
change of expression suggests that a transcriptional regulator repressor is regulated by 
acetylation and that it is active when it is deacetylated. The transcriptional regulators have 
shown an affinity to DNA, however, when they suffer acetylation the positive charge of 
the lysine residue that interacts with the negative charge of the phosphodiester backbone 
of DNA is inhibited and the proteins detach from the DNA. This phenomenon has been 
observed in several transcriptional regulators and DNA-binding proteins as histones (Kuhn 
et al., 2014; Ghosh et al., 2016; Sang et al., 2017; Brosh, 2019; Ren et al., 2019; Koo et 
al., 2020). Indeed, a GntR transcriptional regulator (NGO1360) with a similar structure is 
found in the neisserial genome, however, it is found upstream from the ace operon, this 
regulator is flanking lactate-permease and the mtrCDE operon. This transcriptional 
regulator showed a decreased of acetylation in the site K252 in Δpta. The decrease of 




transcription of the ace operon. Indeed, qPCR of the component 2 of the PDC showed a 
decreased expression in Δpta (table 5.1). 
 
Figure 4.25 aceEF-lpd operon. The sequence from both operons were obtained from NCBI and 
the genes were mapped. a) The operon of E. coli K-12 possesses the pdhR gene downstream to the 
aceE. b) N. gonorrhoeae FA 1090 lacks of the pdhR in the operon. pdhR, pyruvate dehydrogenase 
transcriptional repressor; ace, pyruvate dehydrogenase E1; aceF, dehydrolipoyl acetyltransferase; 
lpd, dehydrolipoyl dehydrogenase. 
Pyruvate dehydrogenase E1 (AceE) is one of the few enzymes that presented one of the 
highest number of acetylation sites. Vibrio alginolyticus, Bacillus subtilis, Salmonella 
enterica serovar Typhimurium, E. coli and N. gonorrhoeae have also shown high numbers 
of acetylation sites, suggesting a regulation of the enzyme by post translational 
modifications (Yu et al., 2008; Kuhn et al., 2014; Kosono et al., 2015; Pang et al., 2020). 
Indeed, phosphorylation of pyruvate dehydrogenase causes the inhibition of the enzyme 
(Sgrignani et al., 2018). However, post translational modifications are not the only 
regulating mechanisms. Pyruvate dehydrogenase is also repressed at high concentration of 
acetyl-CoA and NADH (Hansen and Henning, 1966; Schwartz and Reed, 1970).  
The regulation of the pyruvate node has been described, however, this does not explain the 
underlying mechanism of the carbon overflow. Furthermore, this explanation has not taken 
in account why in PTA-AK mutants the metabolism is slowed down and there is an increase 




combination of different regulatory mechanisms involving catabolic repression, post 
translational modification but none of the studies have considered that this regulation could 
be driven by the acetylation of the PTA-AK pathway. 
 Carbon overflow is possibly regulated by acetylation of Pta 
The analysis of the enzyme models to map all the acetyl-phosphate dependent sites, showed 
that some of the acetylation sites are found in the active sites and that this could be affecting 
the binding of the substrate. Thus, acetylation could possibly inhibit the enzyme activity. 
Indeed, some studies have reported the inhibition of the enzymatic activity by lysine 
acetylation. For instance, the acetylation of K55 decreased the activity of isocitrate 
dehydrogenase in E. coli (Venkat et al., 2018); the deacetylation of the isocitrate lyase by 
the deacetylase CobB increases its activity in E. coli (Castaño‐Cerezo et al., 2014); DNA 
topoisomerase I reduced the binding to DNA when acetylated (Zhou et al., 2018); and in 
Mycobacterium tuberculosis a similar effect was observed in the nucleoid-associated 
protein HU (Ghosh et al., 2016). Interestingly, some studies have shown that acetylation 
stabilises protein-protein interactions, improves protein folding, and increases enzymatic 
activity (Lin et al., 2013; Venkat, Gregory, Sturges, et al., 2017; Ree, Varland and Arnesen, 
2018).  
Different studies have shown that acetylation neutralises the positive charge of the lysine 
residues and a change in the conformation of the active site (Tzeng et al., 2004; Lu et al., 
2011; Xiong and Guan, 2012; Baeza, Smallegan and Denu, 2016; Nakayasu et al., 2017; 
Barbosa Leite et al., 2020). Moreover, the site of acetylation has been attributed to the 
sequence or to the secondary structure of the protein, finding the majority of acetylation in 
alpha helices (Lu et al., 2011; Carabetta and Cristea, 2017). In a study conducted by Lu et 




residues that had been shown to be acetylated to other amino acids. They found that lysine 
residues stabilises the alpha helix structure, however, when acetylated the alpha helix is 
destabilised. 
However, no study has considered the electrostatic charge surface (EPS) of the proteins as 
a clue to identify the location of acetylation. Only one study reported that the EPS was 
changed by the acetylation in the active site of the fructose 1,6-bisphosphate aldolase in 
Trypanosoma brucei (Barbosa Leite et al., 2020). EPS accounts for the stability and 
conformation of the proteins, the charges that amino acids possess determine the interaction 
with neighbouring proteins and substrates (Strickler et al., 2006; Tsai et al., 2016; Vascon 
et al., 2020). The analysis of EPS in all the central metabolic pathways showed that acetyl-
phosphate dependent acetylation occurs in positive EPS. 
 The analysis of the 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 
(GPMA) revealed that acetylation occurred exactly in a cluster that showed a positive EPS. 
Furthermore, this cluster was found in the active site. The acetylation of K97 was shown 
to be highly regulated by acetyl-phosphate. Interestingly, in humans the acetylation of 
K100 in this enzyme was shown to inhibit its activity and it was regulated by a deacetylase 
Sirt1 (Hallows, Yu and Denu, 2012). The alignment of both sequences showed that the 
lysine residue is conserved in both organisms, however, in N. gonorrhoeae the regulation 
is by the acetyl-phosphate acetylation. This could suggest the evolution of the enzymatic 
activity regulation (fig. 4.26). This idea is supported by the evidence provided by Nakayasu 
et al., 2017, where they found that acetylation sites were conserved among several bacterial 






Figure 4.26 Alignment of phosphoglycerate mutase sequences. The sequences from N. 
gonorrhoeae (Uniprot: Q5F7C0) and Homo sapiens (Uniprot: P18669) were aligned by Clustal W 
and the site K100 showed to be conserved in both sequences. 
The EPS analysis and acetylation mapping on the different enzymes of the central 
metabolic pathways suggests that enzymes from the Embden Meyerhof Parnas 
(glycolysis/gluconeogenesis), Entner-Doudoroff and pyruvate metabolism could be 
inhibited by acetyl-phosphate due to the acetylation of lysine residues that are part of the 
active sites. However, the enzymes from the TCA cycle did not present acetyl-phosphate 
dependent acetylation sites that could inhibit the enzymatic activity.  
The aim to construct both isogenic mutant strains, ΔackA and Δpta, was not only to create 
strains of N. gonorrhoeae MS11 with different concentration of acetyl-phosphate but also 
used to observe the role of the acetate switch in the gonococcus. In this study, I propose a 
mechanism for the role of the PTA-AK pathway and the intermediate acetyl-phosphate in 





Figure 4.27 Proposal of the regulation of the central metabolic pathway by 
acetylation. The PTA-AK pathway converts acetyl-CoA to acetate with the production of acetyl-
phosphate as intermediate metabolite. 1) During carbon overflow, the TCA cycle is saturated and 
acetyl-CoA accumulates. One mechanism to deal with carbon overflow is to convert acetyl-CoA to 
pyruvate and lactate which then they are secreted. 2) However, PTA-AK pathway is used as the 
secondary pathway to release the load of acetyl-CoA accumulation. This causes the increase of 
acetyl-phosphate concentration since the enzymatic activity of acetate kinase is lower than 
phosphotransacetylase. As consequence, acetyl-phosphate dependent acetylation increases and 




inhibits the activity of the enzymes. 3) Phosphotransacetylase suggests an inhibition caused by the 
acetylation of K450, molecular docking showed interactions between K450 and the substrate 
acetyl-CoA. Moreover, this post translational modification alters the conformation of the active site 
pocket. K450 is a conserved residue found in 81% of the sequences analysed. 4) In the isogenic 
strain Δhdac, the fold change of acetylation for K450 was higher than in ΔackA suggesting that this 
is a target for the histone deacetylase like protein (HDAC). Therefore, the acetylation by acetyl-
phosphate and deacetylation by HDAC could be the regulatory mechanism for PTA. The 
acetylation of PTA causes the enzymatic inhibition, thus, the acetyl-CoA further accumulation. 5) 
Acetyl-CoA inhibits the pyruvate dehydrogenase complex enzymatic activity which stops the 
carbon flux towards the TCA cycle. 6) The accumulation of acetyl-CoA activates the activity of 
HDAC and the increase of acetyl-phosphate leads to a global acetylation of the CMP. 7) However, 
this was only found to inhibit the enzymes from glycolysis, Entner-Doudoroff pathway and 
pyruvate metabolism. This suggests carbon overflow is regulated by the acetylation of the enzymes 
to halt the production of acetyl-CoA and favour the activity of the TCA cycle to oxidise the pool 
of acetyl-CoA and to maintain the homeostasis of the bacteria metabolism. When the levels of 
acetylation decrease due to the reduction of acetyl-CoA, the central metabolic pathway is re-
activated. The enzymes show the acetyl-phosphate dependent acetylation sites that are located in 
the active site (yellow circle) and that were significantly increased. FBA, fructose-1,6-
bisphosphatase class 1; PGK, phosphoglycerate kinase; GPMA, 2,3-bisphosphoglycerate-
dependent phosphoglycerate mutase; G6PDH, glucose-6-phosphate 1-dehydrogenase; PGLS, 6-
phosphogluconolactonase; EDD, Phosphogluconate dehydratase; E1, pyruvate dehydrogenase 
component E1; E2, dehydrolipoyl acetyltransferase; E3, dehydrolipoyl dehydrogenase; HDAC, 




The metabolism of glucose in N. gonorrhoeae is catabolised through the Entner-
Doudoroff pathway (EDP) (Stephen A. Morse, Stein and Hines, 1974; Chen et al., 1989; 
Mizuno et al., 2016). Interestingly, three from the four enzymes of the EDP showed an 
increase of acetyl-phosphate dependent acetylation in the active site, modifying the 
conformation of the cavity pocket and the interaction with the substrates. Moreover, this 
enzymes shown the highest fold change from the rest of the CMP. Entner-Doudoroff 
pathway is considered as the precursor of glycolysis, thus, the regulation of this pathway 
suggests that is driven by the ancient molecule acetyl-phosphate (Romano and Conway, 
1996; Nakayasu et al., 2017; Camprubi et al., 2018). 
The enzymes from gluconeogenesis that showed acetylation in the active site were 
fructose-1,6-bisphosphate aldolase (FAB), phosphoglycerate kinase (PGK), and 2,3-
bisphosphoglycerate-dependent phosphoglycerate mutase (GPMA). 
From these three enzymes FBA has an important role in the CMP of bacteria, thus the 
regulation of FBA is relevant. In glycolysis, FBA acts as the control point, it is also a 
transcriptional regulator for the transcription of genes involved in host redox homeostasis 
and immune response (Shestov et al., 2014; Ziveri et al., 2017). Fructose 1,6-
bisphosphate, the product of FBA, has shown to regulate the activity of lactate 
dehydrogenase, acetate kinase, and phosphoenolpyruvate carboxylase (Sauer and 
Eikmanns, 2005; Puri et al., 2014; Kim, Ahn and Burne, 2015). In E. coli, FBA has shown 
high levels of acetylation compared to other enzymes, however they showed that the 
enzymatic activity was not altered (Zhang et al., 2013; Schütze et al., 2020). Contrary to 
our results where acetylation suggests to inhibit the activity of FBA. Indeed, in 
Trypanosoma brucei it was determined that acetylation of K157 inhibits the activity due 
to a change in the conformation of the active site that inhibits the binding of the substrate 




The pyruvate metabolism showed the highest number of acetylation sites and it has been 
shown that the pyruvate node is the bottleneck for carbon overflow (Castaño-Cerezo et 
al., 2009b; Bernal, Castaño-Cerezo and Cánovas, 2016). The accumulation of acetyl-CoA 
inhibits the activity of the pyruvate dehydrogenase complex, therefore, it is halted the 
conversion to pyruvate (Yang, Bennett and San, 1999; D. G. Christensen et al., 2019; 
Schütze et al., 2020). In this scenario, PTA-AK pathway converts acetyl-CoA to acetate 
to release the metabolism from carbon overflow, effect known as acetate switch. The 
acetate switch generates high levels of acetyl-phosphate (Wolfe, 2005; Valgepea et al., 
2010; Bernal, Castaño-Cerezo and Cánovas, 2016).  
In this study, we propose that the increase of acetyl-phosphate led to the inhibition of the 
phosphotransacetylase (PTA) enzyme. K450 showed an increase of acetyl-phosphate 
dependent acetylation. This residue is located in the active site, moreover, it is a conserved 
site that showed 81% of conservation among 439 sequences of different species. 
Interestingly, the PTA activity was decreased in the ΔackA isogenic strain which 
possessed high levels of acetyl-phosphate production (396.56 ± 87.94 nmol-1min-1mg-1). 
The reduction of the enzymatic activity was by 4.5 folds compared to the WT (1789.43 ± 
267.38. nmol-1min-1mg-1) (table 3.1). Indeed, the growth of N. meningitidis in pyruvate 
showed that the enzymatic activity of PTA was decreased in pyruvate growth compared 
to glucose (Leighton et al., 2001). The molecular docking revealed that this site interacts 
with acetyl-CoA and that the acetylation of K450 modifies the conformation of the active 
site, blocking the binding to the substrate. Although, this suggests that the enzymatic 
activity of PTA is regulated by acetylation further studies are needed to determine the 
role of K450. 
Since K450 only showed an increase of acetylation in the strain ΔackA, and no significant 




is enzymatically regulated. Indeed, the isogenic strain Δhdac showed a higher fold change 
of acetylation in K450 compared to ΔackA. In chapter 3, it was described the possible 
targets of HDAC and the site K450 of PTA was a candidate. This supports the idea that 
PTA is deacetylated by HDAC to activate the enzyme during carbon overflow when high 
levels of acetyl-phosphate are found. As mention previously, acetyl-CoA is accumulated 
during carbon overflow. Interestingly, it was demonstrated that acetyl-CoA activates 
HDAC (Vogelauer et al., 2012). This suggests that the regulation of PTA is driven by 
negative feedback and HDAC. 
Curiously, acetyl-phosphate dependent acetylation was only observed in the phase of the 
oxidation of glucose to acetyl-CoA, suggesting that acetylation only inhibits the enzymes 
for the formation of acetyl-CoA and TCA cycle is favoured to metabolise acetyl-CoA. In 
TCA cycle, only isocitrate dehydrogenase presented acetylation by acetyl-phosphate near 
the active site. Interestingly, a study conducted in E. coli showed the activation of 
isocitrate dehydrogenase when acetylated, contrary to what it has been described in 
enzymes from glycolysis, pentose phosphate pathway and pyruvate metabolism (Venkat 
et al., 2018). However, in N. meningitidis, Leighton et al., 2001, measured the enzymatic 
activity of the TCA cycle and PTA-AK pathway enzymes when the bacteria grew on 
either glucose or pyruvate. All enzymes showed a decreased in the enzymatic activity 
when growth in pyruvate compared to glucose. This suggests that increase of acetylation 
slows down the global enzymatic activity of the central metabolic pathways, however, 
TCA cycle enzymes are not inhibited by the acetylation of the active sites, as observed in 
this study. Indeed, in Staphylococcus aureus it was observed that metabolites from the 
TCA cycle were increased when the PTA-AK pathway was inactivated. Furthermore, 
they found a 4 fold increase of citrate synthase enzyme, the first enzyme that catalyses 




pyruvate accumulates during carbon overflow, thus, the growth in pyruvate resembles the 
conditions of carbon overflow due to the imbalance between oxidation and respiration. 
Therefore, the proposed regulation of carbon overflow is that the increase of acetylation 
inhibits the production of acetyl-CoA by acetylating the active sites and blocking the 
binding of the substrates in the enzymes from glycolysis, Entner-Doudoroff and pyruvate 
metabolism. The PTA-AK pathway is also inhibited by the acetylation of the site K450 
in PTA which blocks the production of acetate. This directs the flux of acetyl-CoA to 
TCA cycle where acetyl-phosphate acetylation was not found in the active sites of the 
enzymes. The depletion of acetyl-CoA leads to the decrease of acetyl-phosphate 
dependent acetylation, causing the reactivation of the production of acetyl-CoA. As 
consequence, the balance between oxidation and cellular respiration. 
 Future work 
In order to prove this mechanistic proposal and to determine that in fact, ED and pyruvate 
metabolism is regulated by acetyl-phosphate. Enzymatic assay to measure enzymatic 
activity from each isogenic mutants must be performed. By analysing the enzymatic from 
each isogenic mutant would be possible to compare it to the WT and observe any increase 
or decrease of the activity. Furthermore, if any statistically significant difference is 
observed, the next step would be to perform site directed mutagenesis to determine if the 
lysine that showed to be acetylated by mass spectrometry and the structure analysis is 
indeed important for the regulation of the enzyme. The enzymes would it be more 
interesting to analyse in detail are pyruvate dehydrogenase, due to its high number of 
acetylation sites, and phosphotransacetylase, since the site K450 is locates in the active 
site and the histone deacetylase-like protein shows to target that site.  This approach 




the lysine residue that is acetylated for a neutral aminoacid as glutamine that mimics the 
structure of lysine (Venkat et al., 2018).  In a study conducted in Trypanosoma brucei the 
lysine of the aldolase active site was mutated by a glutamine, a polar uncharged amino 
acid that contains an amine group as lysine. They found that the enzymatic activity was 
decreased, showing that acetylation regulates the activity of aldolase (Barbosa Leite et 
al., 2020). Therefore, this technique could be applied to enzyme Pta, G6PDH, EDD, and 
the PDC. If the enzymatic activity is altered, this would indicate that acetylation of the 












5 Role of acetyl phosphate in the virulence of N. 
gonorrhoeae MS11 
5.1 Introduction 
Sexually transmitted infections (STI) are a major public health issue, the World Health 
Organisation (WHO) has estimated that every year, 376 million people get a STI (WHO, 
2019b). In 2016, 86.9 million cases corresponded to the STI gonorrhoea, caused by the 
bacteria N. gonorrhoeae (Rowley et al., 2019). The WHO has taken action due to the high 
prevalence and incidence of STI and has set a goal to reduce 90% of cases of gonorrhoea 
by 2030 (WHO, 2019a). However, since the discovery of azithromycin resistance of N. 
gonorrhoeae in 2009 in Japan, the number of cases with gonococcal resistant strains has 
increased (Yahara et al., 2018). This has caused a surge of cases worldwide, in 2020, the 
UK reported the highest number of cases of gonorrhoea since it started to record data in 
1918. The number increased from 56,232 in 2018 to 70,936 in 2019, this meant an 
increase of 26% (Wise, 2020). 
N. gonorrhoeae is an obligate human pathogen that has evolved at the same time as 
human which has led the bacteria to adapt for survival. Therefore, it possesses many 
mechanisms to evade the immune system (Stern et al., 1986; Lu et al., 2018; Quillin and 
Seifert, 2018). Furthermore, it has shown to modulate the differentiation and regulation 
of immune system cells (Chen and Seifert, 2011; Ortiz et al., 2015; Château and Seifert, 
2016). The virulence of the gonococcus has been studied, however, the relation with 
acetylation has not been studied deeply. 
In this chapter, we explore different mechanisms that might be altered by acetylation and 





In this chapter we analysed the effect of acetylation in the virulence of N. gonorrhoeae. 
Assays included proteomics, RT-qPCR, Galleria mellonella and human monocyte-
derived macrophages (MDM), antibiotics resistance by disc diffusion and in vitro 
microscopy. 
 Acetylation alters the intracellular survival of N. gonorrhoeae 
Macrophages (MΦ) are the first line of defence in the innate immunity. MΦ polarise 
depending on the infection, M1- MΦ shows a strong microbicidal activity and releases 
proinflammatory cytokines, while M2- MΦ is polarised during parasite infection, reduces 
inflammation and modulates the immune response (Boorsma, Draijer and Melgert, 2013; 
Duque and Descoteaux, 2014). N. gonorrhoeae is a pathogen with the capacity to survive 
intracellularly in polymorphonuclear cells and macrophages through different mechanism 
evading the immune response of the cells (Johnson and Criss, 2013; Atack et al., 2014; 
Château and Seifert, 2016; Ritter and Genco, 2018).  Interestingly, N. gonorrhoeae has 
been shown to modulate the polarisation and apoptosis of MΦ, and the production of 
cytokines, which makes the investigation of acetylation in N. gonorrhoeae an important 
area of study (Ortiz et al., 2015). 
Monocyte-derived macrophages (MDM) were isolated from healthy volunteer donors and 
infected with the 4 different isogenic strains of N. gonorrhoeae MS11. The assay was 
first optimised to determine the concentration of gentamicin and saponin to perform the 
experiment, as well as the growth curve in BHI to grow the bacteria prior to the infection 
of the MDM. 
Gentamicin, the antibiotic that was used to kill the extracellular bacteria for the killing 




concentration that inhibited the growth by 99.98% was gentamicin 100 µg/mL. The 
optimisation was also performed for the detergent saponin, used to dissolve the MDM´s 
membrane. We tested the saponin at 0.5, 1, 1.5 and 2 % and 1.5% saponin that was 
ultimately used showed no effect in bacterial viability. 
The growth in BHI showed that the mid-logarithmic phase was at 4 h, time used to collect 
the bacteria for the infection of the MDMs (fig. 5.1). 
 
Figure 5.1 Growth curve of isogenic strains of N. gonorrhoeae in BHI. The strains were 
grown at 37 °C with shaking and the optical density (OD) was read at 600 nm every hour to 
determine the mid-logarithmic phase. 
Once the conditions were standardised, MDM were infected with an MOI of 5 of the 
isogenic strains of N. gonorrhoeae MS11. The MDM were processed at 2 and 3 h post-
infection to quantify the number of alive intracellular bacteria. The colony formation units 
were normalised to the initial inoculum. It was found that the isogenic strain ΔackA after 
2 h of infection was phagocytosed significantly higher than WT, although  Δpta was not 




the WT and Δhdac strains. However, after 3 h post-infection, Δpta was phagocytosed 
significantly higher than the three other strains (fig 5.2). 
 
Figure 5.2 Intracellular survival of N. gonorrhoeae in MDM. MDM obtained after 14 
days of differentiation were infected with the isogenic strains of N. gonorrhoeae with an MOI of 
5. The MDM were lysed after 2 and 3 h post-infection and the dilutions 10-3 and 10-4 were plated 
by Miles-Misra technique to quantify the number of colony formation units (CFU) that were 
intracellular. The CFU/mL was normalised to the initial inoculum. A Student’s t-test was 
performed for statistical analysis, setting the WT strain as the reference. The p value and 
significance are found at the top of the graph the experiment was performed with 3 technical 
replicates and 4 biological replicates each. 
 
 Acetylation in N. gonorrhoeae affects immune system evasion 
In order to escalate the analysis of the intracellular survival of N. gonorrhoeae, 
fluorescence microscopy was employed. After several trials to obtain a neisserial strain 
that synthesises the green fluorescence protein (GFP) that resulted in no success 




the decision was a better approach for the purpose of the experiment to observe the 
phagocytosis of N. gonorrhoeae by monocyte-derived- macrophages (MDM).  
MDM were stained with NucBlue which dyes the nuclei and the bacteria were stained 
with pHrodo. The latter is a pH sensitive dye, this molecule binds to the membrane surface 
of bacteria and emits low fluorescence at neutral pH and high fluorescence at acid pH. 
Therefore, this dye is used to observe phagocytosis, when MΦ engulf pathogens they are 
encapsulated in the phagosome which fuses with granules that acidify the phagosome in 
order to kill the pathogen (Lindner, Burkard and Schuler, 2020). In this experiment, the 
isogenic strains of N. gonorrhoeae were labelled with pHrodo, when the bacteria are 
found extracellularly they don´t emit fluorescence, however, when phagocytosed by the 
MDM the environment changes to an acidic pH which activates the fluorophore of 
pHrodo (green) and emits fluorescence a green fluorescence that is detected by the camera 
of the microscope (fig 5.3). 
 
Figure 5.3 Phagocytosis of N. gonorrhoeae labelled with pHrodo. The images taken with a 
fluorescence microscope show the process of phagocytosis in MDM (red nucleus) and how 
pHrodo is activated by the decrease of the pH when the phagosome fuses with the lysosome to 
form the phagolysosome, emitting fluorescence. The process is indicated in minutes and inside 





MDM were infected with an MOI of 5 and a control condition was set with non-infected 
MDM. Pictures were taken every 4 min for 7.5 h using a 20x objective. Five locations at 
the centre of the well were chosen for each strain and a control which was MDM without 
bacteria. The nuclei are observed in a red colour and phagocytosed bacteria in green (fig. 
5.3). The control showed no particles engulfed just a green background due to pHrodo 
traces. The four isogenic strain of N. gonorrhoeae showed phagocytosis of bacteria. In 
the fig. 5.4 is shown a location for each strain and the control.  It was observed that the 





Figure 5.4 Fluorescence microscopy for in vitro phagocytosis of N. gonorrhoeae MS11 by MDM. In vitro microscopy of MDM phagocytising N. 
gonorrhoeae. Pictures were taken with a 20x objective every 4 minutes for 7.5 h in a fluorescent microscope in a chamber with CO2 at 37 °C. The bacteria were 
stained with pHrodo dye (green, left) and MDM with NucBlue (red, middle), and the image was merged with the bright field channel and the two fluorescent 
channels (right). The diagram shows the MDM control which was not infected, and the MDM infected with each of the four isogenic strains of N. gonorrhoeae 




The images were analysed using ImageJ as described in section 2.15.2. Briefly, the file 
was adjusted to a certain threshold to detect only the desired component of the image 
(nuclei or bacteria), the image was then masked and the particles were analysed to 
quantify the number of either nuclei of bacteria in the image.  
The analysis was divided for the number of cells and bacteria by splitting the image in 
channels, according to the dye used. The average size of more than 894,000 nuclei showed 
two populations across all conditions, with an average size of 38 µm2 and 67 µm2 (fig. 
5.5a). The total area was analysed and comprises the total area that cells or bacteria 
occupy in the image. In cells, we observed two peaks in the density of the total area at 38 
µm2 and 67 µm2 and the total area decreased after 5 h in all conditions. However, cells 
infected with N. gonorrhoeae MS11 WT increased in number and the number stabilised 
after 6 h post-infection. In bacteria, the total area detected, corresponded to the bacteria 
phagocytosed by MDM (fig. 5.5b-c). Phagocytosis was similar for all the strains at 2 h 
post- infection except for N. gonorrhoeae M11 Δpta which was increased. However, the 
differences in the level of phagocytosis across the four strains changed after 4 h of 
infection and the tendency continued until the 7 h. The strains ΔackA and Δhdac were 
significantly less phagocytosed compared to the WT. Interestingly, the isogenic strain 
Δpta was phagocytosed significantly higher than WT (fig 5.5d). 
The ratio between the total area of cells and bacteria showed that cells infected with N. 
gonorrhoeae M11 Δpta was higher compared to the WT, while it was lower in the 
isogenic strains ΔackA and Δhdac after 6 and 7 h post-infection. Curiously, the curve for 
ratio of number of cells and bacteria showed the similar pattern, however, in the WT it 
was observed that the curve flattened from 5 h post-infection. The relation between total 
area and number of cells and bacteria showed that in the isogenic strain Δpta the relation 







Figure 5.5 Analysis of fluorescence microscopy. a) Density of average size of the nuclei 
for the five conditions. The two highest peaks show the two most frequent average sizes 
of cells in µm2. b) Total area of cells and bacteria. c) Density plots of the total area of 
cells and bacteria for every hour. d) Boxplot comparing the total area of bacteria 
phagocytosed every hour. e) Ratio of total area between cells and bacteria. f) Ratio of 
number of cells by number of bacteria. g) Relation between the ratios of total area and 
count. h) Boxplot for the comparison of the relation between total area and number. For 
the statistical analysis N. gonorrhoeae WT was set as reference and a T-test was 
performed. The significance is shown at the top of the plots. ns, no significance;*, p  value 




This experiment was only performed once due to the beginning of the pandemic and no 
further technical replicates where performed. The experiment and analysis performed was 
from 5 different images taken from 2 different wells. Although, it is not enough replicates 
to conclude a result, this experiment shows that acetylation could be involved in the 
virulence of N. gonorrhoeae. Since the isogenic strains ΔackA and Δhdac were less 
phagocytosed and Δpta more phagocytosed, this could suggest that acetylation is 
correlated to the evasion of phagocytosis. 
  Pili biosynthesis and a two-component system is possibly altered 
by acetylation 
N. gonorrhoeae is an obligate human pathogen and possesses the ability of intracellular 
survival. In order to colonise new tissues, the gonococcus binds to the cells and it is 
internalised. N. gonorrhoeae possesses different molecules that are involved in the 
binding to host cells including Opa proteins, porins, lipooligosaccharides, and type IV 
pili (Edwards and Apicella, 2002, 2004; Edwards, 2010; Criss and Seifert, 2012; Sintsova 
et al., 2015; Quillin and Seifert, 2018). 
In order to regulate the synthesis of these adhesion molecules and other virulence factors, 
bacteria possess a number of transcriptional regulatory systems including two-component 
systems (TCS). TCS function as sensors for chemical and physical signals from the 
environment. The TCS are formed by of two proteins, a sensor kinase and a response 
regulator. When an external signal is detected by the bacteria the sensor kinase 
phosphorylates the response regulator which leads to a response, usually in the 
transcription of a gene. Previous studies have shown that AcP can act as a direct 





N, gonorrhoeae is reported to have three TCS; NtrXY (NGO1866, NGO1867) and NarPQ 
(NGO0752, NGO0753), these TCS regulate the expression of genes involved in the 
respiration and the adaptation to anaerobic environment, respectively; and MisRS 
(NGO0177, NGO0176) which is involved in the virulence of the gonococcus, this TCS 
regulates the synthesis of membrane proteins when the gonococcus is in stress conditions 
(Overton et al., 2006; Atack et al., 2013; Gangaiah et al., 2017). 
From the previous experiment it was suggested that acetylation is involved in the 
virulence of the bacteria by evading phagocytosis. Therefore, we examined the expression 
of genes and proteins of the molecules involved in the adhesion to cells, as well as a 
killing assay in the animal model of Galleria mellonella to observe the virulence of the 
isogeneic strains of N. gonorrhoeae MS11. 
Interestingly, we found that proteins that are involved in the synthesis or as a component 
of the type IV pili were expressed significantly different only in the isogenic strains 
ΔackA and Δpta. The strain Δhdac showed no significant difference in the expression of 
proteins. The isogenic strain ΔackA showed a significant lower expression of the protein 
MafA (NGO0229) and an increase of the pilin protein PilA (NGO11165). While the strain 
Δpta showed a significant decrease of the pilus assembly protein PilC (NGO0055). The 







Figure 5.6 Volcano plot of the proteome of N. gonorrhoeae. a) Protein extracts of the 
isogenic strains were analysed by mass spectrometry and the expression was analysed. In red and 
blue are the non-significant and significant different proteins for the isogenic strains ΔackA and 
Δpta. The significant different proteins are labelled with the name and abbreviation. b) Significant 
different expressed proteins identified from mass spectrometry. The gene name or locus is shown 







To observe if acetylation alters the virulence of N. gonorrhoeae, a killing assay using G. 
mellonella was performed. G. mellonella, commonly known as wax moth, is an insect 
that has been used for the study of bacterial pathogenesis and virulence (Leuko and 
Raivio, 2012; Loh et al., 2013; Mizerska-Dudka and Andrejko, 2014; Tsai, Loh and Proft, 
2016).  
To determine the median lethal dose (LD50) of N. gonorrhoeae MS11 and if N. 
gonorrhoeae MS11 killed G. mellonella, groups of 15 larvae were infected with different 
concentrations of N. gonorrhoeae MS11. After 144 h a 60% survival was observed with 
the concentration of bacteria at 108 CFU/mL (fig. 5.7a). This concentration was then used 
for the infection with the isogenic mutant strains. 
The virulence of the neisserial strains WT, Δpta, and ΔackA were compared (fig 5.7b). 
The non-infected group of the larvae showed a survival of 100%. However, the larvae 
infected with ΔackA died 3 times faster compared to the WT and with a similar percentage 
of survival of 27% compared to the 60% of the WT. In contrast, the isogenic Δpta strain 
showed after 6 days post-infection a survival percentage of 87%, higher than the WT and 
similar to the group infected with PBS. In order to prove the survival of the gonococcus 
within the larvae, samples of haemolymph from each group were plated on CHO and GC-
Kanamycin agar plates. Gram staining revealed the presence of diplococcus suggesting 





Figure 5.7 Killing assay of Galleria mellonella infected with N. gonorrhoeae. Survival graph at top showing the percentage of survival for 6 days of 
experiment recording results every 24 h. The table in the middle shows the number of larvae at risk of dying and the bottom graph shows the number of alive 
larvae for each day. a) Groups of 20 larvae were infected each with 10 µL of different gonococcus concentration. Three groups were used as control; one infected 
with PBS; non-infected; and to observe if the larvae dead was indeed caused by live bacteria the bacterial growth was heat killed at 95 °C for 10 min. After 6 days 
post-infection a survival of 55% was only observed in the group of larvae infected with the highest dilution infected with approximately 3.14x105 CFU. The t-
test showed a significant difference between for the larvae infected with 108 CFU. b) Larvae were infected with the three strains. WT, Δpta, ΔackA strains. The 
group inoculated with Δpta showed a higher survival than WT, similar to the control group infected with PBS. In contrast, ΔackA was the strain with the lowest 




Since pili proteins and the virulence of the gonococcus showed alteration. The expression 
of genes related to pili biosynthesis and the two-component system were quantified. The 
primers for RT-qPCR were designed using Primer Blast website. In order to prove that 
the primers were specific, PCR was performed using as template the gDNA from the fours 
neisserial strains. All set of primers showed specificity except PilEuss2 and PilS2c1 (fig 
5.8a-c). However, after RT-qPCR the gene PilS2c1 showed specificity (fig 5.8d). RNA 
was extracted from the 4 neisserial strains and a gel was run to prove the extraction (fig 
5.8e). Thus, the RT-qPCR was standardised by doing a standard curve using as 
housekeeping gene the 16S rRNA. It was determined that best RNA concentration for the 






Figure 5.8 Quality control of primers for RT-qPCR of genes involved in virulence of N. gonorrhoeae. a) Agarose gel of the genes amplified by PCR of the 
four neisserial isogenic strains. b) PCR of genes involved in two-component system and oxidative stress. c) PCR of genes involved in pili biosynthesis and 
pyruvate metabolism. d) Amplification of pilEuss3 and pilSc1 after RT-qPCR. e) Agarose gel of RNA extraction from fours isogenic strains. f) Standard curve 




In total, 23 genes were quantified from the fours isogenic strains. The relative mRNA 
expression was calculated from the quantification of the WT mRNA expression 
(supplement fig 8.3). The mRNA from TCS genes showed significant different 
expression especially in the regulator proteins. The genes narP and ntrX showed a 
significant decrease of expression in the isogenic mutant ΔackA, while an increase of the 
regulator misR was observed in this strain. The isogenic strain Δpta showed a significant 
decreased of ntrX.  
Expression of genes controlled by the misSR TCS showed significant differences. Genes 
involved in iron acquisition were expressed at a higher level compared to the WT. The 
mutant ΔackA showed a significant increase of hemO and tbpA a relative expression of 
1.8 and 1.5, respectively. While Δpta showed an increase in hmbR and tbpA with an 
expression of 3.3 and 3.6, respectively. The unique gene from the multidrug efflux pump 
that showed a significant difference was mtrD in the strain Δpta with a relative expression 
of 1.7. Interestingly, the results of genes involved in the pili biosynthesis corresponded to 
the proteome. The gene pilS2c1 showed a significant decrease in ΔackA and Δpta with a 
relative expression of 0.2 and 0.3, respectively. pilQ showed a significant decrease in the 




Table 5.1 Gene expression in isogenic strains of N. gonorrhoeae MS11. Gene 
expression was quantified by RT-qPCR and the relative expression level of mRNA was 
determined from N. gonorrhoeae MS11 WT gene expression. The relative expression was 
compared by t-test statistical analysis. The table shows the genes that showed a significant 
decreased or decreased expression, followed by the significance and the mean of the relative 
mRNA expression and the standard deviation. Each gene expression was replicated 3 to 5 times. 





ns/0.662 ± 0.273 
 
ns/1.03 ± 0.241 
 
ns/0.98 ± 0.323 
pta 
 
ns/0.939 ± 0.452 
Increased 
*/1.56 ± 0.331 
 





ns/0.998 ± 0.231 
Decreased 
**/0.349 ± 0.032 
Decreased 





ns/0.754 ± 0.126 
Decreased 
**/0.56 ± 0.02 
Decreased 
*/0.758 ± 0.093 
mtrR 
 
ns/0.503 ± 0.393 
 
ns/0.777 ± 0.205 
 




ns/0.831 ± 0.198 
Increased 
**/2.308 ± 0.341 
 
ns/1.233 ± 0.376 
misS 
 
ns/1.071 ± 0.925 
 
ns/1.558 ± 0.478 
 
ns/1.997 ± 0.568 
narP 
Decreased 
*/0.701 ± 0.02 
Decreased 
**/0.563 ± 0.032 
 
ns/0.921 ± 0.126 
narQ 
 
ns/0.657 ± 0.507 
 
ns/0.637 ± 0.315 
 
ns/1.317 ± 0.401 
ntrX 
Decreased 
*/0.776 ± 0.025 
Decreased 
**/0.388 ± 0.092 
Decreased 
**/0.672 ± 0.019 
ntrY 
 
ns/0.78 ± 0.213 
Decreased 
*/0.609 ± 0.03 
Increased 




ns/0.725 ± 0.328 
 
ns/0.698 ± 0.721 
Decreased 
*/0.442 ± 0.221 
kat 
Decreased 
*/0.452 ± 0.008 
Decreased 
*/0.317 ± 0.127 
 







ns/0.749 ± 0.12 
Increased 
*/1.837 ± 0.312 
 
ns/1.282 ± 0.597 
hmbR 
Increased 
*/1.986 ± 0.481 
 
ns/1.624 ± 0.543 
Increased 
**/3.344 ± 0.643 
tbpA 
Increased 
*/1.584 ± 0.077 
Increased 
*/1.516 ± 0.283 
Increased 





ns/0.673 ± 0.264 
 
ns/1.16 ± 0.381 
 
ns/1.152 ± 0.251 
mtrD 
 
ns/0.704 ± 0.448 
 
ns/0.931 ± 0.181 
Increased 
**/1.696 ± 0.101 
mtrE 
 
ns/0.737 ± 0.093 
 
ns/1.384 ± 0.264 
 





ns/0.495 ± 0.258 
 
ns/0.739 ± 0.519 
 
ns/1.186 ± 0.33 
pilQ 
Decreased 
*/0.546 ± 0.258 
Decreased 
**/0.324 ± 0.26 
Decreased 




ns/0.915 ± 0.407 
Decreased 
**/0.247 ± 0.159 
Decreased 
**/0.316 ± 0.261 
Sialyltransferase lst 
 
ns/1.104 ± 0.426 
 
ns/0.9 ± 0.626 
 
ns/1.26 ± 0.784 
 ns, no significance;*, p  value <0.05; **, p  value <0.01 
Interestingly, the acetylome showed significant different acetylation in several virulence 
factors, including pili, two-component system protein, iron-acquisition protein and 
transporters, porin and multidrug efflux pumps (supplement fig 8.4).  
The proteins type IV pilin (NGO_0465) and pilus assembly protein PilP (NGO_0095) 
showed the highest number of significant increased acetylation sites compared to the 
other pili proteins. The isogenic strain ΔackA showed more acetylation sites in the PilP 
protein (fig 5.9). This protein is related to the protein PilQ for the polymerisation of the 





Figure 5.9 Acetylation sites of pili-related proteins. The significant different acetylation 
sites of the pili-related proteins were identified. Each plot shows the protein name and locus. The 
tiles are fill with a gradient according to the fold change in acetylation. The bar at the background 
shows the length of the protein. 
Finally the antibiotic resistance of the isogenic strains was performed by the method of 
disc diffusion for the growth inhibition. Five different families of antibiotics were tested. 
Beta-lactam and cephalosporin are a family of antibiotics that inhibit the bacterial wall 
synthesis. ΔackA and Δpta showed significant decrease of resistance to the six antibiotics 
(fig 5.10a). Aminoglycoside, fluoroquinolone and naphtacene are a family of antibiotics 
that inhibit protein synthesis by binding to the ribosomes and the latter inhibits 
replication. From the three different antibiotics used, only ΔackA and Δpta showed a 
significant decrease of resistance to ciprofloxacin which inhibits replication. (fig 5.10b). 





Figure 5.10 Antibiotic resistance of N. gonorrhoeae MS11. The disc diffusion test for antibiotic resistance was performed in the four isogenic strains of 
N. gonorrhoeae MS11. Bacterial suspensions with an OD600 of 0.1 were plated on GC agar and incubated at 37 °C for 24 h at 5% CO2. The halo of inhibition 
was measured and the relative resistance of the strains was calculated (bottom). The diameter of inhibition is illustrated for each strain and the relative resistance 
is represented in columns. The relative expression of the WT was considered as 1 for to use as reference for the calculation of the other strains a) Antibiotics for 
the inhibition of bacterial wall (beta-lactam and cephalosporin)..b)  Antibiotics for the inhibition of protein synthesis and bacterial replication (aminoglycoside, 
naphtacene and fluoroquinolone). Replicates of 3 was performed and a T-test was performed for statistical analysis. The significance and p  value are shown at 




 Phosphotransacetylase crystallisation 
The increment of new antibiotic resistant strains has led the necessity for new approaches 
to combat the development and spread of these strains. N. gonorrhoeae is currently is 
considered by the WHO a high risk bacteria due to the concerning increase of cases of 
neisserial strains resistant to azithromycin and ceftriaxone, the current treatment against 
the gonococcus (Grad et al., 2016; Yahara et al., 2018; Rowley et al., 2019).  
The previous results observed in the isogenic mutants, showed that the strain Δpta is more 
susceptible to phagocytosis and to be less virulent compared to the WT and opposite to 
the behaviour of ΔackA, which showed more resistance to phagocytosis. Although these 
experiments need further replicates and more analysis. I proposed in this study to target 
the enzyme phosphotransacetylase for drug discovery to inhibit its activity. Therefore, 
the protein was cloned into a strain of E. coli BL21 for the overexpression (supplement 
fig 8.6), thus it was purified and finally, crystallised for the discovery of the structure. 
The structure of the N. gonorrhoeae MS11 phosphotransacetylase or any N. gonorrhoeae 
has never been crystallised. In comparison to other sequences, the neisserial Pta protein 
contains approximately 120 more amino acids. This sequence is similar to a domain for 
the biosynthesis of biotin (fig 5.11). 
Figure 5.11 Domains of neisserial Pta. The protein sequence of Pta was blasted and the 
domains were searched on the website NCBI. The protein show to different domain. The first 
domain is a PtaN superfamily domain that belongs to a BioD-like N-terminal domain which 
function is the biosynthesis of biotin. The next domain is the phosphate acetyltransferase domain 





The expression of Pta was through the system of pET28a which induces the transcription 
of the insert by the addition of the inducer IPTG. Briefly, E. coli DH5α was used for the 
obtainment of the protein expression vector pET28a. E. coli XL1-blue was transformed 
with the vector containing the pta gene since this bacterium possesses a high 
transformation rate. The third strain was E. coli BL21-DE3, a bacterium that used for the 
overexpression of the Pta protein.  In order to determine the best concentration of IPTG 
the expression of pta was induced with 0.1 and 1 mM IPTG (fig 5.12a-b). However, the 
insoluble phase showed presence of the overexpressed Pta. Therefore, different 
conditions were tested. The growth temperature was decreased and the IPTG 
concentration was increased. Glucose was also added in order to favour the induction of 
the protein, however, the expression was reduced when glucose was added. It was 
determined that the optimal condition for the protein expression was with 0.25 mM IPTG 
growing at 18 °C for 18 h (fig 5.12c).  
For the purification of the protein, different columns were used. The protein was modified 
with 6 histidine at the C-terminus of the protein to purify it. It was determined that 150 
mM imidazole was the optimal concentration for the elution of the protein from the His-
Trap column (fig 5.12d). The bacteria were grown and the synthesis of protein induced, 
the bacteria were sonicated and the cell free extract was passed through the His-Trap 
column (fig, 5.12e), the eluate was then passed through two ion exchange columns 
(monoQ and monoS) with a positive and negative charge to discard proteins from the 
extract (fig 5.12f). The final purification step was the separation of the protein by gel 
filtration which separates the proteins by size, obtaining a single band of the desired 





Figure 5.12 Optimisation of expression, purification and crystallisation of N. gonorrhoeae Pta. a-b) Induction of Pta expression by using 0.1 and 
1 mM IPTG, respectively. c) Cell free extracts of bacteria induced with 0.25 mM IPTG with and without 1% glucose at 18 °C. d) Optimisation of elution buffer 
concentration. e) Purification of cell free extract through a His-Trap column. f) Purification through ion exchange Q and S columns and finally through a gel 




The crystallisation was optimised after several combinations of conditions. The final 
condition that resulted in the crystallisation of Pta was using acid malic, the precipitant 
PEG, the utilisation of the screening portfolio silver bullet which are different buffers. 
The protein was also seeded to improve the formation of crystals. After two weeks, 
crystals were observed and collected to send them to the synchrotron Diamond Light 
Source, located in Oxford, UK (fig 5.12g). The processing of the crystal in the X-ray 
machine and the preparation to send it to the synchrotron was performed by Dr. Domen 
Zafred which kindly helped me during the whole process of expression, purification and 
crystallisation of the protein. 
The crystal sent showed a resolution of 2.0 Å. The data obtained from the synchrotron 
was analyse on the WinCOOT- CCP4 software. The electron density cloud obtained from 
the synchrotron was refined and structure was obtained. The structure shows that the sites 
affected by acetyl-phosphate, K400 andK450, are located in the same coordinate as the 
PHYRE2 predicted model (fig 5.13).  
 
Figure 5.13 Predicted structure of the crystal of the N. gonorrhoeae Pta 
(NGFG0350). The predicted model of Pta obtained by Phyre2 was used as a template to model the 
crystal utilising the electron density obtained from the X-ray crystallography obtained from the synchrotron. 
The file .mtz was used on the WinCOOT- CCP4 software for the refinement of the structure. The sites 






The disease gonorrhoea was one of the first ever infections recorded in history. The 
characteristic white purulent liquid was first described in the bible and from then the 
bacteria has been able to adapt to humans not only biologically but adapting into our 
intelligence and technology. The surge of antibiotic resistant strains has brought it to the 
attention of the worldwide public health. The World Health Organisation (WHO) has 
classified N. gonorrhoeae as a high risk bacteria due to the increase of incidence and 
antibiotic resistant cases. However, the gonococcus not only is effective in human 
invasion due to the resistance, it possesses several mechanisms that confers the ability to 
evade the immune system and survive within cells (Johnson and Criss, 2011; Criss and 
Seifert, 2012; Yahara et al., 2018; W. J. Kim et al., 2019; WHO, 2019a). 
In this chapter, we focused in two particular pathogenic features of N. gonorrhoeae, 
intracellular survival and immune system evasion. For the study of intracellular survival, 
monocyte-derived macrophages (MDM) were used since the study of bacterial 
phagocytosis is more reliable in primary cells than in cell lines like THP-1 and U937 
(Château and Seifert, 2016). MDM infected with ΔackA showed a significant increase in 
the number of intracellular bacteria at 2 h post-infection, while the number of intracellular 
bacteria was increased in the Δpta strain after 3 h of infection, both were compared to the 
WT. Although these results showed that an imbalance of acetyl-phosphate production 
altered their ability to be phagocytosed, the performance of the gentamicin protection 
assay (GPA) still generating conflict among researches. Studies have shown that the use 
of gentamicin is not reliable since the membrane of cells is permeable molecules of the 
antibiotic passes through the membrane and kill the intracellular bacteria, other 
researchers claim that gentamicin is present in the phagosome when phagocytosis occurs 




have been confirmed in Yersinia pestis and  Streptococcus pyogenes (Flannagan, Heit and 
Heinrichs, 2016; VanCleave et al., 2017; J.-H. Kim et al., 2019). 
However, two different studies on N. gonorrhoeae were performed using the GPA with 
a gentamicin concentration of 200 µg/mL and this showed the viability of the gonococcus 
when the cells were plated. Contrary to this study where an MOI of 5 was used, other 
studies utilised an MOI of 100 and 1000, and the CFU counted intracellularly after the 
GPA was of 1% from the initial inoculum. However, the ratio of intracellular bacteria 
corresponds to the one from Ortiz et al., 2015, proving that N. gonorrhoeae can survive 
at a high concentration of gentamicin during the GPA (Leuzzi et al., 2005; Ortiz et al., 
2015). 
In order to investigate the phagocytosis assay further and to observe it in real time, 
fluorescence microscopy in real time was used, infecting MDM with the four strains of 
N. gonorrhoeae. Different techniques are used to observe the phagocytosed bacteria, 
however, to observe them in real time the bacteria are labelled. The majority of studies 
tended to use fluorescein isothiocyanate (FITC), however, this method is not 
recommended since both extracellular and intracellular bacteria emits fluorescence. In 
2009, a novel label was found using a pH sensitive dye. pHrodo was used to observe the 
phagocytosis of apoptotic cells. Several studies have now used this labelling to observe 
the phagocytosis of bacteria in real-time. The rationale of using this label is that bacteria 
that are phagocytosed enter to the phagosome and this matures through the fusion with 
lysosomes to generate the phagolysosome. As consequence of the fusion, the internal pH 
drops and the dye is activated to emit fluorescence that is recognised by the microscope 





The real-time fluorescence microscopy showed that acetylation might be involved in the 
regulation of N. gonorrhoeae to inhibit apoptosis and to synthesise pili. The curve of 
number of MDM cells showed a similar pattern across all the isogenic mutant strains and 
the control, however, the number of MDM infected with N. gonorrhoeae MS11 WT 
significantly increased compared to the rest of the conditions which showed a decrease in 
the number of cells after 4.5 h post-infection.  
Macrophages (MΦ) are the first line of defence during infections, these cells are polarised 
into M1 or M2 MΦ depending on the activation of the cells. M1- MΦ possess a 
proinflammatory and high microbicidal activity and M2- MΦ is the anti-inflammatory 
type which is necessary for the healing (McWhorter et al., 2013). Interestingly, it has 
been shown that N. gonorrhoeae suppresses the production of TNF-α, molecule that 
activates the immune response. Instead, it induces the production of immunoregulatory 
cytokines (Escobar et al., 2013). In 2015, it was then found that this production of 
immunoregulatory cytokines like IL-6 and IL-10 coordinates the polarization of MΦ to a 
M2- MΦ type. Furthermore, they observed an induction of the programmed death ligand 
(PD-L1) which acts as an immunosuppressive molecule that suppresses the activity of 
lymphocytes T, observation found in several studies. (Zhu et al., 2012; Escobar et al., 
2013; Ortiz et al., 2015; Escobar, Rodas and Acuña-Castillo, 2018).  
This immunoregulatory induction could explain the observation done by Leuzzi et al., 
2005 where the intracellular survival of N. gonorrhoeae was longer in MDM, a result 
shown in this study. Furthermore, the analysis of nuclei size showed the presence of two 
cell line populations, the cells with the 38 µm2 nuclei size could be lymphocytes, and 
these cells might be regulated by the PD-L1 leading to the neisserial intracellular survival. 
Interestingly, image analysis showed the division of MDM infected with N. gonorrhoeae 




also induces the cellular division and that modulation is altered by changes in the 
acetylation of proteins since the other isogenic mutants showed the same pattern number 
as the control which was MDM non-infected. 
Antigenic variation is an immune evasion mechanism of N. gonorrhoeae to be 
phagocytosed. This mechanism allows to synthesise a great number of proteins that vary 
in few amino acids and that prevent to the protein being recognised by antibodies due to 
the level of variation, this is found mainly in the synthesis of opacity proteins (Opa) and 
pili (Haas and Meyer, 1986; Rudel et al., 1992; Stein et al., 2015). Pili in N. gonorrhoeae 
confers the capacity to adhere and colonise epithelial cells, furthermore is has shown to 
be correlated to the adhesion to T cells, therefore, pili biosynthesis is important in the 
virulence of the gonococcus (Merz and So, 2000; Winther-Larsen et al., 2001; Plant and 
Jonsson, 2006). However, other studies have shown that pili biogenesis inhibits the 
adhesion to macrophages (Escobar, Rodas and Acuña-Castillo, 2018).  
In this study we found differences in the expression of pili-related proteins and genes 
among the isogenic strains. PilE is the major pilus component also known as pilin and it 
required for epithelial adherence together with PilC which has been shown to be necessary 
for pili biogenesis and they were found significantly increased and decreased in ΔackA 
and Δpta, respectively (Rudel et al., 1992; Obergfell and Seifert, 2016). Pilus biogenesis 
is required to cross the bacterial outer membrane and this is possible by the action of PilQ 
a channel that transports pili and DNA. The pilQ mRNA was significantly decreased in 
both ΔackA and Δpta mutant strains. Interestingly, it was described that PilP is involved 
in the synthesis of PilQ, indeed a mutant ΔpilP showed the phenotype of a non-pilated 
strain, however, in this same study it is claimed that PilP is not involved in the synthesis 
of PilQ (Drake, Sandstedt and Koomey, 1997; Tammam et al., 2011). Furthermore, PilP 




in the acetylation could be the responsible for the altering of the pili biogenesis and 
therefore, less phagocytosis compared to Δpta. Indeed, it was found that acetylation of 
PilT altered the viability of N. gonorrhoeae showing that acetylation of pili-related 
proteins modifies their activity (Hockenberry et al., 2018). 
The infection of G. mellonella, resulted in an antagonistic response. The ΔackA killed 
faster than the WT and with a similar survival percentage, while the Δpta resulted in a 
~90% survival.  A study shown that infection of G. mellonella with E. coli mutated in the 
Cpx envelope stress regulator (CpxR) lost the ability to cause a lethal infection compare 
to the WT (Leuko and Raivio, 2012). In N. gonorrhoeae there are homologues of the Cpx 
TCS, called MisRS, where similar to other TCS, the response regulator can be 
phosphorylated by AcP (Mitrophanov and Groisman, 2008; Lima et al., 2016). The 
results of the larvae killing assay showed a difference in the virulence of the mutant 
strains. The TCS is involved in the regulation of expression of virulence factor, suggesting 
that the MisRS can be altered by levels of acetyl-phosphate. MisRS was shown to be 
responsible for the resistance to cationic antimicrobials peptides (CAMP) and some 
antibiotics in N. gonorrhoeae. Levels of mtrCDE, genes encoding an efflux pump, were 
shown to be lower in a misR mutant and as consequence the susceptibility to CAMP and 
aminoglycosidases increased (Justin L Kandler et al., 2016).  The relation of this to our 
results are that G. mellonella has been reported to produce antimicrobial peptides (AMP). 
These AMP are gloverins and cecropins, which act on the LPS by inhibiting the 
conformation of the outer membrane (Vogel et al., 2011). ).  
In this study, misR was increased in ΔackA, however, none of the mtrcCDE genes were 
significantly different. Interestingly, the Δpta isogenic strain showed a significant 
increase in mtrD, hmbR and tbpA, the two latter are genes controlled by misRS and 




gonorrhoeae (Zhao et al., 2010; Zughaier, Kandler and Shafer, 2014; Justin L. Kandler 
et al., 2016; Post et al., 2017).  Ren et al., 2016 showed that acetylation of the homologue 
of misR in Salmonella Typhimurium inhibits DNA binding and therefore demonstrated a 
decrease in the transcription of genes. Furthermore, these results are similar as a study 
performed in N. gonorrhoeae (Post et al., 2017). A recent study has shown that MisRS is 
required by N. gonorrhoeae, for a successful colonisation of mice and that it is involved 
in the upregulation of porin synthesis for serum resistance (Gangaiah et al., 2017). 
Moreover, the disc diffusion experiment showed a significant decrease of antibiotic 
resistance in the isogenic strains ΔackA and Δpta, especially in the beta-lactams and 
cephalosporin antibiotics. 
The resistance to this antibiotics can be driven by the efflux pump encoded in the mtrCDE 
operon, this operon is regulated by the TCS MisRS and the expression is repressed by 
MtrR (Cámara et al., 2012; Justin L Kandler et al., 2016; Handing et al., 2018). 
Interestingly, a study showed that the level of MisR does not affect the expression of 
mtrCDE (Justin L Kandler et al., 2016). Indeed in the ΔackA the expression of misR was 
increased, however the expression of MtrCDE were not altered.  MtrR, is a transcriptional 
repressor that is autoregulated by the expression of MtrR, interestingly, it also controls 
the expression of the pili related operon pilMNOPQ  in N. gonorrhoeae (Folster et al., 
2007). However, a recent study showed that expression of MtrR also regulates the 
expression of the repressor GdhR, a transcriptional regulator of central metabolic 
enzymes (Rouquette-Loughlin et al., 2017b). Although, mtrR expression was not altered 
in the different isogenic strains, the acetylation was indeed increased in ΔackA. This 
might suggest that the acetylation of MtrR is more important in the regulation of the 
transcription of genes rather than the expression (supplement 8.5). Indeed, since it has 




al., 2010; Ghosh et al., 2016; Ren et al., 2016; Sang et al., 2017), the acetylation of several 
transcriptional regulators in ΔackA leads to the increase of synthesis of several genes, 
which leads to a better fitness to colonise and infect cells. 
Although the gene expression of the genes was different between strains, a specific 
pattern for each strain was not observed. We would´ve expected from the role that has 
acetylation in the transcriptional factors, a decrease of gene expression, since it has been 
shown that acetylation inhibits the protein-DNA binding (Ren et al., 2016; Sang et al., 
2017; Li, Krishnan and Duncan, 2018; Koo et al., 2020). Since global acetylation was 
altered, it cannot be determine that the gene expression is determine by the specific 
acetylation of the transcriptional regulators. Instead, a study of individual transcriptional 
regulators would be needed to determine if acetylation inhibits the binding to DNA. This 
could be approach by site-directed mutagenesis from a lysine to a glutamine. Then a 
electrophoretic mobility assay shift would show the ability of the transcriptional regulator 
to bind DNA by observing the electrophoretic gel (Ghosh et al., 2016). This experiments 
should be done in the two-component system involved in the virulence of N. gonorrhoeae 
MisRS. 
Although ΔackA and Δpta showed differences in the virulence. The strain with less 
acetylation presented more susceptibility to phagocytosis and a lower virulence to kill G. 
mellonella. Indeed, more studies are needed to better understand the role that acetylation 
possesses in the virulence, however, with the results obtained in this study and the results 
from the literature there is a consensus that bacteria with less acetylation expressed less 
virulence features. The next step to show that acetylation is involved in the virulence of 
N. gonorrhoeae would be to infect mice. This could be performed by infecting female 
mice intravaginally, and samples would be taken daily after 2 days post-infection to 




in the ΔackA isogenic strain compared to the WT and less CFU in mice infected with 
Δpta we could conclude that the virulence of N. gonorrhoeae is regulated by lysine 
acetylation (Gangaiah et al., 2017).     
I proposed in this study the enzyme Pta as an enzyme to further analyse as a possible 
target to treat gonorrhoea. Interestingly, a Pta mutant of Salmonella enterica serovar 
Typhimurium showed less virulence. Mice were infected intraperitoneal with the WT and 
the mutant and mice infected with the Pta mutant showed a significant longer survival 
compared to the group of mice infected with the WT (Kim et al., 2006).   
Contrary to other homologous Pta enzymes, the neisserial presents a BioD-like N-
terminal domain that is related to the biosynthesis of biotin. A study in S. enterica, which 
also contains this domain, proposed that the domain is for the allosteric binding of NADH 
and pyruvate to regulate the enzymatic activity (Brinsmade and Escalante-Semerena, 
2007). However, in E. coli, Pta lacks of this domain and the binding of this molecules 
was found in a P-loop NTPase domain, different to the BioD-like domain (Campos-
Bermudez et al., 2010). In the case of the Pta from Salmonella the structure was not 
obtained and although the paper concludes that the crystal will be performed no further 
publications were found for the structure. This is the first time that a PTA with a BioD-











6 Overall conclusions 
N. gonorrhoeae is an obligate human bacterium that has adapted and evolved to survive 
in our cells. This has led to the bacteria to get resistant at a point it has converted into a 
worldwide public health risk. Last year, 2020, a pandemic broke and the pandemic still 
going by the end of this thesis. The pandemic has brought millions of infected people and 
sadly, thousands of deaths. The rise of this type of pandemics is not new to human kind 
and it is not going to be the last one. In fact, it is predicted that the number one cause of 
deaths by 2050 will be bacterial infections, causing the death of a person every 3 seconds 
(O’Neill, 2016). This is mainly to the increment of bacterial antibiotic resistance due to 
the non-legislated and uncontrolled use of antibiotics in some countries and N. 
gonorrhoeae is on the high risk list of bacteria that required R&D of new drugs. 
In this study, the acetylation of N. gonorrhoeae MS11 and the relation it possesses in the 
regulation of metabolism and virulence was investigated. Acetyl-phosphate, a reactive 
molecule that donates either the phosphoryl group for phosphorylation or the acetyl group 
for acetylation, we focused in the acetylation of proteins. It was shown that alteration in 
the phosphotransacetylase-acetate kinase pathway (PTA-AK pathway) led to a change in 
the intermediate metabolite acetyl-phosphate, and therefore, different acetylation sites 
were found in the isogenic strains Δhdac, ΔackA, and Δpta, two with a higher acetylation 
and a lower acetylation, respectively. The experiments performed showed us that 
acetylation in N. gonorrhoeae is involved in enzymes of the central metabolic pathway, 





Figure 6.1 Role of acetyl-phosphate in N. gonorrhoeae. The experiments performed 
showed that acetylation is found in enzymes involved in metabolism, gene expression and 
virulence factors involved in immune system evasion. The acetylation of them suggest to cause 
an inactivation of activity or inhibition to DNA binding. 
The acetylome allowed us to analyse the enzymes with a change in the acetylation pattern 
due to differences in intracellular acetyl-phosphate levels. The enrichment analysis 
showed that central metabolic were mainly affected by this change, therefore each 
enzyme of each central metabolic pathway was studied and it was possible to determine 
a regulation of the PTA-AK pathway. The data obtained from the acetylome showed that 
in the ΔackA the majority of enzymes from gluconeogenesis, Entner-Doudoroff pathway 
and pyruvate metabolism were acetylated in the active sites. The in silico analysis of the 
structure and the binding to the substrate showed that some of these acetylation sites 
altered the conformation of the active site suggesting an inhibition of the enzymatic 
activity. However, enzymes from the TCA cycle showed no alteration in the active site. 
It was found that acetylation mainly occurs in clusters of the enzyme that show a positive 
electrostatic potential surface (EPS). The high concentration of acetyl-phosphate 
recreates the intracellular environment of the bacteria during carbon overflow, which 
leads to an increase of substrates including acetyl-phosphate. The information gathered 




of a regulatory mechanism of the PTA-AK pathway. The regulation involves the 
acetylation of the phosphotransacetylase (Pta) in the lysine K450 which is conserved in 
bacteria, being the histone- deacetylase like protein (HDAC) the predicted enzyme that 
could reactivate Pta activate by the deacetylation of K450 (fig 6.2).  
 
Figure 6.2 Proposal of a regulatory mechanism of the PTA-AK pathway in N. 
gonorrhoeae. During carbon overflow the enzymes from the TCA cycle saturate and the 
metabolites from the previous pathways accumulate. This leads to an accumulation of acetyl-CoA 
that is redirected to the PTA-AK pathway. Levels of acetyl-phosphate increase leading to an 
increase of the acetylation, causing an enzymatic inhibition of enzymes from the Entner-
Doudoroff pathway, and pyruvate metabolism. The acetylation also was found in Pta in the site 
K450. This is a conserved site among bacteria and it is found in the active site where acetyl-CoA 
binds. The acetylation of Pta blocks the enzymatic activity, however, it was found that this site 
could be a target for the HDAC enzyme, suggesting a regulation of Pta. When the levels of the 
metabolite diminish due to the TCA cycle activity, the intracellular concentration of acetyl-
phosphate decreases and the previous pathways are reactivated. 
The study of neisserial virulence showed that acetylation could be involved in the 
intracellular survival of the bacteria and the regulation gene expression. The killing assay 




immune system evasion. This suggested that virulence factors could be altered by 
acetylation. It was found from the proteome that proteins involved in the Type IV pili 
(Tfp) biosynthesis were expressed at different levels. Since Tfp is involved in the binding 
to the cells, levels of mRNA pili-related genes were analysed. It was found that some of 
the genes were downregulated and that some of these genes showed a higher acetylation. 
Although it is not well understood how acetylation could alter the function of the pili 
components, a hypothesis of the difference in phagocytosis could be that the acetylation 
of the pilin changes the positive charges of the protein, and therefore the interactions with 
the cell are inhibited causing immune system evasion (fig. 6.3). 
 
Figure 6.3Acetylation of pili-biosynthesis proteins and electrostatic interactions. The 
microscopy showed a correlation between acetylation and immune system evasion. Levels of 
protein related to pili-biosynthesis were overexpressed in ΔackA and decreased in Δpta. a) 
Diagram of the type IV pili structure, the pili is formed by monomers of pilin, and crosses both 
membranes through the channel PilQ assisted by the protein PilP, the stabilisation of the pili is 
driven by PilC. Levels of these proteins were expressed differently in ΔackA (red) and Δpta (blue). 
In ΔackA the major pilin components showed an increase of acetylation in the sites K20 and K203 
which could altered the electrostatic surface of the protein, b) interfering with the interaction with 





The killing assay with Galleria mellonella showed an increase virulence the ΔackA 
isogenic strain, while Δpta showed a reduced virulence compared to WT. Some of the 
virulence factors are controlled by two-component system. Therefore, we analysed the 
expression of the TCS MisRS and its gene targets. We found an overexpression of MisR 
in ΔackA and an overexpression of its targets in both isogenic strains. This could be due 
to the increase of acetyl-phosphate in ΔackA that increased the activation of MisS and 
therefore the activation of MisR for gene transcription while in Δpta the decrease of 
acetylation leads to a better binding between MisR and DNA. The genes studied for this 
TCS were genes involved in the efflux pump complex and iron acquisition (fig. 6.4).  
 
Figure 6.4 Effect of acetylation in the two-component system MisRS in N. gonorrhoeae. Two-
components system are formed by a sensor (MisS) that detects changed in the environment and 
when they are activated they auto-phosphorylate, and acetyl-phosphate has been shown to be able 
to donate the phosphoryl group. This leads to the phosphorylation of the transcriptional regulator 
(MisR) that binds to the DNA for gene transcription. Some of the gene targets of the MisRS TCS 
are genes for the biosynthesis of the efflux pump MtrCDE, and genes for iron acquisition (TbpA, 
HmbR, and Hemo). This set of genes are involved in the virulence of N. gonorrhoeae for the 
transportation of molecules to the environment such as antibiotics and antimicrobial peptides, and 
iron acquisition, respectively. It was found that levels of these genes were overexpressed in ΔackA 





Although more repetitions and further assays are required, these results demonstrate that 
acetylation could be an important post-translational modification to control the virulence 
of N. gonorrhoeae, since this has been shown in other bacteria. It was proposed that Pta 
could be a good target for an antibiotic due to these results, however, it could also be that 
an inhibition of Pta allows N. gonorrhoeae to disseminate more in the organism due to 
the action of macrophages to phagocytosed bacteria more and spread them. Therefore, it 
would be interesting to test the colonisation of the urinary genital tract of mice to observe 
any difference among the two isogenic strains possessing different levels of acetylation.  
In any scenario, Pta has shown that it plays a key role in the regulation of acetyl-phosphate 
production which is linked to the regulation of metabolism and virulence due to the 
control of gene expression by the acetylation of transcriptional regulators. These are just 
the first steps in this study in our lab and it will be interesting what future generations 
find. However, I conclude with this study that Pta is a key enzyme for the pathogenesis 
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8  Supplements 
 
Table 8.1 Genes of proteins with five or more acetylation sites identified in the 
KEGG pathway sin N. gonorrhoeae MS11 
KEGG.name Count Genes 
ABC transporters 15 macB, fbpC, NGO_2139, NGO_2056, potA, NGO_0269, lolD, 
NGO_1605, NGO_2137, msbA, NGO_0196, NGO_0217, 
NGO_1253, NGO_0195, NGO_1922 
Alanine, aspartate and 
glutamate metabolism 
17 carA, pyrB, NGO_1358, pyrI, NGO_1600, carB, purF, 
NGO_1452, argH, NGO_1711, gabD, NGO_1568, glmS, aspA, 
NGO_1047, purA, argG 
Amino sugar and nucleotide 
sugar metabolism 
11 pgi1, NGO_0375, glmS, glmU, murA, glmM, murB, glk, 
NGO_0220, NGO_1896, pgi2 
Aminoacyl-tRNA 
biosynthesis 
23 ileS, leuS, proS, glyQ, cysS, gltX, metG, glnS, glyS, lysS, alaS, 
argS, fmt, valS, gatB, gatA, trpS, pheT, thrS, pheS, tyrS, hisS, 
gatC 
Arginine and proline 
metabolism 
17 argB, NGO_1358, NGO_0949, argD, NGO_1600, NGO_1487, 
NGO_1452, argH, NGO_0435, NGO_0713, proC, proA, argG, 
speB, argC, argJ, argF 
Bacterial secretion system 9 ffh, NGO_0188, secA, ftsY, yidC, secY, secE, secD, tatA 
Base excision repair 7 NGO_0414, polA, ligA, NGO_1994, nth, NGO_0710, NGO_1561 
Butanoate metabolism 7 aceE, NGO_0186, NGO_0921, gabD, NGO_1235, NGO_1236, 
NGO_0923 
C5-Branched dibasic acid 
metabolism 
6 sucD, leuD, NGO_1235, NGO_1236, leuC, sucC 
Carbon fixation pathways in 
prokaryotes 
17 NGO_1231, ackA, NGO_0929, NGO_0921, NGO_0214, ppc, 
accA, NGO_0200, sucD, fhs, NGO_0044, accD, sucC, 
NGO_1082, NGO_0923, fumC, folD 
TCA cycle (TCA cycle) 15 NGO_0562, gltA, aceE, NGO_0916, NGO_1231, NGO_0921, 
sucA, sucD, NGO_0925, NGO_0915, NGO_0564, sucC, 
NGO_1082, NGO_0923, fumC 
Cysteine and methionine 
metabolism 
20 NGO_0386, NGO_1209, NGO_1149, metXS, NGO_1773, 
NGO_0956, NGO_0340, NGO_0676, NGO_1452, metE, 
NGO_0435, NGO_0779, asd, metK, mtnN, NGO_1795, 
NGO_0873, NGO_1329, NGO_1991, luxS 
DNA replication 11 dnaG, NGO_1031, NGO_0283, dnaQ, NGO_0078, polA, 
NGO_0002, ligA, NGO_0347, dnaX, NGO_0451 
Fatty acid biosynthesis 10 NGO_1763, fabH, accA, fabZ, NGO_0044, NGO_1666, 
NGO_2166, NGO_0045, accD, fabG 
Folate biosynthesis 5 NGO_1342, NGO_0131, NGO_0266, NGO_2112, NGO_0323 




6 NGO_1216, gpsA, plsX, psd, NGO_1492, NGO_2069 
Glycine, serine and 
threonine metabolism 
18 NGO_0562, NGO_0386, gcvT, trpA, thrB, NGO_1468, 
NGO_1773, glyA, NGO_0956, NGO_0925, NGO_0915, 
NGO_0689, NGO_0779, trpB, serC, gcvP, ilvA, asd 
Glycolysis / Gluconeogenesis 18 NGO_0562, aceE, gapA, gpmA, NGO_1931, eno, pgi1, 
NGO_0375, NGO_0925, NGO_1881, NGO_0915, tpiA, 






5 gltA, NGO_1231, NGO1052, NGO_0713, NGO_0203 
Histidine metabolism 11 hisG, NGO_1860, hisI, hisA, hisH, hisB, hisF, hisD, hisC, hisZ, 
hisE 
Homologous recombination 17 NGO_0414, NGO_1031, NGO_0283, recB, dnaQ, NGO_0078, 
polA, recA, NGO_0002, recD, recR, ruvC, NGO_0347, ruvA, 
dnaX, recC, ruvB 
Lipopolysaccharide 
biosynthesis 
12 hldD, lpxD, NGO_0987, NGO_0105, NGO_1915, kdsA, lpxA, 
NGO_1608, lpxK, gmhA, kdsB, lpxB 
Lysine biosynthesis 15 argB, NGO_0460, dapB, NGO_0956, argD, dapE, dapD, 
NGO_0779, asd, dapA, argC, murE, dapF, murF, lysA 
Methane metabolism 13 NGO_1767, gpmA, ackA, NGO_1468, NGO_0929, eno, glyA, 
NGO_0214, ppc, NGO_0200, NGO_0034, serC, fbp 
Mismatch repair 14 NGO_0414, mutL, NGO_1031, xseA, NGO_0283, dnaQ, 
NGO_0078, mutS, NGO_1757, NGO_0002, xseB, ligA, 
NGO_0347, dnaX 
Nicotinate and nicotinamide 
metabolism 
7 NGO_1565, nadA, NGO_1568, pncB, NGO_1933, nadK, pntB 
Nitrogen metabolism 10 NGO_0386, gcvT, NGO_1024, NGO_1358, NGO_1600, 
NGO_2079, NGO_0574, aspA, NGO_1276, NGO_1514 
Nucleotide excision repair 7 uvrB, uvrA, polA, NGO_1757, mfd, ligA, uvrC 
One carbon pool by folate 9 gcvT, NGO_0929, glyA, fmt, fhs, purH, thyA, folD, purN 
Oxidative phosphorylation 21 atpG, atpH, ppa, atpC, NGO_0921, NGO_1373, atpA, NGO_1746, 
nuoI, nuoB, atpF, NGO_2029, nuoD, atpD, NGO_1745, 
NGO_1747, NGO_0923, ppk, NGO_2031, nuoC, NGO_1372 
Pantothenate and CoA 
biosynthesis 
13 NGO_1307, acpS, ilvC, birA/coaX, ilvD, NGO_1235, NGO_1236, 
panB, NGO_1665, panC, coaD, coaE, panD 
Pentose phosphate pathway 14 NGO_0714, pgl, rpiA, pgi1, NGO_0375, zwf, NGO_1914, prs, 
NGO_0034, NGO_1028, NGO_0713, tal, fbp, pgi2 
Peptidoglycan biosynthesis 12 ddl, NGO_0107, NGO_0443, murA, murB, murG, mraY, murD, 
murJ, murC, murE, murF 
Phenylalanine, tyrosine and 
tryptophan biosynthesis 
17 trpD, trpC, trpA, NGO_1695, hisC, NGO_1452, aroC, aroK, trpF, 
trpB, trpE, aroA, aroD, pheA, NGO_1204, NGO_1329, aroB 
Porphyrin and chlorophyll 
metabolism 
9 gltX, hemH, hemA, hemL, hemE, NGO_0385, NGO_1580, 
NGO_0234, NGO_0360 
Propanoate metabolism 8 ackA, NGO_0214, accA, sucD, NGO_0044, NGO_0045, accD, 
sucC 
Protein export 10 ffh, NGO_0188, NGO_0343, secA, ftsY, yidC, secY, secE, secD, 
tatA 
Purine metabolism 36 NGO_0221, NGO_1041, pnp, rpoC, NGO_0614, NGO_1382, 
guaB, NGO_0283, dnaQ, rpoA, purD, NGO_0375, rpoB, 
NGO_0078, polA, prs, purF, apaH, purC, NGO_1711, purH, 
NGO_1881, NGO_0002, guaA, purM, adk, purL, NGO_1308, 
NGO_2035, NGO_0347, purE, dnaX, purA, purK, apt, purN 
Pyrimidine metabolism 29 carA, cmk, pnp, rpoC, NGO_0614, pyrB, pyrI, NGO_0283, dnaQ, 
NGO_0580, rpoA, rpoB, pyrD, NGO_0078, carB, polA, pyrG, 
NGO_0002, tmk, pyrE, upp, pyrC, thyA, NGO_0347, dnaX, pyrF, 
pyrH, dut, dcd 
Pyruvate metabolism 19 NGO_0562, aceE, leuA, ackA, NGO_0214, NGO_1336, ppc, 
accA, NGO_0200, lldD, NGO_0925, NGO_1881, NGO_0915, 
NGO_0564, dld, NGO_0044, NGO_0045, accD, mqo 
Riboflavin metabolism 5 ribA, NGO_0089, ribH, NGO_0068, ribB 
Ribosome 52 rplW, rplX, rplC, rplA, rplE, rpsB, rpsT, rplB, rplF, rplV, rpsE, 
rpsC, rpsA, rplO, rplP, rplL, rplN, rpsR, rplD, rplY, rpsJ, rpmE, 




rpsL, rplT, rpmH, rplQ, rplK, rpsO, rpmA, rpsQ, rplM, rpsK, rpsN, 
rpmG, rpmD, rpsI, rpsF, rpsU, rpsD, rpmC, rpmI 
RNA degradation 12 groL, pnp, eno, rho, dnaK, rnr, pcnB, rne, rppH, NGO_1722, ppk, 
hfq 
RNA polymerase 5 rpoC, NGO_1944, rpoD, rpoA, rpoB 
Starch and sucrose 
metabolism 
5 pgi1, NGO_0375, glk, NGO_0220, pgi2 
Streptomycin biosynthesis 5 NGO_0375, NGO_0671, NGO_0332, NGO_2161, glk 
Terpenoid backbone 
biosynthesis 
9 dxs, NGO_1675, ispG, ispD, dxr, NGO_1735, ispH, ispE, ispF 
Thiamine metabolism 6 NGO_0221, thiG, iscS, thiL, NGO_1160, thiE 
Two-component system 5 NGO_0752, dnaA, NGO_1600, glnD, NGO_1182 
Tyrosine metabolism 5 NGO_1860, hisC, NGO_1452, gabD, NGO_1329 
Ubiquinone and other 
terpenoid-quinone 
biosynthesis 
6 ubiB, ubiG, ubiD, ubiE, ubiX, ubiA 
Valine, leucine and 
isoleucine biosynthesis 
15 ileS, aceE, leuS, leuA, ilvC, leuD, valS, ilvD, NGO_1235, 
NGO_1236, leuC, NGO_1047, ilvA, NGO_1665, leuB 
Valine, leucine and 
isoleucine degradation 






Table 8.2 Acetylome of isogenic mutant strains. The proteins with more than 2 significant 
acetylation sites were selected in the three isogenic mutant strains. The sites were classified 
according to the fold change difference and the position of the acetylated lysines are indicated in 








ΔackA Δpta Δhdac 
10 kDa chaperonin  Q5F542 groS Increased 20, 34, 47, 
76, 69, 64, 
60 
34, 47, 64, 
76 
20, 34, 47 
10 kDa chaperonin  Q5F542 groS Decreased - 69, 64 - 
16S rRNA methyltransferase Q5F5P8 NGO_1869 Increased 191, 107 - - 
2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase  




Q5F829 ispD Increased 212, 145 - - 
2-isopropylmalate synthase  Q5F8D4 leuA Decreased 69, 400 - - 
2-oxoglutarate 
dehydrogenase  













Q5F7C0 gpmA Increased 103, 97, 
152, 174, 






Q5F7C0 gpmA Decreased - 98, 97 - 
23S rRNA pseudouridine 
synthase RluD 
Q5F9V9 NGO_0278 Increased 47, 228 - - 
3'-5' exonuclease Q5FA73 NGO_0156 Increased 240, 253 - - 
3-deoxy-D-manno-
octulosonic acid transferase  
Q5F5K9 NGO_1915 Decreased - 157, 223 - 
3-hydroxyacyl-[acyl-carrier-
protein] dehydratase FabZ  
Q5F5W5 fabZ Increased 14, 125 - - 
3-isopropylmalate 
dehydratase large subunit  
Q5F8T1 leuC Increased 277, 81 - - 
3-oxoacyl-acyl-carrier-
protein synthase 2  
Q5F603 NGO_1763 Increased 316, 66 - - 
3-oxoacyl-acyl-carrier-
protein synthase 3  






phosphate synthase  
Q5F8Q9 ribB Increased 263, 397 - - 
3,4-dihydroxy-2-butanone 4-
phosphate synthase  
Q5F8Q9 ribB Decreased - 263, 397 - 







30S ribosomal protein S10 Q5F5S5 rpsJ Increased 82, 45, 37 - - 
30S ribosomal protein S12 Q5F5S1 rpsL Decreased 30, 20 - - 




30S ribosomal protein S2 Q5F5F3 rpsB Increased 45, 117, 
131, 117 
- - 
30S ribosomal protein S3 Q5F5T3 rpsC Increased 126, 88, 34, 
88, 80 
- 209, 34 
30S ribosomal protein S7 Q5F5S2 rpsG Increased 76, 52, 53 - - 
4-hydroxy-3-methylbut-2-
en-1-yl diphosphate synthase  
Q5F913 ispG Increased 205, 156 - - 
50S ribosomal protein L1 Q5F5R2 rplA Increased 31, 154, 
141 
- 198, 141 
50S ribosomal protein L11 Q5F5R1 rplK Increased 97, 81, 72, 
82, 81 
97, 72 - 
50S ribosomal protein L14 Q5F5T7 rplN Increased 78, 90 - - 
50S ribosomal protein L17 Q5F5V3 rplQ Increased 78, 118 - - 
50S ribosomal protein L18 Q5F5U3 rplR Increased 63, 76 - - 
50S ribosomal protein L20 Q5F9U1 rplT Decreased - 112, 78 - 
50S ribosomal protein L22 Q5F5T2 rplV Decreased 78, 98 - - 
50S ribosomal protein L24 Q5F5T8 rplX Increased 91, 84 - - 
50S ribosomal protein L25  Q5F9F4 rplY Increased 54, 63, 175, 
188, 189 
- - 
50S ribosomal protein L3 Q5F5S7 rplC Decreased 71, 172 - - 
50S ribosomal protein L31 Q5F513 rpmE Increased 64, 64, 60, 
70 
- - 
50S ribosomal protein L33 Q5F683 rpmG Increased 46, 49 - - 
50S ribosomal protein L5 Q5F5T9 rplE Increased - 18, 167, 33 - 
50S ribosomal protein L6 Q5F5U2 rplF Increased 77, 85 - - 
50S ribosomal protein 
L7/L12 
Q5F5R4 rplL Increased 68, 84, 87 68, 103 - 
50S ribosomal protein L9 Q5F922 rplI Increased 82, 45, 71, 
82, 22 
- - 
50S ribosomal protein L9 Q5F922 rplI Decreased 35, 122 - - 
6-phosphogluconolactonase  Q5F8Q1 pgl Increased 197, 125 - - 











throttle protein EttA? 
Q5F6I5 NGO_1573 Increased 390, 370, 
405 
- 538, 405 
ABC transporte Energy-
dependent translational 
throttle protein EttA 
Q5F6I5 NGO_1573 Decreased - 390, 370 - 
ABC transporter sulfate-
transporting ATPase  
Q5F8B6 NGO_0870 Increased 308, 47 - - 
Acetate kinase  Q5F824 ackA Decreased 169, 195 - - 







transferase subunit alpha  









transferase subunit beta  
Q5F9Y5 accD Increased 258, 88 - - 
Acetylornithine 
aminotransferase  
Q5F8W4 argD Increased 305, 105 - - 
Acetyltransferase 
component of pyruvate 
dehydrogenase complex  





component of pyruvate 
dehydrogenase complex  
Q5F940 NGO_0564 Decreased 226, 266, 
430 
- - 







Aconitate hydratase B  Q5F7E7 NGO_1231 Decreased 385, 742 - - 
Acyl-CoA thioester 
hydrolase 
Q5F7U2 NGO_1078 Increased - 72, 140 - 
Adenylate kinase  Q5F9J3 adk Increased 40, 50 - - 
Adenylosuccinate lyase  Q5F655 NGO_1711 Increased - 145, 93 - 
ADP-L-glycero-D-manno-
heptose-6-epimerase  




Agmatinase  Q5F6R3 speB Increased 194, 195 - - 








reductase AhpD  
Q5F7C9 NGO_1249 Increased 13, 13, 14, 
6 
- - 
Amino acid ABC 
transporter substrate-
binding protein 
Q5F9M1 NGO_0372 Increased 193, 66, 92, 
104, 210 
- - 




Aminotransferase  Q5F6U3 NGO_1452 Increased - - 38, 22 
Aminotransferase  Q5F758 NGO_1329 Increased 343, 38, 22 - - 
Arginine--tRNA ligase  Q5F835 argS Increased 259, 126 407, 259 - 
Arginine--tRNA ligase  Q5F835 argS Decreased 418, 537 292, 418 - 
Argininosuccinate lyase  Q5FA15 argH Decreased 284, 96 - - 
Aspartate 
carbamoyltransferase  
Q5F5P0 pyrB Increased 244, 240 - - 
Aspartate 
carbamoyltransferase  




Q5F5P1 pyrI Increased 5, 13 68, 13 - 
Aspartokinase  Q5F842 NGO_0956 Increased 221, 317, 
103 
- - 
Aspartokinase  Q5F842 NGO_0956 Decreased - 7, 103 - 
Aspartyl/glutamyl-tRNA Q5F8V0 gatB Increased 61, 456, 
445 
- - 





helicase Rep  
Q5F8N1 rep Increased 331, 501 - - 
ATP-dependent helicase Q5F7H8 NGO_1199 Decreased 53, 674 - - 
ATP 
phosphoribosyltransferase  




Q5F9J6 hisZ Increased 201, 382 - - 
ATP synthase epsilon chain  Q5F4Y9 atpC Increased 120, 130 - - 
ATP synthase gamma chain  Q5F4Z1 atpG Decreased 252, 31 263, 31, 98 - 





ATP synthase subunit alpha  Q5F4Z2 atpA Decreased - 387, 384 - 
ATP synthase subunit beta  Q5F4Z0 atpD Increased 193, 114, 
233 
- - 
ATP synthase subunit delta  Q5F4Z3 atpH Increased 74, 69 - 74, 69 
Beta sliding clamp Q5FAJ1 NGO_0002 Increased 222, 255 222, 255 - 




Q5F577 glmU Increased - - 155, 248 





NGO_08225 Increased 1028, 1036, 
1044, 246 
- - 





NGO_08225 Decreased 106, 143, 
558 
- - 
Biotin carboxylase  Q5FAH6 NGO_0044 Increased 415, 324, 
326 
- - 
Bis Q5FA03 apaH Decreased - 148, 195 - 
Branched-chain amino acid 
aminotransferase 
Q5F697 NGO_1665 Increased - 161, 250 - 







synthase large chain  
Q5FAH2 carB Increased 358, 469 - - 
Catalase  Q5F601 NGO_1767 Increased 77, 227 - - 
Cell division protein FtsA Q5F6M2 ftsA Decreased - 243, 96 - 
Cell division protein FtsK Q5F8D2 NGO_0851 Decreased - 564, 176 - 
Cell division protein FtsN Q5F9X1 NGO_0265 Decreased - 284, 17 - 
Cell division protein FtsZ Q5F6M3 ftsZ Increased 298, 324 - - 
Cell division protein ZapE Q5F909 NGO_0598 Increased 236, 55 - - 
Cell division protein ZipA Q5F9Z8 NGO_0236 Increased 413, 398, 
140, 92 
- - 




Chaperone protein ClpB Q5F7W9 clpB Increased 61, 96, 463, 
779, 783, 
562, 565 
615, 749 61, 96 
Chaperone protein ClpB Q5F7W9 clpB Decreased - 779, 529 - 
Chaperone protein DnaJ Q5F5M1 dnaJ Increased 31, 46, 48, 
31 
- - 




183, 588 - 
Chaperone protein DnaK  Q5F6W5 dnaK Decreased - 415, 104 - 
Chaperone protein HscA 
homolog 
Q5F8E8 hscA Increased 135, 431 135, 431 - 
Chromosomal replication 
initiator protein DnaA 




initiator protein DnaA 
Q5FAJ2 dnaA Decreased - 262, 273 - 
Chromosome partitioning 
protein ParB 
Q5F4Z9 NGO_2141 Increased 134, 202 134, 202 - 
Clp protease ClpX Q5F9I6 clpA Increased 750, 729 - - 






Q5F7T9 NGO_1081 Decreased - 216, 259 - 
Cobalamin-independent 
methionine synthase 










Q5F7A4 NGO_1276 Decreased - 91, 88 - 
Cro/Cl family 
transcriptional regulator 
Q5F9C0 NGO_0479 Increased 34, 59 - - 
CTP synthase  Q5F7G6 pyrG Increased 536, 101, 
343 
- - 
Cysteine--tRNA ligase  Q5F5D6 cysS Decreased 175, 73 - - 
Cysteine desulfurase IscS  Q5F8X4 iscS Increased 196, 272 - - 
Cysteine desulfurase IscS  Q5F8X4 iscS Decreased - 19, 4 - 
Cysteine synthase  Q5F9Q2 NGO_0340 Increased 89, 236, 18, 
57, 243, 89, 
24, 57, 60 
89, 18, 192, 
57, 243 
18, 57 
Cytochrome Q5F759 NGO_1328 Increased - 189, 201 - 
Cytochrome Q5F759 NGO_1328 Decreased 241, 278 - - 
Cytosine-specific 
methyltransferase II 
Q5F8B3 NGO_0873 Increased 134, 280 - - 
Cytosine-specific 
methyltransferase III 
Q5F7G9 NGO_1209 Decreased - 236, 248 - 












Q5F538 lysA Decreased - 253, 159 - 
Dihydrolipoamide 
dehydrogenase  
Q5F866 NGO_0925 Increased 112, 119 286, 52 - 
Dihydrolipoyl 
dehydrogenase I 







Q5F942 NGO_0562 Decreased 421, 261 - - 
Dihydrolipoyl 
dehydrogenase II 





component of 2-oxoglutarate 
dehydrogenase complex  
Q5F875 NGO_0916 Increased 214, 219 - - 
Dihydroxy-acid dehydratase  Q5F8G6 ilvD Increased 401, 503, 
366 
- - 




polymerase subunit alpha  
Q5F5V2 rpoA Increased 103, 270 - - 
DNA-directed RNA 
polymerase subunit beta'  




polymerase subunit beta'  





polymerase subunit beta  




polymerase subunit beta  





DNA gyrase subunit A  Q5F8Y0 gyrA Increased 404, 505 - - 
DNA gyrase subunit A  Q5F8Y0 gyrA Decreased 285, 490 - - 
DNA gyrase subunit B  Q5F5Z6 gyrB Increased 592, 107, 
638 
- - 
DNA helicase  Q5F609 NGO_1757 Decreased - 695, 728 - 
DNA methylase Q5F6P5 NGO_1504 Increased 77, 329 135, 106 - 
DNA polymerase I  Q5F533 polA Increased 194, 267 - - 
DNA polymerase III subunit 
epsilon II 
Q5F828 dnaQ Increased 199, 69 - - 
DNA primase  Q5F806 dnaG Increased 27, 588 - - 
DNA repair protein RadA Q5F9M6 radA Increased 416, 113 - - 





DNA topoisomerase 1  Q5F5Q4 topA Decreased - 575, 505, 
211 
- 
DNA topoisomerase 4 
subunit A  
Q5F7B9 parC Increased 746, 552, 
692 
- - 
DNA topoisomerase 4 
subunit A  







methyltransferase RlmN  
Q5F911 rlmN Increased 354, 50 - - 
DUF1853 family protein Q5F8U1 NGO_0669 Increased 158, 152 - - 
DUF4043 family protein? Q5F7T0 NGO_1090 Increased 327, 344, 
336, 243 
- - 
Elongation factor 4  Q5F9P9 lepA Increased 55, 316 - - 
Elongation factor G  Q5F5S3 fusA Decreased 143, 551, 
315, 353 
- - 
Elongation factor P  Q5F856 efp Increased 24, 55 - 59, 24 
Elongation factor Ts  Q5F5F4 tsf Increased 98, 216, 
209, 36 
209, 36 - 
Elongation factor Tu  Q5F5Q8 tuf1 Increased 249, 57, 38, 
57, 45, 5, 
304, 295 
- - 
Endonuclease Q5F7D9 NGO_1239 Increased 6, 7 - - 







reductase NADH  
Q5F696 NGO_1666 Increased 129, 194 129, 194 - 







Q5F6V3 adhP Increased 227, 74 - - 
Exopolyphosphatase Q5F7X4 NGO_1041 Decreased - 255, 38 - 
Fe-S binding protein Q5F885 NGO_0904 Decreased 115, 145 - - 
Fe-S cluster binding protein Q5F883 NGO_0906 Increased 154, 252, 7 - - 
Fe-S cluster binding protein Q5F883 NGO_0906 Decreased - 26, 7, 477 - 
Ferredoxin-NADP reductase Q5F8S3 NGO_0687 Increased 93, 84 - - 
Ferric uptake regulation 
protein 
Q5F5Y9 fur Increased 30, 97, 16, 
3, 11, 16 
- - 
Ferrochelatase  Q5F9U6 hemH Increased - - 83, 265 
Formate--tetrahydrofolate 
ligase  
Q5FAG1 fhs Increased 369, 545, 
49, 500, 4 
369, 500, 4 545, 500, 4 
Formate--tetrahydrofolate 
ligase  
Q5FAG1 fhs Decreased 483, 490 - - 
Fructose-1,6-bisphosphate 
aldolase  
Q5FAI4 NGO_0034 Increased 333, 339 - - 
Fructose-1,6-bisphosphate 
aldolase  
Q5FAI4 NGO_0034 Decreased - 331, 339 - 
Glucokinase  Q5F8Q0 glk Increased 36, 229 - - 
Glucose-6-phosphate 1-
dehydrogenase  
Q5F8Q2 zwf Increased 104, 146, 
180, 58 
104, 146 104, 58 
Glucose-6-phosphate 
isomerase 1  





Glutamate--cysteine ligase Q5F8T0 NGO_0680 Increased 277, 268 - - 
Glutamate--tRNA ligase  Q5F5J8 gltX Increased 425, 156, 
241, 425, 
416 
416, 383 156, 343 








Q5F584 glmS Decreased - 62, 23 - 
Glutamine--tRNA ligase  Q5F7G0 glnS Decreased 364, 556 - - 
Glutamine synthetase  Q5F6F9 NGO_1600 Increased 243, 356 - - 
Glutamyl-tRNA 
amidotransferase 
Q5F507 NGO_2133 Increased 55, 58, 12 12, 78 - 
Glutathione peroxidase Q5F865 NGO_0926 Increased 195, 34, 
244, 153, 
162, 187, 






Glutathione synthetase  Q5F7G1 gshB Increased 128, 14, 
266, 179, 
71 
128, 179 - 
Glutathione synthetase  Q5F7G1 gshB Decreased - 266, 71 - 
Glyceraldehyde-3-phosphate 
dehydrogenase  
Q5F5Z2 gapA Decreased 212, 227 - - 
Glycine--tRNA ligase beta 
subunit  
Q5F4Y7 glyS Increased 569, 378 - - 
Glycine--tRNA ligase beta 
subunit  
Q5F4Y7 glyS Decreased - 358, 443 - 
Glycine dehydrogenase  Q5F761 gcvP Decreased - 183, 784 - 
GMP synthase [glutamine-
hydrolyzing]  
Q5F4X9 guaA Increased 320, 371 - - 
GTP-binding protein Q5F8H0 NGO_0803 Increased 537, 539 - - 
GTP cyclohydrolase-2  Q5F7N6 ribA Increased 147, 190, 
155, 147 
- - 




GTP pyrophosphokinase II Q5F707 NGO_1382 Decreased - 160, 689 - 
GTPase Der  O87407 der Increased 245, 199 - - 
GTPase Der  O87407 der Decreased - 330, 443, 
199 
- 
Guanine permease Q5F6M4 NGO_1527 Decreased 280, 16 280, 16 - 
Guanosine-3',5'-bis Q5F777 NGO_1308 Decreased 149, 228 149, 120 - 






Q5F6W7 NGO_1427 Increased 43, 48, 182 - - 
Heme ABC transporter 
ATP-binding protein 
Q5F8K8 NGO_0764 Increased 23, 538 - - 
Heme biosynthesis protein 
HemY 
Q5F9N2 NGO_0361 Increased 382, 372 - - 
Heme biosynthesis protein 
HemY 
Q5F9N2 NGO_0361 Decreased - 102, 382 - 
Heme transporter CcmA Q5F768 NGO_1318 Increased 44, 86 - - 






Q5F7D7 hisC Increased 317, 276 - - 
Holo-ACP synthase Q5F6P2 acpS Increased 51, 21, 20 - - 
Hypoxanthine 
phosphoribosyltransferase 
Q5F594 NGO_2035 Increased 93, 84 - - 
Indole-3-glycerol phosphate 
synthase  
Q5F645 trpC Increased 61, 258 - - 









Q5F8H4 guaB Increased 6, 32 412, 203 - 
Inositol-1-monophosphatase  Q5F8T9 NGO_0671 Increased - 63, 56 - 
Integrase/recombinase, 
phage associated protein 
Q5F6E6 NGO_1613 Increased 317, 62 - - 
Isocitrate dehydrogenase 
[NADP]  
Q5F7T8 NGO_1082 Increased 527, 640, 
39, 121, 
242, 723 
121, 242 121, 242 










Q5F4Y4 NGO_2159 Decreased 270, 134 - - 
Large pilS cassette protein A0A0H4IS
A9 





LD-carboxypeptidase Q5F7A6 NGO_1274 Increased 320, 313 - - 
LdhA, NAD-linked D-LDH Q5F751 NGO_1336 Increased 248, 40 - 248, 40 
LdhA, NAD-linked D-LDH Q5F751 NGO_1336 Decreased 93, 154 93, 63 - 
Leucine--tRNA ligase  Q5FAJ3 leuS Increased 854, 621, 
521 
- - 
Leucine--tRNA ligase  Q5FAJ3 leuS Decreased 309, 32 634, 521 - 
Lipoyl synthase  Q5F8I0 lipA Increased 217, 283, 
34, 27 
- - 
Lon protease  Q5F8J8 lon Increased 678, 147, 
215 
- - 





Long-chain fatty acid--CoA 
ligase II 
Q5F7G5 NGO_1213 Decreased - 35, 296 - 
LysM peptidoglycan-binding 
domain-containing protein 
Q5F901 NGO_0608 Increased 353, 572 - - 
LysR family transcriptional 
regulator II 
Q5F5V6 NGO_1813 Increased 37, 137 - - 
MacA family efflux pump 
subunit 
Q5F6V5 NGO_1440 Decreased 161, 75 161, 75, 
124 
- 
Membrane protein insertase 
YidC  




Methionine--tRNA ligase  Q5F585 metG Increased 130, 650 130, 647 - 
Methionine biosynthesis 
protein MetW 
Q5F857 NGO_0934 Increased - 160, 38 - 
Methylenetetrahydrofolate 
reductase  
Q5F862 NGO_0929 Increased 52, 135, 
231 
- 135, 231 
Molecular chaperone DnaJ Q5F952 NGO_0551 Increased 30, 21 - - 
N-acetylmuramoyl-L-
alanine amidase 
Q5F6P7 amiC Increased 29, 59 29, 338 - 
Na-translocating NADH-
quinone reductase subunit A  
Q5F6Y0 nqrA Increased 112, 117 - - 
Na-translocating NADH-
quinone reductase subunit A  





Q5F6I9 NGO_1565 Increased 152, 233 - - 
Nitrogen regulatory protein 
P-II 1 
Q5F7J5 NGO_1182 Increased - 12, 90 - 
Nitroreductase Q5F7A2 NGO_1279 Increased 78, 78, 79 - - 
Nucleoid-associated protein 
NGO0742 
Q5F8M8 NGO0742 Increased 27, 12 27, 12 - 
Oligopeptidase A Q5F5Z8 NGO_1770 Increased 339, 19 114, 339, 
24, 344 
- 
Oligopeptidase A Q5F5Z8 NGO_1770 Decreased - 19, 424, 
387, 353 
- 
Oligoribonuclease  Q5FAH8 orn Increased 137, 141 - - 
Orotate 
phosphoribosyltransferase  
Q5FAK5 pyrE Increased 19, 10, 19 - - 
Osmoprotectant transport 
activator ProQ 
Q5F755 NGO_1332 Increased 12, 34 12, 34 - 
Peptidase M24 Q5F6U0 NGO_1456 Increased 297, 77 - - 
Peptidase_M14 domain-
containing protein 
Q5F8D7 NGO_0845 Increased 237, 309 237, 309 237, 309 
Peptide chain release factor 
3  
Q5FA25 prfC Increased 52, 63, 49 - - 
Peptide chain release factor 
3  
Q5FA25 prfC Decreased - 52, 49 - 
Peptidoglycan-binding outer 
membrane protein RmpM 




Q5F933 NGO_0571 Decreased - 360, 340 - 
Peptidyl-prolyl cis-trans 
isomerase  
Q5F9L7 NGO_0376 Increased 148, 32, 
118 
148, 118 - 
Peptidyl-prolyl cis-trans 
isomerase  
Q5F9L7 NGO_0376 Decreased 19, 115 - - 
Peptidyl-tRNA hydrolase  Q5F9L4 pth Increased 120, 125 - - 
Peptidylprolyl isomerase 
NGO_1656 
Q5F6A4 NGO_1656 Increased 75, 221, 
129, 86 
129, 164 75, 221, 
129 
Phenylalanine--tRNA ligase 
beta subunit  







beta subunit  




Phosphate acetyltransferase Q5FA20 NGO_0214 Increased 450, 400 - - 




Phosphate acyltransferase  Q5F4X3 plsX Increased 244, 79 - - 
Phospho-2-dehydro-3-
deoxyheptonate aldolase  
Q5F668 NGO_1695 Decreased - 263, 99, 
188 
- 




protein phosphotransferase  





Q5F5A9 ppc Increased 243, 642, 
812, 346 




Q5FA34 NGO_0200 Increased 71, 37, 628, 
631 
- 71, 37 
Phosphoenolpyruvate 
synthase  
Q5FA34 NGO_0200 Decreased 270, 747, 
357 
628, 747 - 
Phosphoglucomutase Q5F9L8 NGO_0375 Increased 10, 165, 
187, 330, 
20 
10, 20 - 
Phosphogluconate 
dehydratase 






Phosphoglucosamine mutase  Q5F746 glmM Increased 386, 383 - - 
Phosphoribosyl-ATP 
pyrophosphatase  
Q5FA47 hisE Increased 36, 39 - - 
Phosphoribosylamine--
glycine ligase  








amidine cyclo-ligase  
Q5F973 purM Increased 237, 23 237, 23 - 
Phosphoribosylformylglycin
amidine synthase  
Q5F7J4 purL Decreased - 786, 395 - 
Phosphoribosyltransferase Q5F4X2 NGO_2172 Increased 129, 115 - - 
Pilus assembly/adherence 
protein PilC NGO_0055 







NGO_10270 Decreased - 957, 550 - 
Polyribonucleotide 
nucleotidyltransferase  
Q5F9Q7 pnp Increased 693, 540, 
246 
693, 80 - 
Probable Fe 2-trafficking 
protein 
Q5F553 NGO2083 Increased 18, 28 - - 
Probable GTP-binding 
protein EngB 
Q5FAC6 engB Increased 8, 181, 154 - - 
Probable GTP-binding 
protein EngB 
Q5FAC6 engB Decreased 54, 143 54, 143 - 
Probable malate:quinone 
oxidoreductase  





determining protein MinC 
Q5F5V4 minC Increased 118, 217 - - 
Probable transcriptional 
regulatory protein NGO1291 
Q5F792 NGO1291 Increased 106, 72, 
216 
- - 
Proline--tRNA ligase  Q5F938 proS Increased 418, 12, 
461 
12, 461 418, 12 
Protease Q5F771 NGO_1314 Increased 290, 297, 
287, 45 
- - 
Protein GrpE  Q5F6X1 grpE Increased 83, 170, 
135, 57, 88 
- - 
Protein GrpE  Q5F6X1 grpE Decreased - 83, 135 - 
Protein translocase subunit 
SecY 
Q5F5U7 secY Decreased - 423, 12 - 
Putative DNA mimic protein 
DMP12? 
Q5F5G1 NGO_1966 Increased - 109, 85 - 
Putative phage associated 
protein 
Q5F6D9 NGO_1620 Increased - 180, 184 - 
Pyridoxal phosphate 
homeostasis protein  
Q5F5L6 NGO_1907 Increased 17, 175 - - 
Pyridoxine 5'-phosphate 
synthase  
Q5F6P1 pdxJ Increased - 118, 59 - 
Pyrroline-5-carboxylate 
reductase  
Q5F5L8 proC Increased 216, 219 - 216, 219 
Pyruvate dehydrogenase E1 
component  












Pyruvate dehydrogenase E1 
component  





Pyruvate kinase  Q5F5N5 NGO_1881 Increased 223, 276 - - 
Quinone-dependent D-
lactate dehydrogenase  
Q5F898 dld Increased 389, 365, 
466, 324 
- 389, 466 
RecBCD enzyme subunit 
RecB  
Q5F9M3 recB Increased 723, 277 - - 
Respiratory L-Lactate 
dehydrogenase 
Q5F8X1 lldD Decreased - 266, 147 - 
Restriction endonuclease 
EcoprrI subunit S 
A0A0H4I
W12 
NGO_02155 Increased - 52, 160 - 
Restriction endonuclease 
HaeII 
Q5F5D7 NGO_1992 Decreased - 75, 83 - 
Restriction endonuclease 
subunit M 
Q5F8W9 NGO_0641 Increased 437, 381 437, 381, 
499, 447 
- 
Restriction endonuclease, M 
subunit 
Q5F9I9 NGO_0404 Increased 206, 422, 
497 
- - 
Ribonuclease E  Q5F5Y3 rne Increased 575, 318, 
452 
- - 
Ribonuclease E  Q5F5Y3 rne Decreased - 517, 575 - 
Ribonuclease II Q5F653 NGO_1713 Increased 596, 119, 
151 
- - 
















Q5F9F5 prs Increased 185, 196 - - 
Ribosomal large subunit 
pseudouridine synthase B 
Q5F8V3 NGO_0657 Increased 150, 76 - - 
Ribosomal RNA large 
subunit methyltransferase H  
Q5F554 rlmH Increased 58, 90 - - 
Ribosomal RNA large 
subunit methyltransferase J  
Q5F8C6 rlmJ Decreased - 171, 182 - 
Ribosomal RNA small 
subunit methyltransferase H  
Q5F6K7 rsmH Increased 253, 257 - - 
Ribosomal RNA small 
subunit methyltransferase J  
Q5F7B7 rsmJ Increased 77, 51, 235 77, 235 - 
Ribosomal small subunit 
pseudouridine synthase A  
Q5F902 NGO_0607 Increased 141, 141, 
131 
- - 
Ribosome-recycling factor  Q5F5X3 frr Increased 140, 141 - - 
Ribosome maturation factor 
RimP 
Q5F799 rimP Increased 97, 99 - - 
Ribosome maturation factor 
RimP 
Q5F799 rimP Decreased - 97, 99 - 
RluA family pseudouridine 
synthase 
Q5F5Y5 NGO_1783 Decreased 193, 206 - - 
RNA polymerase sigma 
factor RpoD  
Q5F805 rpoD Increased - 279, 383, 
394 
- 
RNA polymerase sigma 
factor RpoD  








Q5F8U2 NGO_0668 Increased 367, 328 - 367, 328 
Serine 
hydroxymethyltransferase  





Q5F8C0 glyA Decreased - 275, 353 - 
Shikimate kinase  Q5FAD3 aroK Increased 166, 132 - - 
Signal recognition particle 
protein  
Q5F666 ffh Increased 416, 21, 
278 
- - 
Signal recognition particle 
protein  
Q5F666 ffh Decreased - 14, 372 - 
Site-determining protein A0A0H4I
VK1 
NGO_09675 Increased 104, 112 - - 
Sodium/glutamate 
symporter 
Q5F5N0 gltS Increased 212, 212 - - 
Sodium:alanine symporter Q5F5Y1 NGO_1787 Increased 459, 467 - - 
Stringent starvation protein 
A 





flavoprotein subunit  
Q5F870 NGO_0921 Decreased - 28, 584 - 
Succinyl-CoA synthetase 
subunit alpha 






Q5F878 sucC Increased 368, 41, 46 - - 
Succinyl-diaminopimelate 
desuccinylase  
Q5F812 dapE Decreased - 151, 379 - 
Thiamine ABC transporter 
substrate-binding protein 
Q5F574 NGO_2056 Increased 230, 242 86, 242 - 
Thioredoxin TrxA Q5F8V8 NGO_0652 Increased - 59, 92 - 
Threonine--tRNA ligase  Q5F9U4 thrS Decreased 300, 560 - - 
Threonine synthase  Q5F8S1 NGO_0689 Increased 212, 45 - - 
Transaldolase  Q5F6E9 tal Increased 337, 65 - - 
Transcriptional regulator 
HU subunit alpha 
Q5F8J6 NGO_0777 Increased 18, 75, 78, 
64 
75, 18, 75 - 
Transketolase  Q5F7Y3 NGO_1028 Decreased - 50, 534 - 
Translation initiation factor 
IF-2 
Q5F797 infB Increased 22, 143, 
141, 907 
- - 
Translation initiation factor 
IF-2 




Translation initiation factor 
IF-3 
Q5F9U3 infC Decreased 17, 89, 118 89, 92 - 
Trigger factor  Q5F915 tig Increased 86, 303, 31 - 303, 31 
tRNA uridine 5-
carboxymethylaminomethyl 
modification enzyme MnmG  
Q5F5Y0 mnmG Increased 570, 489, 
621 
- 570, 489 
tRNA uridine 5-
carboxymethylaminomethyl 
modification enzyme MnmG  
Q5F5Y0 mnmG Decreased 283, 191, 
105 
191, 105 - 
Tryptophan--tRNA ligase  Q5F7X0 trpS Increased 219, 220 - - 
Two-component system 
response regulator MisR 
Q5FA55 NGO_0177 Increased 143, 205 - - 
Type IV pilus twitching 
motility protein PilT 
NGO_0346 







Type IV pilus twitching 
motility protein PilT 
NGO_1909 
Q5F5L4 NGO_1909 Increased 203, 20 - - 
Tyrosine--tRNA ligase  Q5FAF7 tyrS Increased 82, 245, 
234 
- - 
Tyrosine--tRNA ligase  Q5FAF7 tyrS Decreased - 266, 245 - 
Ubiquinone biosynthesis O-
methyltransferase  
Q5F562 ubiG Increased 19, 35 - - 
UDP-N-acetylglucosamine 1-
carboxyvinyltransferase  




diaminoheptandioate ligase  
Q5F8G0 mpl Increased 319, 430, 
375, 27 
319, 430 - 
Uncharacterized protein 
NGO_0163 
Q5FA68 NGO_0163 Increased 97, 18 - - 
Uncharacterized protein 
NGO_0701 






Q5F8C2 NGO_0863 Increased 68, 52, 52, 
53, 11, 13 
- 68, 52, 57 
Uncharacterized protein 
NGO_1097 
Q5F7S3 NGO_1097 Increased 112, 352 - - 
Uncharacterized protein 
NGO_1150 
Q5F7M0 NGO_1150 Increased 14, 59 - - 
Uncharacterized protein 
NGO_1215 
Q5F7G3 NGO_1215 Increased - 129, 98 - 
Uncharacterized protein 
NGO_1588 
Q5F6H1 NGO_1588 Increased 92, 44 - - 
UPF0210 protein NGO1297 Q5F786 NGO1297 Decreased 248, 62 248, 62, 
450 
- 
UPF0246 protein NGO0461 Q5F9D8 NGO0461 Increased 182, 183, 
194 
- - 
Uridylate kinase  Q5F5F5 pyrH Increased 196, 193 - - 
UvrABC system protein A  Q5F7H1 uvrA Increased 351, 321, 
665 
- - 
UvrABC system protein A  Q5F7H1 uvrA Decreased - 321, 625, 
467, 789 
- 
UvrABC system protein B  Q5F931 uvrB Increased 384, 195, 
582 
- - 
Valine--tRNA ligase  Q5F5W0 valS Increased 323, 537, 
875 
- - 




Table 8.3 Proteins with acetyl-phosphate-dependent acetylation sites. The terms with 
more than two proteins were classified in four different ontologies (KEGG pathway, biological 
process, molecular function and family). 














Glutamate--tRNA ligase  
 
Isoleucine--tRNA ligase  
 
Cysteine--tRNA ligase  
 
Tyrosine--tRNA ligase  
 
Threonine--tRNA ligase  
 
Leucine--tRNA ligase  














Phosphoserine phosphatase SerB 
 




Phosphoenolpyruvate synthase  
 
Fructose-1,6-bisphosphate aldolase  












Acetyl-coenzyme A carboxylase carboxyl transferase 




Respiratory L-Lactate dehydrogenase 
 
Probable malate:quinone oxidoreductase  
 
Phosphoenolpyruvate synthase  
 
Pyruvate dehydrogenase E1 component  

















DNA-directed RNA polymerase subunit beta'  
 
Hypoxanthine phosphoribosyltransferase 









30S ribosomal protein S13 
 
30S ribosomal protein S3 
 
50S ribosomal protein L25  
 
30S ribosomal protein S7 
 













Phosphoserine phosphatase SerB 
 
Serine hydroxymethyltransferase  
 
Threonine synthase  
 
Aspartokinase  









Transcription-repair-coupling factor  
 
UvrABC system protein A  
 
DNA helicase  
 
UvrABC system protein B  










Dihydroxy-acid dehydratase  
 
Isoleucine--tRNA ligase  
 
Pyruvate dehydrogenase E1 component  
 








ATP synthase gamma chain  
 
ATP synthase subunit alpha  
 
Inorganic pyrophosphatase  











Fructose-1,6-bisphosphate aldolase  
 
Pyruvate dehydrogenase E1 component  





DNA polymerase III subunit epsilon II 
 
Exodeoxyribonuclease 7 small subunit  
 
DNA helicase  








Acetyl-coenzyme A carboxylase carboxyl transferase 


















30S ribosomal protein S13 
 
30S ribosomal protein S3 
 
50S ribosomal protein L25  
 
30S ribosomal protein S7 
 










Protein GrpE  
 
Chaperone protein DnaJ 
 













Aspartate ammonia-lyase  
 
2-oxoglutarate dehydrogenase  
 




























































ABC transporte Energy-dependent translational throttle 
protein EttA 
ATP synthase gamma chain  
 
Glutamate--tRNA ligase  
 
ATP synthase subunit alpha  
 
Clp protease ClpX 
 
Transcription-repair-coupling factor  
 
DNA topoisomerase 4 subunit A  
 
Shikimate kinase  
 
Lon protease  
 
Isoleucine--tRNA ligase  
 
Macrolide export ATP-binding/permease protein 
MacB  
 
UvrABC system protein A  
 
Acetyl-coenzyme A carboxylase carboxyl transferase 
subunit beta  
 
Cell division protein FtsK 
 
Cysteine--tRNA ligase  
 
Glutathione synthetase  
 
Argininosuccinate synthase  
 
Phosphopantetheine adenylyltransferase  
 
Chromosomal replication initiator protein DnaA 
 
DNA helicase  
 
RecBCD enzyme subunit RecD  
 





DEAD/DEAH box helicase NGO_0650 
 
Multidrug ABC transporter ATP-binding protein 
 




















UvrABC system protein B  
 
Phosphoenolpyruvate synthase  
 
Chaperone protein ClpB 
 
10 kDa chaperonin  
 
Threonine--tRNA ligase  
 

































































Glutamate--tRNA ligase  
 
Protein GrpE  
 
Transcription-repair-coupling factor  
 
Shikimate kinase  
 
Lon protease  
 
Probable cytosol aminopeptidase  
 
Serine hydroxymethyltransferase  
 
Translation initiation factor IF-2 
 
Isoleucine--tRNA ligase  
 
Exodeoxyribonuclease 7 small subunit  
 
Peptide chain release factor 3  
 
UvrABC system protein A  
 
Cysteine--tRNA ligase  
 
Argininosuccinate synthase  
 
Phosphopantetheine adenylyltransferase  
 
Chromosomal replication initiator protein DnaA 
 
ATP phosphoribosyltransferase regulatory subunit 
 
DNA helicase  
 
Chaperone protein DnaJ 
 
Ribonuclease E  
 
Inorganic pyrophosphatase  
 
Ferric uptake regulation protein 
 
Ribosome maturation factor RimP 
 
Tyrosine--tRNA ligase  
 
UvrABC system protein B  
 
Chaperone protein ClpB 
 
10 kDa chaperonin  
 
Threonine--tRNA ligase  
 
































Molecular chaperone DnaJ 
 
Cell division protein ZipA 
 
Mechanosensitive ion channel family protein 
NGO_1771 
 
Macrolide export ATP-binding/permease protein 
MacB  
 




Protein translocase subunit SecE 
 
Heme biosynthesis protein HemY 
 
Multidrug ABC transporter ATP-binding protein 
 
RDD family protein 
 
Protein translocase subunit SecY 
Molecular 
function 




















Glutamate--tRNA ligase  
 
Isoleucine--tRNA ligase  
 
UvrABC system protein A  
 
Acetyl-coenzyme A carboxylase carboxyl transferase 
subunit beta  
 
Cysteine--tRNA ligase  
 
Chaperone protein DnaJ 
 
Ribonuclease E  
 
GTP cyclohydrolase-2  
 






















DNA polymerase III subunit epsilon II 
 
DNA topoisomerase 4 subunit A  
 
UvrABC system protein A  
 
Cell division protein FtsK 
 
DNA helicase  
 
DNA topoisomerase 1  
 
RecBCD enzyme subunit RecD  
 
DNA-directed RNA polymerase subunit beta'  
 

























DNA polymerase III subunit epsilon II 
 
Dihydroxy-acid dehydratase  
 




DNA topoisomerase 1  
 
Ferric uptake regulation protein 
 
Phosphoenolpyruvate synthase  
 
Pyruvate dehydrogenase E1 component  
 






















Ribonuclease E  
 
Tyrosine--tRNA ligase  
 

















ATP synthase gamma chain  
 
ATP synthase subunit alpha  
 
Cell division protein ZipA 
 
Macrolide export ATP-binding/permease protein 
MacB  
 
Protein translocase subunit SecE 
 
















ABC transporte Energy-dependent translational throttle 
protein EttA? 
 
Clp protease ClpX 
 
Macrolide export ATP-binding/permease protein 
MacB  
 
UvrABC system protein A  
 














Glutamate--tRNA ligase  
 
30S ribosomal protein S13 
 
Isoleucine--tRNA ligase  
 
30S ribosomal protein S7 
 


















30S ribosomal protein S13 
 
30S ribosomal protein S3 
 
50S ribosomal protein L25  
 
30S ribosomal protein S7 
 














30S ribosomal protein S13 
 
30S ribosomal protein S3 
 
50S ribosomal protein L25  
 
30S ribosomal protein S7 
 












30S ribosomal protein S13 
 
30S ribosomal protein S3 
 
30S ribosomal protein S7 
 













Shikimate kinase  
 
3,4-dihydroxy-2-butanone 4-phosphate synthase  
 
Ribonuclease E  
 












Translation initiation factor IF-2 
 
Peptide chain release factor 3  
 
GTP cyclohydrolase-2  
 










Protein GrpE  
 
Chaperone protein DnaJ 
 










30S ribosomal protein S13 
 
50S ribosomal protein L25  
 










Aspartate ammonia-lyase  
 
2-oxoglutarate dehydrogenase  
 


















DNA polymerase III subunit epsilon II 
 
Transcription-repair-coupling factor  
 
UvrABC system protein A  
 
DNA helicase  
 
DNA topoisomerase 1  
 
RecBCD enzyme subunit RecD  










Acetyl-coenzyme A carboxylase carboxyl transferase 




Respiratory L-Lactate dehydrogenase 
 
Phosphoenolpyruvate synthase  
 
Pyruvate dehydrogenase E1 component  











Phosphoenolpyruvate synthase  
 
Fructose-1,6-bisphosphate aldolase  







Pilus assembly protein PilM 
 
Pilus assembly/adherence protein PilC NGO_0055 
 
Protein translocase subunit SecE 
 
Protein translocase subunit SecY 





Ribosomal RNA large subunit methyltransferase J  
 
Ribonuclease E  
 
RluA family pseudouridine synthase 







Phosphoserine phosphatase SerB 
 
Threonine synthase  
 
Aspartokinase  







DNA polymerase III subunit epsilon II 
 
DNA topoisomerase 4 subunit A  
 
DNA topoisomerase 1  







Transcription-repair-coupling factor  
 
UvrABC system protein A  
 
DNA helicase  





Lon protease  
 















Multidrug ABC transporter ATP-binding protein 
 
Stringent starvation protein A 





Protein translocase subunit SecE 
 
Phospho-2-dehydro-3-deoxyheptonate aldolase  
 





Table 8.4 Acetylation sites of tRNA proteins in the three isogenic mutants of N. 
gonorrhoeae MS11 
Protein name Protein entry ΔackA Δpta Δhdac 
Alanine--tRNA ligase Q5F7C4 
K703, K831, K646, 






Arginine--tRNA ligase Q5F835 






K61, K386, K24, 
K456, K445 
K58, K472 K58 




K52 - - 
Glutamate--tRNA ligase Q5F5J8 
K425, K156, K428, 









K55, K58, K12 K12, K78 - 
Glutamyl-tRNA reductase Q9ZHD6 - K145 - 
Glycine--tRNA ligase alpha 
subunit 
Q5F4Y8 
K290 - - 
Glycine--tRNA ligase beta 
subunit 
Q5F4Y7 
K569, K378 K358, K569, 
K443 
- 
Isoleucine--tRNA ligase Q5FAF5 
K913 K424, K913, 
K280 
- 
Leucine--tRNA ligase Q5FAJ3 





Lysine--tRNA ligase Q5F6U2 K351 K165 - 




- K205 - 

















Proline--tRNA ligase Q5F938 








K120 - - 
Threonine--tRNA ligase Q5F9U4 K300, K323, K560 K323 - 


















K283, K570, K191, 
K489, K621, K105 
K191, K105 K570, 
K489 
Tryptophan--tRNA ligase Q5F7X0 K227, K219, K220 K227 - 
Tyrosine--tRNA ligase Q5FAF7 K82, K245, K234 K266, K245 - 
Valine--tRNA ligase Q5F5W0 











Figure 8.1 Ontologies of the possible target of HDAC. Heat map of gene ontologies and the 
enzymes classified as possible targets of HDAC. The terms correspond to the gene ontologies of biological 




Table 8.5 T-test analysis of growth in different carbon sources. The growth of the 




Glucose Lactate Pyruvate 
p  value Significance p  value Significance p  value Significance 
0 
ΔackA 0.0078 ** 0.0131 * 0.72915 ns 
Δpta 0.01244 * 0.0032 ** 0.57992 ns 
Δhdac 0.83495 ns 0.0754 ns 0.47679 ns 
1 
ΔackA 0.02549 * 9.40E-06 **** 0.02522 * 
Δpta 0.35928 ns 3.90E-06 **** 0.06052 ns 
Δhdac 0.90723 ns 0.6161 ns 0.52659 ns 
2 
ΔackA 0.0059 ** 0.0071 ** 0.00391 ** 
Δpta 0.01818 * 0.0068 ** 0.00481 ** 
Δhdac 0.01021 * 0.6311 ns 0.26542 ns 
3 
ΔackA 0.00031 *** 0.0438 * 0.00211 ** 
Δpta 0.00133 ** 0.0442 * 0.00068 *** 
Δhdac 0.03373 * 0.5802 ns 0.1378 ns 
4 
ΔackA 0.05263 ns 0.0624 ns 0.00112 ** 
Δpta 0.04246 * 0.0633 ns 0.00087 *** 
Δhdac 0.06692 ns 0.559 ns 0.16023 ns 
5 
ΔackA 0.14309 ns 0.044 * 0.00127 ** 
Δpta 0.06468 ns 0.0458 * 0.00148 ** 
Δhdac 0.07093 ns 0.3209 ns 0.18022 ns 
6 
ΔackA 0.34847 ns 0.0164 * 5.80E-05 **** 
Δpta 0.10656 ns 0.0175 * 4.30E-05 **** 
Δhdac 0.07813 ns 0.4604 ns 0.75285 ns 
7 
ΔackA 0.68511 ns 0.013 * 0.0002 *** 
Δpta 0.15478 ns 0.0145 * 0.0002 *** 
Δhdac 0.10733 ns 0.4645 ns 0.3038 ns 
8 
ΔackA 0.25729 ns 0.0228 * 0.00062 *** 
Δpta 0.04898 * 0.0312 * 0.00092 *** 
Δhdac 0.11266 ns 0.5298 ns 0.13682 ns 
9 
ΔackA 0.32928 ns 0.0368 * 0.0009 *** 
Δpta 0.1511 ns 0.0703 ns 0.00124 ** 
Δhdac 0.1535 ns 0.4857 ns 0.09689 ns 
10 
ΔackA 0.14549 ns 0.0431 * 0.00288 ** 
Δpta 0.07112 ns 0.0893 ns 0.00393 ** 







Figure 8.2 Construction of pLES2-GFP. a) Procedure for the construction of pLES2-GFP. gfp 
was amplified from pBHR1 by PCR, with primers containing the restriction sequence for BamHI. 
pLES2 and the PCR GFP product were digested with BamHI and then both were ligated. b) For 
the selection of the colonies with the plasmid, agar plates were located onto a UV transilluminator 
to prove the synthesis of GFP. At the top left corner is E. coli DH5α and E. coli XL1-Blue with 
any plasmid as controls; on the top right corner is E. coli DH5α with pBHR1-GFP showing 
fluorescence; and at the bottom are the 9 selected colonies after pLES2-GFP transformation, and 
the control (10). Colonies from 1-7 showed fluorescence and the colonies 2 and 7 were selected 
for PCR amplification and sequencing. c) Agarose electrophoresis gel. The pLES2 plasmid of 6.0 
kb (2) and the gfp PCR product (3), 1.1 kb, were ligated to form pLES2-GFP (4) of ≈7.1 kb. A 





Figure 8.3 Relative mRNA expression of genes involved in the virulence and metabolism of N. gonorrhoeae MS11. RNA was extracted from the neisserial 
strains and the relative mRNA expression was determined by RT-qPCR. The relative expression was calculated from the housekeeping gene 16S rRNA and the 
expression of the WT. Replicates were performed between 3-5 times for each gene. The significance and p value are shown on top of the graphs. ns, no 






Figure 8.4 Acetylation sites of two-component system proteins and virulence factors. The 
significant different lysine acetylation sites were identified. Each plot shows the protein name 
and locus. The tiles are fill with a gradient according to the fold change in acetylation. The 





Figure 8.5 Acetylation sites of transcriptional regulators. The significant different 
lysine acetylation sites were identified. Each plot shows the protein name and locus. The 
tiles are fill with a gradient according to the fold change in acetylation. The bar at the 





Figure 8.6 Construction of E. coli BL21 pET28a-pta-His6 for the overexpression 
of the phosphotransacetylase of N. gonorrhoeae. a) Workflow for the construction of 
E. coli BL21 pET28a-pta-6His. b) The gene pta was amplified by PCR adding the 
restriction sites for NcoI and BamHI, and the 6 His tag (pta-His6) for the purification of 
the protein. c) The plasmid pET28a and pta-His6 were digested with NcoI and BamHI 
and d) then ligated, e) for the transformation of E. coli XL1-Blue, used for the 
production of the plasmid. The plasmid was extracted and f) then the strain of E. coli 
BL21 was transformed with the plasmid for the expression of the protein. 1.5% agarose 
gels. The insert was amplified for validation using T7 primers. 
